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Abstract
Epidural opioids and local anesthetics may depress the neonatal reflexes necessary for
breastfeeding success. Literature review yielded no data for hydromorphone and conflicting
results for fentanyl. This study investigated whether breastfeeding effectiveness would be less in
infants whose mothers received epidural analgesia with hydromorphone compared with those
whose mothers received no analgesia, and whether the total amount of drugs given or the
presence of multiple stressful events or interventions would be related to the effectiveness of
breastfeeding.
Breastfeeding behaviors were studied in 51 infants whose mothers chose epidural analgesia
compared with 51 infants whose mothers chose to have no analgesia. Women with epidural
analgesia received 1.5% lidocaine with 1:200,000 epinephrine as a test dose and/or 0.25%
bupivacaine with 1:200,000 epinephrine as a bolus, and 100 µg hydromorphone followed by
continuous infusion of 0.05% bupivacaine with 3 µg/mL hydromorphone at 14 mL/hour. The
hospital setting strongly supported breastfeeding. Effectiveness of breastfeeding was measured
with the LATCH Breastfeeding Assessment Tool at 3, 12, and 24 hours after birth.

Cynthia Ann French – University of Connecticut, 2015

LATCH scores did not differ significantly between groups at any time point and were not
related to total amount of drugs administered. The presence of multiple stressful events and
interventions, e.g., long duration of labor, large amount of IV fluids, oxytocin administration,
induction of labor, and meconium staining/suctioning of the baby, did not significantly affect
breastfeeding behavior in the overall study population (n=102), altogether contributing not more
than 8% of the variability of LATCH scores in the regression model. The group receiving
epidural analgesia (n=51) had significantly longer duration of labor, higher rates of oxytocin
administration and induction of labor, and larger amounts of IV fluid administration. These
factors contributed approximately 30% of the variability of LATCH scores at 3 and 24 hours.
However, this finding was not significant.
Although the study was limited by its nonrandomized nature, these data indicate that, by
itself, epidural analgesia with hydromorphone does not decrease effectiveness of breastfeeding
behaviors. Epidural analgesia increases risk of multiple stressful events or interventions, which
may contribute to breastfeeding difficulties and necessitate intensive help from the nurse to
achieve success in breastfeeding.
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Chapter 1: Introduction
Chapter one provides background information on the importance of breastfeeding and the
nurse’s role in supporting mothers who breastfeed. The chapter describes the problem presented
by potential negative effects of epidural analgesia on breastfeeding and discusses the significance
and rationale for studying the effects of labor epidural analgesia with hydromorphone. The
chapter also defines key terms; discusses the theoretical framework, assumptions of the
researcher, study purpose, and specific research questions; and gives an overview of the study
methods.
The benefits of breastfeeding to mother and neonate in both the short- and long-term are
significant. Infants who are breastfed have a lower risk of respiratory tract infections, necrotizing
enterocolitis, sudden infant death, asthma, diabetes, leukemia, and lymphoma, as well as
improved neurodevelopment outcomes (Eidelman, 2012). Maternal benefits of breastfeeding in
the short term include decreased postpartum blood loss and more rapid involution of the uterus.
Long-term maternal benefits include decreased risk of hypertension, diabetes, and ovarian and
breast cancer (Eidelman, 2012). The American Academy of Pediatrics (AAP) recommends
exclusive breastfeeding for about 6 months, with continuation up to 1 year or more (Eidelman,
2012). The American College of Obstetrics and Gynecologists (ACOG) also supports this
recommendation (American College of Obstetricians and Gynecologists, 2007).
Because the benefits of breastfeeding are well known, the rates in the United States
continue to rise. According to the 2014 Breastfeeding Report Card issued by the Centers for
Disease Control and Prevention, 79% of infants born in the United States started to breastfeed
(Centers for Disease Control, 2014). Yet the duration of breastfeeding was not as long as
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recommended by the AAP and ACOG: According to the 2014 report card, 49% of infants were
breastfeeding at 6 months and 27% at 12 months (Centers for Disease Control, 2014). The
reasons cited in the literature for early cessation of breastfeeding are varied. However, it has
been consistently reported that mothers who perceive breastfeeding initiation as problematic are
more likely to wean than those who perceived breastfeeding as non-problematic (Leff, Gagne, &
Jefferis, 1994; Matthews, 1991). The goal of Healthy People 2020 is to increase the proportion of
infants who start to breastfeed to 81.9%, continue to breastfeed at 6 months, 60.6%; and at 1
year, 34.1% (CDC BF Report Card 2014).
The literature identifies multiple factors affecting the initiation of breastfeeding, including
milk insufficiency, sore nipples, discontented crying baby, socioeconomic status, social support,
social norms, and hospital practices (American College of Obstetricians and Gynecologists,
2013). One consistent factor is that women who perceive breastfeeding as difficult, no matter the
reason, are more likely to stop breastfeeding during the first week postpartum than women who
perceive no problems (Leff et al., 1994). If breastfeeding is established in the first hours after
delivery, many of these factors can be overcome to improve breastfeeding success and duration.
The Nurse’s Role in Supporting Breastfeeding
In the US, 98% of all births occur in a hospital where nurses are the primary caregiver
supporting women through labor, birth and discharge home (AWHONN, 2015). Nurses have a
crucial role in preparing, educating supporting women to breastfeed and are instrumental in
facilitating the initiation and continuation of breastfeeding.
Nurses are in a unique position to provide an environment conducive to breastfeeding
initiation in the immediate postpartum period. The profession of nursing has always had the goal
of using knowledge to advance the goals of the health of people in their environment.
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Breastfeeding places the mother and infant in the best possible situation of health. Given the
benefits of breastfeeding and the recommendations for its promotion, nurses should help nature
by providing an environment that is conducive to breastfeeding success. The nurse’s knowledge
and attitude are crucial. To succeed at providing an optimal environment for nature to act on
breastfeeding, nurses must know which factors are beneficial and which factors are detrimental
to establishing effective breastfeeding. Thus, nurses and other health care providers who care for
mother/infant dyads should acquire the knowledge and competence to provide evidence-based
breastfeeding information and support throughout the preconception, prenatal, and postpartum
periods.
Statement of the Problem
One factor that may affect the success of early breastfeeding is the administration of pain
medicine during labor. The advent of labor epidural analgesia allowed small amounts of
narcotics to be placed directly into the epidural space instead of high doses of opioids
administered systemically, thus providing intense pain relief without depression of the central
nervous system (CNS). Epidural analgesia has been shown to provide more effective pain relief
during labor than other types of pain medication (Anim-Somuah, Smyth, & Jones, 2011), and its
use during labor has increased exponentially over the past few decades. It was estimated that in
2001, 77% of infants born in the United States were exposed to epidural analgesia during labor
and birth, a rise from 21% in 1981 (Bucklin, Hawkins, Anderson, & Ullrich, 2005). However,
epidural analgesia may be a barrier to breastfeeding success.
The most common drugs used for epidural analgesia contain a combination of local
anesthetics with an opioid, which may affect neonatal behavior. To establish lactation, the
neonate must be awake, alert, and able to latch on to the breast and suck, swallow, and breathe in
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a coordinated pattern in order to express milk from the breast (Auerbach, 1988; Kuhnert, Linn, &
Kuhnert, 1985; L'Esperance & Frantz, 1985; Lawrence & Lawrence, 2011; Marmet & Shell,
1984; Neifert & Seacat, 1986; Shrago & Bocar, 1989). Epidural opioids and local anesthetics are
known to readily cross the placenta (Reynolds, 1991) and may depress these reflexes (Chang &
Heaman, 2005), thus decreasing the likelihood of breastfeeding success. However, despite 35
years of research, scientists still cannot unequivocally answer the question of whether maternal
use of labor epidural analgesia affects the success of breastfeeding (French, Cong, & Chung, in
press). Therefore, it is imperative to continue to investigate whether maternal epidural analgesia
affects early establishment of breastfeeding behaviors.
Rationale and Significance of the Study
Bupivacaine is the standard local anesthetic used for labor epidural analgesia and is
commonly combined with fentanyl. The dosage frequently used in this setting for continuous
labor epidural infusions is 0.125% bupivacaine with 2-3 µg/mL fentanyl. The results of research
on effects of epidural analgesia with these drugs on breastfeeding so far remain inconclusive. For
example, two studies have shown an adverse effect of increasing doses of fentanyl on the success
of breastfeeding (Beilin et al., 2005; Jordan, Emery, Bradshaw, Watkins, & Friswell, 2005),
although another study showed no effect (Wieczorek, Guest, Balki, Shah, & Carvalho, 2010).
At Yale New Haven Hospital, the standard protocol for otherwise healthy parturients who
request epidural analgesia for vaginal delivery calls for continuous infusion of 0.05%
bupivacaine with 3 g/mL hydromorphone instead of fentanyl. Hydromorphone has not been
widely accepted in the management of pain in the obstetric setting. However, clinical evidence
suggests its safety and efficacy in management of labor pain (Sinatra et al., 2002; Sinatra, Levin,
& Ocampo, 2000). Hydromorphone has been used at Yale New Haven Hospital in continuous
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labor epidurals since the 1990s and is believed to exhibit the pharmacodynamics necessary to
promote analgesia without the clinically significant adverse effects—such as excessive maternal
sedation, profound hypotension, respiratory depression, sensory motor blockade, and severe fetal
bradycardia—that are seen with traditional opioid infusions (Sinatra et al., 2000). The use of
hydromorphone as the narcotic in the epidural infusion appears to represent a promising
alternative to fentanyl and may deliver acceptable analgesia without the unintended side effects
seen with traditional opioid infusions. If so, neonates whose mothers received labor epidural
analgesia with hydromorphone and those whose mothers did not receive labor analgesia may
show similar breastfeeding behaviors and neurobehavior. No data on hydromorphone and
breastfeeding are available. Thus, a study comparing infants whose mothers received labor
epidural analgesia containing hydromorphone with infants whose mothers received no labor
analgesia would provide valuable information needed to decide whether to use epidural analgesia
during labor.
Definition of Key Terms
The key terms used in the study are defined as follows:
Breastfeeding
The failure of many studies to define terms relating to breastfeeding has led to
misinterpretation of data and difficulty of comparisons across studies. In an attempt to provide
consistent terminology for researchers and agencies involved in breastfeeding, Labbok and
Krasovec recommended the terms full, partial, and token to describe the types of breastfeeding
behaviors (Labbok & Krasovec, 1990). For this study breastfeeding was defined as the process
by which milk is expressed from the lactiferous sinuses in the nipple of the breast, by the
compression of the soft palate by rhythmic pulsations of the infants tongue (Weber, Woolridge,
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& Baum, 1986). Exclusive breastfeeding was defined as the infant taking all nourishment from
the breast, with no other liquid or solid consumed.
Breastfeeding Behaviors
Breastfeeding behaviors are a series of suckling behaviors necessary for the infant to draw
the nipple into the mouth, remove the milk, and consume the milk. Breastfeeding behaviors
include latching on to the breast, sucking, swallowing, and breathing in a coordinated pattern in
order to express milk from the breast (Lawrence & Lawrence, 2011). The coordination of tongue
movements, swallowing, and breathing was described by Bu'Lock and colleagues (Bu'Lock,
Woolridge, & Baum, 1990), based on the historic cineradiographic studies of Ardran and
colleagues (Ardran, Kemp, & Lind, 1958), with confirmation by the ultrasound studies of Weber
(Weber et al., 1986). “A bolus of fluid is delivered to the pharynx by a phased application of the
dorsum of the tongue to the nipple or teat in an anteroposterior peristaltic wave of contraction.
Coordinated movement of the mandible and apposition of the gums traps the milk in the lacteal
sinuses of the breast or teat of the bottle. Milk is then expressed by the teat, into the pharynx.
From the pharynx, a series of reflex muscular contractions and relaxations transfer milk into the
oesophagus and onward into the stomach by peristalsis. At the same time milk is prevented from
entering the nasal/tracheal airway by elevation of the soft palate and closure of the larynx”
(Bu'Lock et al., 1990).
The LATCH Breastfeeding Assessment Tool is a charting system that provides a systematic
method for measuring breastfeeding behaviors in individual breastfeeding sessions (D. Jensen,
Wallace, & Kelsay, 1994).
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Epidural Analgesia
Epidural analgesia involves placement of an indwelling catheter placed in the epidural
space of the lower lumbar spinal column for pain management. Continuous infusions of local
anesthetic and opioids provide pain relief and allow sufficient motor function for labor patients.
For this study an infusion of bupivacaine and hydromorphone were used for labor and delivery.
Neonatal Neurobehaviors
Neonatal neurobehaviors are physiologic and behavioral patterns that measure function of
the CNS. The Neurologic and Adaptive Capacity Score (NACS) is a screening test for full-term
neonates to detect CNS depression from drugs and also to differentiate these effects from those
found after birth trauma and perinatal asphyxia (Amiel-Tison et al., 1982b).
Theoretical Framework of the Study
The theoretical framework of this study is rooted in Brazelton’s theory that neonates exist
in six newborn behavioral states and cycle through these states on a continuum at all times
(Brazelton & Nugent, 2011). The neonate’s skill in organizing these behavior states determines
the ability to accomplish developmental tasks such as feeding, as well as forming relationships
and learning about the world (Gottesman, 1999). Factors that negatively affect the CNS and lead
to a disorganized behavioral state may hinder the effectiveness of breastfeeding (Karl, 2004;
Radzyminski, 2005).
Brazelton’s Newborn Behavioral States
Brazelton’s newborn behavioral states include two sleep states (deep or quiet sleep and
light or active sleep), a transitional state (drowsy); and three alert states (quiet alert, active alert,
and crying). Each state has identifiable behaviors, and as an infant’s state changes, its
physiological and behavioral patterns change as well (Brazelton & Nugent, 2011). For instance,
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when the baby moves from sleep state to crying, autonomic functions such as respiratory rate and
heart rate increase, muscle tone increases, and reflexes become stronger (Brazelton & Nugent,
2011; Karl, 2004). As the neonate moves from alert to crying, smooth movements of the body
transition to jerky disorganized movements, often accompanied by tremors. During quiet alert,
alertness is at its peak; however, responsiveness diminishes during the active alert state and
completely disappears with crying as the neonate is no longer cued into the environment.
The neonate’s ability to achieve the quiet alert state is important, because this is when the
neonate is able to accomplish new tasks (White, Simon, & Bryan, 2002). The neonate is
responsive to environmental stimuli, and more likely to be able to make eye contact and interact
with others during the quiet alert state. The neonate may respond to voices or animate objects,
letting the parent know the neonate is a capable and willing participant.
Newborns who are unable to experience state organization have greater difficulty with
important undertakings such as latching on to the breast and making eye contact with their
parent. Neonates who are neurologically intact experience states in defined organizational
patterns. The patterns are consistent with developmental success (Brazelton & Nugent, 2011).
Each state has a particularly purpose, and an infant that is organized uses all the behavioral
states. For instance, crying signals for needs, sleep is for rest and recovery and quiet alert is for
learning and interacting (Karl, 2004). Active alert and drowsiness are transitional states that
signal where the neonate has been and where they are going on the behavioral continuum.
Neonates who use all states accomplish tasks with less difficulty than infants who linger in one
state with the exclusion of others (Karl, 2004).
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CNS Integrity
The neonate’s ability to achieve behavioral organization of state, muscle tone, and sucking
reflexes depends on CNS integrity. Neonatal behaviors such as sucking represent a measure of
CNS function (behavioral organization) and suggest the infant has achieved the level of maturity
required for effective oral feeding (Radzyminski, 2005). A delayed CNS response can manifest
itself as difficulty latching on or as an uncoordinated suck/swallow reflex.
Breastfeeding behaviors are a series of complex interactive maternal and neonatal
behaviors typically involving rooting, sucking, and swallowing by the infant and milk ejection
by the mother. Milk production and milk let-down are induced by maternal hormonal changes
that occur with labor, birth, and delivery of the placenta. Neonates are born with an instinct to
root, latch on to, and suck the breast. When the infant sucks, afferent impulses from sensory
stimulation of nerves on the areola travel to the mother’s CNS, where they promote the release of
oxytocin from the posterior pituitary. In women, oxytocin release is often associated with the
sight, sound, or even thought of their infant, indicating a psychological component of the
neuroendocrine reflex (Neville, 2001). The mother must have all the functioning anatomical
components to allow passage of milk from the alveoli into the ducts and the subareolar sinuses.
For the neonate, sucking is a complex motor and behavioral skill. For the infant to successfully
suck, the brainstem pathway must be intact and impulses must be transmitted through cranial
nerves to healthy musculature of the tongue, mouth, and pharynx. To suck, the lips close around
the nipple or breast, and the tongue seals the pharynx posterior forming a closed intraoral cavity.
Successful breastfeeding behavior requires coordinated intraoral movements of the rhythm of
sucking, breathing, and swallowing in synchronicity, with the mother allowing the pressure to
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carry milk into the infant’s mouth (Bu'Lock et al., 1990). The sinuses refill as the action of
oxytocin continues to force milk from the alveoli to the ducts.
On the one hand, epidural analgesia preserves the beneficial stress response of the fetus to
labor and reverses the negative maternal physiological and biochemical changes of labor
(Westgren, Lindahl, & Norden, 1986). In this respect, epidural analgesia may exert a positive
influence on breastfeeding. On the other hand, epidural analgesia may also negatively affect
breastfeeding success. Studies on the impact of labor epidural analgesia have noted subtle
changes in the CNS function of neonates whose mothers received continuous epidural infusions
containing a narcotic (Beilin et al., 2005; Loftus, Hill, & Cohen, 1995). These changes may
influence breastfeeding behaviors. Thus, epidural analgesia may impair the CNS response,
decreasing the likelihood of successful breastfeeding.
Various other factors during labor and delivery may affect CNS integrity in the newborn
and thus influence the success of breastfeeding. The overwhelming physiologic stress in labor
experienced by the mother can cause physiologic stress to the fetus, which may delay the infant’s
initiation of breastfeeding at birth (Montgomery, Hale, & Academy of Breastfeeding Medicine,
2012). Furthermore, in addition to the direct negative effects of epidural analgesia on neonatal
behavior, epidural analgesia may indirectly decrease the success of breastfeeding through its
effects on the labor process and maternal condition. A 2011 Cochrane review analyzed 38 of the
most rigorous studies on epidural analgesia and concluded that, compared with other methods of
pain relief, epidural analgesia was associated with significantly longer second stage of labor,
higher rates of instrumental delivery, increased use of oxytocin to augment labor, lower maternal
blood pressure, and increased risks of motor blockade and maternal fever (Anim-Somuah et al.,
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2011). The combination of these factors may account for at least a portion of any negative effects
of epidural analgesia on the success of breastfeeding.
Researcher Assumptions
The premise of the study was that fetal exposure to epidurally administered opioids used
for maternal labor pain may affect breastfeeding by interrupting the neonate’s CNS. Specifically,
the effects of epidural hydromorphone have never been investigated. The neonate may be
impaired to the point of being unable to initiate breastfeeding behaviors that are crucial for
lactogenesis to occur during the first 24 hours postpartum. The neonate must possess the ability
to latch onto the breast and suck in a coordinated matter for breastfeeding to successfully occur.
The underlying assumptions were:


The defining characteristic of mammals is the provision of milk which is a fluid
composition of exactly what the young of the species needs.



The young of the mammalian species are born with the innate ability to suckle known as
breastfeeding behaviors.



Humans are mammals and lactation is critical to the development, growth and survival of
mammalian species.



In order for the mother to produce milk the neonate must suckle at the breast.



Many intrapartum and postpartum factors can influence the ability of the neonate to suck
at the breast.



An intact CNS is necessary for the neonate to exhibit breastfeeding behaviors that
produce correct suckling for milk removal.



An impaired CNS with depression of the neonate will interfere with these breastfeeding
behaviors.
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Purpose of the Study and Research Questions
The primary purpose of this study was to determine whether a relationship exists between
labor epidural analgesia containing hydromorphone and breastfeeding behaviors the first 24
hours postpartum. The addition of this knowledge is expected to give healthcare workers the
information needed to assist new mothers in making informed decisions related to their care, find
effective techniques for managing these issues, and enable provision of breastfeeding support to
women who need it postpartum.
Based on current knowledge from review of the literature, the following specific research
questions were formulated:
1) Does the administration of epidural analgesia with hydromorphone to the mother for labor
pain have a negative effect on breastfeeding behaviors in healthy term infants?
2) Is the duration of infusion/amount of drug given for epidural analgesia with
hydromorphone for labor pain in the mother negatively related to effectiveness of
breastfeeding behaviors in healthy term infants?
3) During labor or immediately after birth, is the presence of multiple stressful events or
interventions that may affect the condition of the mother or infant during labor (e.g.,
oxytocin administration, induction of labor, ruptured membranes, total amount of
intravenous fluids administered, longer long duration of labor, meconium staining, and
need for baby suctioning) negatively related to the effectiveness of breastfeeding behaviors
in healthy term infants?
Overview of Methodology
A prospective observational cohort study was performed to gather data in answer to these
questions. The study assessed breastfeeding behaviors in neonates whose mothers received a
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continuous epidural infusion containing bupivacaine (local anesthetic) and hydromorphone
(narcotic) for labor pain compared with infants whose mothers received no analgesia during
labor and delivery. The neonate’s ability to feed was measured at 3, 12, and 24 hours after birth
by the LATCH Breastfeeding Assessment Tool (D. Jensen et al., 1994).
Organization of the Dissertation
This dissertation is organized into five chapters. Chapter 1 provided background on the
importance of breastfeeding and the nurse’s role in fostering its success. The problem to be
addressed in this research is that, because of potential effects on the CNS of the neonate, epidural
analgesia for labor pain management may be detrimental to the success of breastfeeding.
Research on this subject has remained inconclusive; in particular, no data exist regarding the
effects of epidural analgesia with hydromorphone. Therefore, the purpose of the study was to
determine whether a relationship exists between labor epidural analgesia containing
hydromorphone and breastfeeding behaviors the first 24 hours postpartum.
Chapter 2 reviews the literature on the history, physiology, and benefits of breastfeeding
and the factors that influence its success, including epidural analgesia during labor and other
maternal or neonatal variables that may interfere with breastfeeding initiation. Chapter 3 presents
the research design and describe the selection of subjects, the setting of the study, the study
procedures and methods used for data collection and analysis, and the methods used to ensure
rigor of the study and protection of human subjects. Chapter 4 describes the findings of the
study. Chapter 5 discusses the results in relation to the study aims and in the context of the
literature review, as well as the study limitations and implications for nurses and other health
care providers.
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Chapter 2: Review of the Literature
To provide background for the study, Chapter 2 reviews the literature on the history and
physiology of breastfeeding, the benefits breastfeeding provides to the infant, the mother, and the
public, and factors that influence its success. The chapter also reviews literature on
pathophysiology and factors that influence labor pain, analgesia during labor, including epidural
analgesia, and other maternal or neonatal variables that may interfere with breastfeeding
initiation. It should be noted that in some areas older references were included because of their
significance as classics works, or because no more current research on the topic exists.
History of Breastfeeding
Breastfeeding throughout history has been shaped by cultural values, beliefs, and customs.
From prehistoric times to the preindustrial period found customs varied little and the likely
survival of the infant was related to breastfeeding or by utilizing a wet nurse as a substitute.
When a wet nurse was not available, infants were suckled directly on animal udders, given milk
using a vessel, or given pre-chewed foods that were poor in nutrients and contaminated, which
caused high mortality rates (Diez Castilho & de Azevedo Barros Filho, 2010; Fildes, 1986).
During prehistoric times when humans hunted and gathered their food, if a woman could
not breastfeed her child, the child died unless another woman took her place. It is thought at that
time the child would breastfeed until they were able to find their own food. Even the Neolithic
period, when humans began planting, harvesting and raising livestock, it would still be a long
time before animals would be milked (Colon & Colon, 1999; Diez Castilho & de Azevedo
Barros Filho, 2010). With the formation of domestic herds, children survived after they were
given animal milk with a vessel or directly on the animal udder (Diez Castilho & de Azevedo
Barros Filho, 2010; Fildes, 1986; Greenberg, 1980).
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From about 1800 BC, regulations on the practice of wet nursing were contained in
Hammurabi's Code. Feeding cups were found throughout Europe and Greece in the graves of
infants dating from 2000 BC. Even the story of Moses in the Old Testament describes Hebrews
and Egyptians utilizing wet nurses for the survival of infants separated from their mothers (Diez
Castilho & de Azevedo Barros Filho, 2010). In 200 BC, teachings in the Talmud emphasized that
breastfeeding during the first 2 years of life was important to the preservation of life (Fildes,
1986). The people of Mesopotamia, Hebron, and Egypt cared for their children in the same way
for millennium despite their cultural differences (Colon & Colon, 1999; Fildes, 1986). Children
were considered divine gifts from God. After Egypt was dominated by Rome, the Greco-Roman
culture came to prevail and children lost their value. The problem of abandoned children during
this time paralleled information about feeding techniques. Families would contract wet nurses,
who took the children into their own homes and return them years later. In fact so many infants
were abandoned during the time of the early popes in Rome, foundling homes were started. This
custom spread through the Greek and Roman Empire and throughout Europe (Lawrence &
Lawrence, 2011).
In the 1700's French foundling homes were staffed by carefully selected wet nurses, whose
lives were monitored to insure proper nutrition for the abandoned infants (Lawrence &
Lawrence, 2011). Infant feeding habits changed when it was discovered that infants fed goat or
mule milk in the Foundling Hospitals or who were given substitute foods did not survive as long
as infants given breast milk (Fildes, 1986). After “infirmaries” were set up, the relationship was
confirmed when mothers breastfed during the first few days immediately after delivery and
onwards (Colon & Colon, 1999).
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Wealthy Englishwomen did not nurse their infants from A.D. 1500 to 1700 (Fildes, 1986).
It was well known in Great Britain during this time that breastfeeding was a means to delay
another pregnancy, however these women preferred to have 12-20 babies rather than breastfeed
them (Yalom, 1997). They believed breastfeeding aged them and ruined their figures. Wet nurses
were soon replaced by cereal or bread gruel fed to infants from a spoon. The death rate was close
to 100% in the foundling homes that practiced this feeding technique.
From the 15th through the 18th century, as poor rural women who had breastfed their own
children as well as those of wealthy women moved to the city, century-old feeding practices
changed. In this era no method for preserving fresh milk had been discovered yet, so other foods
were introduced earlier. During this time, mothers started to prefer giving “paps” and “bread
sops” rather than having wet nurses (Diez Castilho & de Azevedo Barros Filho, 2010). The first
recipes for this were recorded in the 15th century. The recipe called for the use of a liquid, beer,
wine, vegetable or meat stock, water, a cereal, bread, rice, wheat or flour, and an additive sugar,
meat, eggs, honey, spices, herbs, or meat (Colon & Colon, 1999; Fildes, 1986). Mortality rates of
100% during the first week of life were reported with pap feeding (Radbill, 1981).
The American Industrial revolution saw identical changes in feeding practices.
Urbanization changed the way families lived; they needed money for survival because they were
no longer farming and raising livestock for sustenance. The living conditions were poor, with
people crowded together in slums with little hygiene. Labor was exploited through low wages
and women were forced to work. There were few wet nurses and little money to pay for them.
Infants were left at home and cared for by elderly women or very young girls who fed them an
array of artificial foods, some of which were laced with opiates so the infants would sleep until
the mothers returned home (Fildes, 1986). These areas contained the highest rates of infant
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malnutrition, morbidity and mortality in the country (Fildes, 1986). Rural areas, which
maintained a 90% breastfeeding rate, with duration of breastfeeding 6 months or greater, had the
lowest infant mortality (Fildes, 1986).
During the 20th century there were dramatic changes in the way infants were fed (A. L.
Wright & Schanler, 2001). In the early 1900s, approximately two-thirds of mothers breastfed
(Hirschman & Butler, 1981). Then both the incidence and duration of breastfeeding began to
decline, dropping from almost 70% of women in 1911-1915 to about 50% in 1926-1930, and
only 25% in 1946-1950 (Hirschman & Butler, 1981). The lowest level was reached in 1972,
when only 22% of women breastfed (Eckhardt & Hendersgot, 1984).
The 20th century was a time of unprecedented cultural, technological, and social changes
involving the roles of women, their education and income and their childbirth practices.
Beginning in the 1920's the emancipation of women was symbolized by short skirts, short hair,
birth control, cigarette smoking, and bottle feeding (Lawrence & Lawrence, 2011). The early
portion of the 20th century also brought the development of formula milk and the use of milk
from other mammals to feed infants, a move away from breastfeeding (Radbill, 1981).
Sterilization practices improved which resulted in significant drops in mortality to infants who
were not breastfed (Barness, 1987). After WWII there was an increase in commercially prepared
infant formula and women were entering the work force.
During the 1930s, medical societies no longer stressed the importance of breastfeeding and
came to the believe in the healthfulness of formula for infants. Bottle feeding directions for
commercial or home use came from the physician or physician surrogate, such as a nurse (Apple,
1994). Women acted on the belief that what the medical community recommended was best for
the baby. At the same time, cow's milk was being introduced earlier and earlier, with a further
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decrease in breastfeeding rates between 1930 and 1970 (Fomon, 2001; Jelliffe & Jelliffe, 1978)
Commercial formula was often used only for a short time because of the expense compared with
cow's milk (Fomon, 2001).
In the 1940's formula was made at home mixing water with pasteurized cow's milk or
evaporated milk with sucrose or corn syrup. The processed milk was fortified with vitamin D,
and children could be given juice which contained vitamin C thereby eliminating the threat of
scurvy or rickets. Medical doctors at that time felt there was no difference between breastfeeding
and formula regarding safety or satisfaction (Fomon, 2001).
At the start of the 20th century, laboratories were investing in the development of a good
substitute for breast milk, producing modified milks or industrial formula. It was becoming
increasingly difficult even for physicians to choose an appropriate formula because there were so
many options on the market. With WWII causing birth rates to fall, manufacturers wanting to
increase profits started a promotion of breast milk substitutes (Rea, 1990). After the war, in
response to huge advertising campaigns and with the baby boom sales increased and formula
dominated between 1950 and1960. Interestingly, in 1956, as women who wanted to breastfeed
were met with resistance from the medical profession the La Leche League was formed in
Chicago to provide mothers with support to breastfeed. Women wanted to be informed and many
wanted the right to choose how they would feed their infants.
The feminist movement and the contraceptive pill caused birth rates to fall again in 1960.
The attitude of the female breast changed from one of the ability to nurture to the breast as a sex
object. Feeding bottles became symbols of women's liberation (Diez Castilho & de Azevedo
Barros Filho, 2010). The food industry increased its advertising diversifying even more and
expanded into the third world (Rea, 1990). Composition of the formula was also changing based
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on new discoveries in nutrition with manufacturers increasing sales by promoting their formulas
advantage over similar products at reduced costs (Diez Castilho & de Azevedo Barros Filho,
2010; Fomon, 2001; Jelliffe & Jelliffe, 1978). All these changes caused breastfeeding rates to
drop and the increased use of supplementation reaching the nadir in 1972 of only 22% of US
women breastfeeding (Eckhardt & Hendersgot, 1984).
In 1978, Dr Derrick Jelliffe coined the term “commerciogenic malnutrition” to refer to the
infant starvation caused by the promotion and use of infant formula in areas of poor water
supplies and low income, triggering a renewed interest in the promotion and practice of
breastfeeding on an international level (Jelliffe & Jelliffe, 1978). Increased awareness of the
health consequences of corporate promotion of infant formula led to the “Baby Killers Scandal”
and the boycott of Nestle, because of accusations that industry was using aggressive advertising
campaigns and interfering with breastfeeding (Joseph, 1981). The prevailing mentality began to
change in the 1970s, shifting to support breastfeeding in.
Physiology of Breastfeeding
Anatomy
Complex neuroendocrine reflex responses are involved in mammary gland growth, the
production of breast milk, the removal of milk, and the maintenance of lactation. The human
breast is composed of glandular (secretory) tissue and fat tissue and is supported by loose
connective tissue. The breast is made up of 15-20 lobes that extend from the nipple to the wall of
the thorax in a tree like fashion. The lobes are composed of lobules which each contain between
10-100 alveoli. It is thought that 15- 25 ducts drain the alveoli. Alveoli join their ducts
(intralobular ducts), forming a distinct lobar duct, which then converges separately to the nipple
via lactiferous ducts. The lactiferous ducts open into lactiferous sinuses on the surface of the
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nipple that serve as small reservoirs for milk (Buhimschi, 2004). Alveoli are composed of
epithelial cells, myoepithelial cells, contractile cells for milk ejection and connective tissue that
contains fat and a generous blood supply (Neville, 2001). The interstitial space is where plasma
cells are formed which secrete immunoglobulin's into milk during lactation. Milk is constantly
secreted into the alveolar lumina and stored, until the let-down reflex causes the myoepithelial
cells to contract and milk is ejected (Neville, Morton, & Umemura, 2001). The hormones of
pregnancy contribute to complete alveolar-lobular development (mammogenesis) and maturation
of the epithelium (lactogenesis).
Lactogenesis
Lactogenesis refers to the evolution of the mammary gland as it develops the ability to
secrete milk. Progesterone and prolactin are necessary for the final steps of mammary growth
and secretory differentiation which begins with a rise in mRNA for milk proteins and enzymes
important for milk formation and secretion (E. Jones & Spencer, 2007; Neville & Morton, 2001).
The secretory differentiation is known as stage I lactogenesis and occurs at midpoint of the
pregnancy. During this stage the mammary gland has developed extensive lobular clusters and
secretes small amounts of milk, the gland continues to grow until parturition, with milk secretion
held in place by the high levels of progesterone in the blood (Kuhn, 1969; Neville, McFadden, &
Forsyth, 2002).
After delivery of the neonate and the expulsion of the placenta there is a sudden drop in
progesterone, estrogen and placental lactogen levels and a simultaneous rise in prolactin levels.
The sudden drop in progesterone levels and concurrent rise in prolactin levels prompt
lactogenesis II which is the onset of copious milk secretion and occurs at 30-40 hours
postpartum. Mothers do not typically notice the sensation of full breasts until 50-73 hours after
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birth. The milk composition also changes significantly at this time with a decrease in sodium and
chloride concentration and an increase in lactose concentration which is complete usually by 72
hours after delivery (E. Jones & Spencer, 2007; Neville et al., 1991). Immunoglobulin IgA and
lactoferrin rise substantially during this period after delivery and despite their concentration
decline due to the increased milk production, the secretion rate remains significant the duration
of lactation. Lactogenesis II is hormonally driven and milk removal is not necessary during this
phase for most women (Kulski, Hartmann, Martin, & Smith, 1978). Nonetheless, the milk must
be removed by day 3 for lactation to continue successfully.
Prolactin is crucial to milk synthesis, as shown in a study that intentionally inhibited
prolactin using bromocriptine(Peters, Del Pozo, Conti, & Breckwoldt, 1986). Prolactin is found
in the lactating breast and in milk and the prolactin in milk originates in the pituitary lactotroph
(Buts, 1998; Nolin & Witorsch, 1976). Pituitary lactotrophs have automatic secretory action (M.
E. Freeman, Kanyicska, Lerant, & Nagy, 2000), and the pituitary gland functions primarily under
a hypothalamic dopamine inhibitory effect. The most important stimuli for prolactin release are
high levels of estrogen and suckling stimulus (de Greef, Plotsky, & Neill, 1981; Neill, Freeman,
& Tillson, 1971). Estrogen levels decline after delivery of the fetus and placenta, therefore it is
necessary for frequent suckling at this time to maintain elevated prolactin levels that are crucial
for milk synthesis. Dopamine inhibits prolactin release, but the stimulation of suckling interferes
with the inhibitory response (de Greef et al., 1981). Evidence suggests the release of prolactin
occurs via a neurogenic pathway from nipple to hypothalamus, with the amount released related
to the number of breastfeeding sessions and the strength of the mechanical suckling. Further
evidence backs catecholamine and serotonin control on the prolactin release and the
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consequences of changes in the hypothalamic dopamine turnover (de Greef et al., 1981; Tyson,
1977).
Oxytocin and Milk Ejection
Removal of milk from the breast is accomplished by contraction of the myoepithelial cells
which the processes of form a basket like network around the alveoli where the milk is stored
(Neville, 2001). When neonates are suckled, afferent impulses from sensory stimulation of nerve
terminals in the areolas travel through the CNS, where they promote release of oxytocin from the
posterior pituitary gland (Neville, 2001). Oxytocin release in women has been associated with
stimuli such as the thought, sight, or sound of the infant, illustrating a substantial psychological
component of the neuroendocrine reflex. The oxytocin travels through the blood stream to the
mammary gland, where it interacts with specific receptors on myoepithelial cells, initiating the
contraction and the expulsion of milk from the alveoli into the ducts (Neville, 2001). The
passage of milk into the ducts is aided by myoepithelial cell possesses which are arranged
longitudinally that shorten and widen during contraction and allow the milk to flow freely to the
nipple. The process by which the milk is forced through the alveoli is milk ejection or let-down
and is necessary for the removal of milk from the lactating breast.
The release of oxytocin is necessary for milk removal and only the mechanical forces of
suckling can remove it (Neville, 2001). Removal of the milk is necessary to continued milk
secretion. When milk ejection is inhibited, milk cannot be removed from the breast and cells
cease milk secretion. The mammary gland loses its ability to secrete milk when milk removal
stops completely. Therefore, frequent suckling combined with adequate milk ejection,
demonstrates the most crucial stimuli needed for milk production.
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Human Milk Composition
It is important to outline the significance of breast milk to infant and mother as part of a
review on breastfeeding. The composition of human breast milk is biologically uniquely suited to
the nutritional needs of the neonate. Human milk contains both the optimal nutrition composition
and non-nutritive bio molecules that contribute to organ development, immune maturation, and
healthy microbial colonization and protect against inflammation and infection. Human milk is a
dynamic fluid that changes its composition from colostrums to mature milk, and varies with
feedings, time of day between mothers and populations.
Stages of Lactation
After delivery, the first fluid produced by the mother is colostrum, which has a unique
composition, volume, and appearance (Ballard & Morrow, 2013). The first days after delivery
low volumes are produced which contain immunological components such as secretory IgA
(sIgA), leukocytes, lactoferrin, and developmental factors such as epidermal growth factor
(Castellote et al., 2011; Kulski & Hartmann, 1981; Pang & Hartmann, 2007). Colostrum contains
low levels of lactose indicating the function is immunological not nutritional. Colostrum contains
higher levels of sodium, magnesium, and chloride and lower levels of potassium and calcium
than late milk (Kulski & Hartmann, 1981; Pang & Hartmann, 2007). As mammary epithelial
cells change, the sodium to potassium ratio declines and lactose concentration increases, leading
to the production of transitional milk.
Transitional milk is the “ramped up”' period of milk production, still containing
characteristics of colostrum while keeping up with the nutritional and developmental needs of
the growing neonate 5-14 days postpartum. After this time, the breast milk is considered
relatively mature. Four to six weeks postpartum, breast milk is considered fully matured and

24
remains relatively fixed in composition, unlike the changing milk composition seen the first
weeks of life (Ballard & Morrow, 2013).
Mature human milk is a complex fluid composed of several phases that can be separated
either by centrifuge or sitting out for several hours (Neville, 2001). The milk fat globules
containing the milk liquids rise to the top forming the cream layer over the skim milk. In human
and bovine milk the fat accounts for 4% of milk volume (R. Jensen, 1989) and contains other
milk components such as phospholipids, cholesterol, and steroid hormones. Cellular components,
of breast milk are primarily sloughed epithelial cells, neutrophils, macrophages, T-cells, stem
cells, and lymphocytes (Neville, 2001). The transfer of maternal living cell offers protection
against pathogens while stimulating the infant’s own immune system.
The composition of mature human milk is reasonably consistent, varying slightly for most
components with stage of lactation and for some constituents, such as fatty acids, more with diet
(Koletzko & Rodriquez-Palmero, 1999). A few components of milk, such as the B vitamins and
selenium, are greatly affected by diet (Neville, 2001). Nutrition received by the fetus through the
placenta is completely dependent on maternal metabolism; however, the nutrients the breastfed
infant receives are not. For almost all the components of milk, the secretory mechanism is
separate from the regulatory mechanism that controls nutritional influx from the mothers making
sufficient milk of adequate composition available to the infant regardless of maternal inadequate
food intake.
Macronutrients
The major macronutrients of milk are lactose, a disaccharide unique to milk,
oligosaccharides, triglycerides, milk fat in the form of proteins, including casein, lactoferrin, α
lactalbumin, sIgA, many others that are present in lower concentrations and minerals, including
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potassium, chloride, sodium and magnesium. The proteins in breast milk can be divided into two
categories—casein and whey—in a ratio of 40:60 (Lonnerdal, 1985). The major casein of human
milk is b-casein, which forms micelles of little volume that form soft curds in the infant’s
stomach. Whey proteins are α lactalbumin, lactoferrin, sIgA, and serum albumin (Lonnerdal,
1985).
Secretory IgA is the principal immunoglobulin of breast milk and the specificity of sIgA
antibodies reflects the mother’s exposure to infection and is independent of the specific profile of
blood borne IgA (Mata, 1986). Many of the proteins in breast milk have multiple functions. For
example, lactoferrin transports and promotes iron absorption, is bacteria static to many
organisms and acts as a nutritional protein by manufacturing amino acids to be absorbed when
digested (Lonnerdal, 1985; Prentice et al., 1987).
More than 98% of the fat in human milk is constructed by the mammary epithelial cells
and is in the form of triglycerides. Palmitic acid and oleic acid are the most abundant fatty acids
in breast milk triglycerides. Half of the triglycerides molecules in breast milk contain palmitic
acid attached to a carbon of the glycerol component making breast milk easier to digest,
increasing absorption and mineral balance (Carnielli et al., 1995; R. Jensen, 1989). Long chain
polyunsaturated fatty acids, arachidonic acid (AA), and docosahexaenoic acid (DHA) are
synthesized from the essential fatty acids linolic acid and linolenic acid respectfully. These fatty
acids are the constituents of brain and neural tissue and are needed in early mental and visual
development of the neonate (Ballabriga, 1994). The lipid component of human milk provides the
transport of fat-soluble micronutrients such as vitamins A, D, E, K and prostaglandins.
The major carbohydrates of human milk are lactose and oligosaccharides. Lactose is the
principal sugar of milk and appears to be specific for newborn growth. It has been shown to
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increase calcium absorption. Lactose is a source of galactose, which is necessary for the
production of galactolipids. Galactolipids are essential for CNS development. For the neonate,
human milk oligosaccharides are non-nutritive bioactive factors (Ballard & Morrow, 2013) that
are prebiotic in that they enhance the growth of beneficial flora such as L. bifidus, indirectly
protecting against gastrointestinal tract infections (Lawrence & Lawrence, 2011). They also have
a role in defenses against other bacteria, as well as viruses and many toxins. The human milk
oligosaccharides are recognized as pathogen-binding inhibitors that function as a “decoy”
receptor for pathogens that have an affinity for binding to oligosaccharide receptors on the
infant’s intestinal wall (Ballard & Morrow, 2013). Oligosaccharides have demonstrated effects
against Helicobacter pylori, E. coli, Streptococcus pneumoniae, and influenza viruses (Lawrence
& Lawrence, 2011).
Protection against infection is also provided by other constituents of human milk, such as
lactoferrin, an iron-binding glycoprotein belonging to the transferrin family, which has enzyme
activity that interferes with microbial function and protects against various bacteria, fungi, and
viruses (Ballard & Morrow, 2013; Beljaars et al., 2004; Sherman, Bennett, Hwang, & Yu, 2004).
Lactoferrin also functions in cell growth regulation, antitumor activity, and immunologic
functions.
Growth Factors
Human milk contains many growth factors that have effects on the intestinal tract, nervous
system, and endocrine system of the neonate. Epidermal growth factor is found in early breast
milk and is critical to the maturation and healing of the intestinal mucosa (Chailler & Menard,
1999; Hirai et al., 2002; Wagner, Taylor, & Johnson, 2008). The immature gut of the infant
includes the enteral nervous system, a branch of the nervous system that governs the function of
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the gastrointestinal tract. For its development, the enteral nervous system requires glial cell-line
derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), which are
detected in human milk 90 days after birth (Fichter et al., 2011; Li, Xia, Zhang, & Wu, 2011).
BDNF enhances peristalsis of the infant intestine and GDNF increases neuron growth and
survival (Fichter et al., 2011).
Also found in human milk are insulin-like growth factors (IGF), which increase tissue
growth, stimulate erythropoiesis, and increase hematocrit (Kling, Taing, Dvorak, Woodward, &
Philipps, 2006; Peterson et al., 2000). Human breast milk contains high amounts of
erythropoietin (Epo), which is the main hormone involved in the production of red blood cells.
Hormones
Adiponectin is a hormone found in breast milk that actively regulates metabolism and
suppresses inflammation. Adiponectin can cross the intestinal barrier and appears to modify
infant metabolism (Martin et al., 2006; Newburg, Woo, & Morrow, 2010). High levels of
adiponectin in breast milk have an inverse correlation to infant weight and BMI, leading
researchers to speculate that adiponectin in breast milk may reduce the incidence of obesity in
later life (Newburg et al., 2010; Woo et al., 2012). Other metabolism-controlling hormones in
breast milk are leptin, ghrelin, and resistin which all appear to play a role in energy conservation,
appetite control, and body composition (Dundar et al., 2010; Palou, Sanchez, & Pico, 2009;
Savino & Liguori, 2008; Savino et al., 2012).
Comparison of Human Milk with Formula
Breast milk is unique in composition when compared to cow’s milk, the basis for most
formula. The protein in formula contains a-casein and beta lactoglobulin; the ratio of casein to
whey protein is 80:20, double that of human milk. The curd formed by casein is hard and
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difficult to digest. Formula cannot replicate the hormones, live living cells immunoglobulins,
active enzymes, and unique chemical compounds found in human milk (Benson & Masor, 1994).
The long chain of fatty acids from breast milk triglycerides, DHA and AA, are not found in cow
milk based formula and if added as a supplement is not absorbed completely; furthermore the
positional difference of fatty acids on the glycerol molecule is lacking. There is no lactose in
some formulas an important carbohydrate for brain development and deficiency in
oligosaccharides which promote intestinal health and fight infection. All of these deficiencies
may impede normal infant growth and development.
Human milk is very complex. Although the composition of formula may be similar, it
cannot duplicate breast milk. The exact composition of breast milk is still unknown, and even
though science continues to increase understanding of breast milk and improve formula, it may
never find a perfect match. Human breast milk contains at minimum 100 ingredients not found in
formula. Breast milk is the perfect food for the growing and developing infant, containing just
the right amount of lactose, fatty acids water, and proteins that are easy for the infant to digest.
Even when formula contains the same nutrients, such as vitamins and minerals, as in breast milk,
they are not absorbed or used in the same way. The differences can affect the infant’s ability to
digest and absorb nutrients.
Benefits of Breastfeeding
Benefits to Infant
If an infant is breastfed exclusively for more than 4 months the risk of hospitalization for
upper respiratory tract infections is reduced by 72% the first year (Ip et al., 2007; Ip, Chung,
Raman, Trikalinos, & Lau, 2009). The severity of respiratory syncytial virus bronchiolitis,
measured by the oxygen requirement and duration of hospital stay, is reduced by 74% in infants
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who breastfed exclusively for 4 months compared with infants who partially or never breastfed
(Nishimura, Suzue, & Kaji, 2009). The incidence of otitis media was reduced by 23% if infants
had ever been breastfed compared with exclusive formula, and the risk of otitis media was
reduced by 50% in exclusive breastfeeding for more than 3 months (Ip et al., 2007). Ear and
throat infections and serious colds were reduced 63% in infants exclusively breastfed for 6
months (Duijts, Jaddoe, Hofman, & Moll, 2010). There was a 64% reduction in the incidence of
nonspecific gastrointestinal tract infections if an infant had ever been breastfed, with this effect
lasting 2 months after breastfeeding stopped (Duijts et al., 2010; Ip et al., 2007; Ip et al., 2009;
Quigley, Kelly, & Sacker, 2007). A study of preterm infants noted a 77% reduction in
necrotizing enterocolitis in infants exclusively fed breast milk compared to those fed breast milk
supplemented by cow’s milk–based formula (Sullivan et al., 2010).
There have been consistent differences in neurodevelopmental outcomes between breastfed
and formula fed infants reported however outcomes have been confounded by differences in
home environment, education of parents intelligence and socioeconomic status (Der, Batty, &
Deary, 2006; Ip et al., 2007). In a large open-label cluster-randomized study, the Promotion of
Breastfeeding Intervention Trial, hospitals in the Republic of Belarus were randomized to
promote and support exclusive breastfeeding (particularly among mothers who had already
decided to breastfeed), or to continue their usual institutional policies. The experimental
intervention led to a large increase in exclusive breastfeeding at age 3 months (43.3% for the
experimental group vs 6.4% for the control group; p < 0.001). Cognitive development of the
children was tested at age 6.5 years with subtests and IQ scores on the Wechsler Abbreviated
Scales of Intelligence and teacher evaluations of academic performance in reading, writing,
mathematics, and other subjects. Adjusted outcomes of intelligence scores and teacher’s ratings
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were significantly higher in children from hospitals which promoted exclusive breastfeeding
(Kramer, Aboud, et al., 2008; Kramer et al., 2001; Kramer, Fombonne, et al., 2008). In another
study, significant effects of human milk on long-term neurodevelopment were observed in
preterm infants, a population more at risk for adverse neurodevelopmental outcomes (Isaacs et
al., 2010; Lucas, Morley, & Cole, 1998; Vohr et al., 2007; Vohr et al., 2006).
Maternal Benefits
Mothers who breastfeed have health benefits both long and short term, including more
rapid involution of the uterus and decreased postpartum blood loss (American Academy of
Pediatrics Section on Breastfeeding, 2012). Continued breastfeeding causes lactational
amenorrhea, leading to increased child spacing. Studies on the effects of breastfeeding on
postpartum weight loss have been inconclusive, given the large numbers of confounding factors
that contribute to weight loss (diet, baseline weight, ethnicity, and activity). In a study of 14,000
women postpartum with covariates adjusted, found women who breastfed more than 6 months
weighed 1.38 kg less than those who did not (Krause, Lovelady, Peterson, Chowdhury, &
Ostbye, 2010). The Nurse’s Health Study found a decreased risk of type 2 diabetes mellitus of
4% to 12% for each year of breastfeeding (Stuebe, Rich-Edwards, Willett, Manson, & Michels,
2005). Another study of 2233 women found that risk of type 2 diabetes increases when term
pregnancy is followed by less than 1 month of lactation (Schwarz et al., 2010).
A report by the Women's Health Initiative, a longitudinal study of 139,000 postmenopausal
women found an association between cumulative breastfeeding experience and cardiovascular
disease (Schwarz et al., 2009). Women who breastfed for 12 to 23 months had significant
reductions in hypertension, high cholesterol, diabetes, and heart disease.
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Cumulative breastfeeding experience also correlated with a reduction in ovarian and breast
cancer (Ip et al., 2007; Ip et al., 2009; Stuebe, Willett, Xue, & Michels, 2009). Breastfeeding for
12 months or longer is associated with a 28% decrease in ovarian and breast cancer
(Collaborative Group on Hormonal Factors in Breast Cancer, 2002). It has been calculated that
each year of breastfeeding results in a 4.3% reduction in the risk of breast cancer (Collaborative
Group on Hormonal Factors in Breast Cancer, 2002; Lipworth, Bailey, & Trichopoulos, 2000).
Public Benefits
In addition to the health benefits there are financial benefits to the family, society, public
and private insurers, government programs, and employers (AWHONN, 2015). A cost analysis
of the financial benefits of breastfeeding estimated that if 90% of mothers breastfed exclusively
for 6 months, 13 billion health care dollars would be saved (Bartick & Reinhold, 2010).
According to the US Surgeon General, the family of a breastfed infant saves approximately
$1500 per year in costs directly related to feeding supplies and formula. Because breastfed
infants are less likely to be sick, the family saves indirectly on health care costs because there are
fewer medical bills and fewer lost days of work (US Department of Health and Human Services
Office of the Surgeon General, 2011). When employers invest in a lactation program and support
breastfeeding, they receive $3 return for every $1 invested (Tuttle & Slavit, 2009). This reduced
costs for health insurance claims, reduced absenteeism reduced turnover rates leading to cost
savings in recruitment and training (US Department of Health and Human Resources Health
Resources and Services Administration, Undated).
Because it does not require packaging, a manufacturing plant, storage, refrigeration, or
transportation, breastfeeding is also beneficial to the environment (Fairfield, 2012). Researchers
have estimated that for every 1 million infants fed formula, 150 million containers used to
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package the formula were disposed of, many in landfills (US Department of Health and Human
Services Office of the Surgeon General, 2011).
Factors Influencing Breastfeeding in the First Days Postpartum
Maternal Intention to Breastfeed
Maternal intention to breastfeed is the strongest modifiable predictor of breastfeeding
duration (Blyth et al., 2002; DiGirolamo, Thompson, Martorell, Fein, & Grummer-Strawn, 2005;
Forster, McLachlan, & Lumley, 2006). Often women have made the decision to breastfeed
before they became pregnant or in the first trimester before their first prenatal visit (Earle, 2002;
J. Henderson & Redshaw, 2011). The influence of the primary care clinician on breastfeeding is
significant (Bentley et al., 1999; Guise et al., 2003; Lu, Lange, Slusser, Hamilton, & Halfon,
2001). Responses of 1229 women in a nationally representative sample showed that, in
population groups that were least likely to breastfeed, the most significant influence was prenatal
encouragement and support (Lu et al., 2001). At office visits during the prenatal period, nurses
and midwives have an opportunity to provide guidance and education. During well-child visits,
pediatric nurses and nurse practitioners trained and certified in lactation can provide
breastfeeding support and discuss a variety of issues (family support, returning to work, sore
nipples etc).
Institutional Practices and Breastfeeding Support
For hospital births, the practices of the institution can act as a barrier or facilitator to
breastfeeding initiation. Such factors must be considered when collecting and interpreting data
from the proposed study. The groundbreaking work by Righard and Alade showed that delivery
room routines are strongly associated with the infant’s ability to initiate breastfeeding (Righard
& Alade, 1990). Of infants placed on the mother’s chest immediately after delivery, 63.2%
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initiated rooting behaviors within 20 minutes and were breastfeeding successfully within the
hour, 10.5% sucked incorrectly, and 26.3%, who were born to women who had narcotic epidural
analgesia, did not exhibit rooting behavior. When infants were separated from their mothers for
routine weighing and exams, only 20% sucked correctly, and none of these infants had received
narcotic epidural analgesia (Righard & Alade, 1990).
Professional breastfeeding support from postpartum nurses and lactation consultants
strongly correlates with breastfeeding initiation (Persad & Mensinger, 2008). In the immediate
postpartum, mothers require professional guidance and support in breastfeeding initiation. A
study in Finland (Tarkka, Paunonen, & Laippala, 1998) used multivariate analysis of predictors
related to breastfeeding success and found five variables that contributed to the establishment of
breastfeeding: the mother’s experience of breastfeeding in the hospital postpartum, the time
when breastfeeding was first initiated, the opinions of the mother’s significant other and the
healthcare staff on her decision to breastfeed, the amount of professional breastfeeding assistance
available to her, and whether she was upset while in the hospital (Tarkka et al., 1998). Mothers
who had a positive experience breastfeeding and started lactating 2 to 3 days postpartum coped
better than those whose experience was not as positive and who did not start lactating until later.
In addition, the more emotional support and interactive lactation assistance the mother received
from her significant other and healthcare staff the better she coped with breastfeeding. In
comparison, the mothers who were upset during their hospitalization did not cope well with
breastfeeding.
A 2005 Cochrane review analyzing interventions for promoting initiation of breastfeeding
showed that breastfeeding education had a significant effect on increasing breastfeeding
initiation compared to standard care (Dyson, McCormick, & Renfrew, 2005). Five studies with a
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total of 582 women on low incomes in the USA showed breastfeeding education clearly
increased breastfeeding rates compared to providing routine care (Brent, Redd, Dworetz,
D'Amico, & Greenberg, 1995; Coombs, Reynolds, Joyner, & Blankson, 1998; Hill, 1987; Ryser,
2004; Serwint, Wilson, Vogelhut, Repke, & Seidel, 1996). One trial with 165 women showed
peer support for women considering breastfeeding also increased breastfeeding rates (Chapman,
Damio, Young, & Perez-Escamilla, 2004). Needs based, one-to-one, informal education or
support sessions, delivered either before or before and after the birth by a trained breastfeeding
professional or peer counsellor, was the most effective intervention among women of different
ethnicity and feeding intention in three studies.
Breastfeeding usually begins in the hospital so it is reasonable to examine hospital
practices and the association to breastfeeding initiation. Because breastfeeding has so many
positive health benefits, the United National Children's Fund and World Health Organization
launched a program in 1991 called the Baby-Friendly Hospital Initiative (BFHI) to promote
exclusive breastfeeding for the first 6 weeks of life. The Ten Steps to Successful Breastfeeding
were formulated to address the negative impact of maternity care birth practices in hospitals had
on the initiation, exclusivity, and maintenance of breastfeeding (World Health Organization &
UNICEF, 1989). The 10 steps to successful breastfeeding as stated by the BFHI are to: (1) have a
written breastfeeding policy; (2) train staff with skills to implement the breastfeeding policy; (3)
inform all pregnant women of the benefits/ management of breastfeeding; (4) help mothers
initiate breastfeeding within an half hour of birth; (5) show mothers how to breastfeed, and how
to maintain lactation even if they should be separated from their infant; (6) give newborn infants
no food or drink other than breast milk unless medically indicated; (7) use proactive rooming- in
to allow mothers and infants to remain together 24 hours a day; (8) encourage breastfeeding on
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demand; (9) give no artificial teats or pacifiers to breastfeeding infants; (10) Foster the
establishment of breastfeeding support groups and refer mothers to them on discharge from the
hospital or clinic. Additionally, procedures that may interfere with breastfeeding are to be
limited.
The 10 steps were operational targets for hospitals and became the basis for the BFHI
(Brodribb, Kruske, & Miller, 2013). The implementation of BFHI accreditation brought about
increases in the initiation of breastfeeding, any breastfeeding and exclusive breastfeeding the
first days postpartum (Braun et al., 2003; Broadfoot, Britten, Tappin, & MacKenzie, 2005;
Merewood, Mehta, Chamberlain, Philipp, & Bauchner, 2005; Philipp, Malone, Cimo, &
Merewood, 2003; Philipp et al., 2001; Venancio, Saldiva, Escuder, & Giugliani, 2012), and
increased duration of breastfeeding (Braun et al., 2003; Duyan Camurdan et al., 2007; Merten,
Dratva, & Ackermann-Liebrich, 2005; Venancio et al., 2012), most notably in hospitals with low
breastfeeding rates to begin with. However, it was found that, in hospitals with high rates of
breastfeeding initiation and where infant-friendly practices are the norm, breastfeeding initiation
and duration rates did not increase when BFHI accreditation was achieved (Brodribb et al.,
2013). Women who received at least four of the 10 Baby-Friendly Hospital practices, including
implementing skin-to-skin at birth, attempted breastfeeding in the first hour, no formula
supplementation, and 24-hour rooming in, had an increased probability of breastfeeding at 1 and
4 months compared with women who experienced fewer than four of these practices (Brodribb et
al., 2013). The authors concluded that baby-friendly, evidence-based practices in the hospital
environment were more important than the accreditation.
The Ten Steps are relevant to the research described here because the facility where the
study took place (Yale New Haven Hospital) is in the process of achieving the BFH designation

36
and has initiated these steps. The process requires each nurse to complete 20 hours of formal
breastfeeding education and requires that patients receive initial breastfeeding instruction within
6 hours after delivery. A hospital environment strongly supportive of breastfeeding may be able
to at least partially offset any potential negative effects of epidurals on breastfeeding (Halpern et
al., 1999; Wieczorek et al., 2010).
Literature regarding the steps relevant to the current study will be discussed in the
following sections.
Immediate Skin-to-Skin Contact and Immediate Breastfeeding Initiation
The early postpartum period is an important time for mother and infant to develop this
synchrony and reciprocity (Kennell, Trause, & Klaus, 1974). Skin-to-skin contact between the
neonate and the mother within the first hour postpartum, which is known as the “sensitive
period,” enhances the long-term interaction between mother and neonate. When the newborn is
placed skin-to-skin between the mother's breasts, oxytocin is released as the newborn exhibits
instinctual behavior by rooting, finding the breast, and sucking at approximately 1 hour of age
(Matthiesen, Ransjo-Arvidson, Nissen, & Uvnas-Moberg, 2001; Nissen, Gustavsson, Widstrom,
& Uvnas-Moberg, 1998). Endogenous oxytocin during labor and birth is necessary for the
development of maternal behavior that facilitates the process of breastfeeding. Oxytocin induces
the milk ejection reflex and contributes to the release of prolactin, which is linked to milk
production (Dawood, Khan-Dawood, Wahi, & Fuchs, 1981).
Oxytocin and prolactin are pivotal to breastfeeding and are associated with behavioral and
physiological adaptations in breastfeeding women (Jonas et al., 2009; Nissen et al., 1998; UvnasMoberg, Widstrom, Werner, Matthiesen, & Winberg, 1990). When this early contact occurs,
mothers are more likely to be breastfeeding at 1 and 4 months or longer after delivery (Bystrova
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et al., 2009; E. R. Moore, Anderson, Bergman, & Dowswell, 2012; Salariya, Easton, & Cater,
1978; Wiberg, Humble, & de Chateau, 1989).
Skin-to-skin contact immediately postpartum allows development of innate neonatal
behaviors such as temperature regulation, crying, respiration, and nursing behavior. It assists the
neonate in the transition to extrauterine life by decreasing the stress of birth through the mother’s
warmth, touch, and odor, guiding the neonate to her nipple, and triggering release of maternal
oxytocin. Unmedicated spontaneous vaginal deliveries with immediate maternal-infant skin-toskin contact have an increased likelihood of successful baby-led breastfeeding (E. R. Moore et
al., 2012; Righard & Alade, 1990; Widstrom, Liilja, & Aaltomaa, 2011). The timing of the first
breastfeed is associated with duration of breastfeeding. Bramson and colleagues analyzed data
from a prospective cohort of 21,842 mother-infant pairs and determined that the longer the
mother experienced skin-to-skin contact with the infant in the first 3 hours after delivery, the
more likely she was to be exclusively breastfeeding during her hospital stay (Bramson et al.,
2010) A systemic review of 59 studies found increased breastfeeding initiation rates in hospitals
that promoted early mother-neonate contact as part of their initiatives (Fairbank et al., 2000). The
earlier the initiation of the first breastfeed and/or mother-neonate contact, the longer the duration
of breastfeeding with decreased incidence of early postpartum breastfeeding cessation (Berra et
al., 2003; Buxton et al., 1991; Salariya et al., 1978). Step 4 of the 10 steps encourages that
neonates be placed near the breast immediately after birth to initiate a latch-and-feed response,
preferably within the first hour of delivery (DiGirolamo, Grummer-Strawn, & Fein, 2008; Hung
& Berg, 2011; Mahmood, Jamal, & Khan, 2011; E. R. Moore et al., 2012; Murray, Ricketts, &
Dellaport, 2007; Thukral et al., 2012).
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Neonatal-Maternal Interaction and Infant Neurobehavior
Early contact between mother and neonate establishes the interaction necessary for
breastfeeding. Lower neurobehavior scores at birth are associated with slower initiation of
optimal sucking behavior (Beilin et al., 2005; Chang & Heaman, 2005; Radzyminski, 2005).
Persistence of neurobehavior disorganization can interfere with development of optimal motherinfant synchrony necessary for the establishment of sucking and feeding (A. D. Murray, R. M.
Dolby, R. L. Nation, & D. B. Thomas, 1981; A.D. Murray, R.M. Dolby, R.L. Nation, & D.B.
Thomas, 1981). If mothers identify their neonate as being too sleepy and unable to latch onto the
nipple and suck during the first day of life, mothers may perceive their neonate’s disorganized
behavior as difficult to care for and behave in ways to reinforce and confirm the behavior (A.D.
Murray et al., 1981). Such factors may result in a vicious circle, preventing good feeding
behaviors in the first 24 hours of life, which may prompt the mother to quit breastfeeding too
soon.
Use of Infant Formula in the Hospital
Step 6 of the 10 steps says that unless medically necessary no food or drink other than
breast milk should be given to the newborn. Despite this recommendation, recent data from the
US Centers for Disease Control and Prevention found that 42% of infants breastfed in US
hospitals were given supplemental formula (Grummer-Strawn, Scanlon, & Fein, 2008). Many
birth facilities give formula, water or glucose water as a first feed or as a supplement to breast
milk (World Health Organization, 1998). In-hospital supplementation has been associated with
fewer breastfeeds, lower maternal milk supply, and shorter breastfeeding duration (DiGirolamo
et al., 2008; Grummer-Strawn et al., 2008; Nylander, Lindemann, Helsing, & et al., 1991;
Semenic, Loiselle, & Gottlieb, 2008). Research has found infants were most likely to receive
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supplemental formula between 7 pm and 9 am, regardless of time of delivery (Gagnon, Leduc,
Waghorn, Yang, & Platt, 2005). This study also found that the infants who had a breastfeed on
the maternity unit were 'protected' from the use of formula up to 10 hours of age (Gagnon et al.,
2005). Despite an early meta-analysis showing the use of infant formula not having a statistically
significant effect on breastfeeding outcomes (Bernard-Bonnin, Stachtchenko, Girard, &
Rousseau, 1989), recent studies from the United States, Turkey, and Italy found the use of
formula during the postpartum hospital period had a negative affect after adjusting for
confounding factors (Alikasifoglu et al., 2001; DiGirolamo, Grummer-Strawn, & Fein, 2001;
Riva et al., 1999).
For US hospitals, the most challenging aspect of fulfilling step 6 is that the BFHI requires
certified hospitals to abide by provisions of the International Code of Marketing of Breastmilk
Substitutes to not distribute any commercial materials from formula manufacturers and to pay
fair market value for formula. Almost all hospitals in the US receive heavily discounted or nocost formula directly from manufacturers. Although the practice is decreasing, many hospitals
also receive formula promotional materials in the form of a “diaper bag” gift to new mothers
(Sadacharan, Grossman, Sanchez, & Merewood, 2011). These promotional gift packs have been
shown to lead to decreased rates of exclusive breastfeeding (Howard et al., 2000; Rosenberg,
Eastham, Kasehagen, & Sandoval, 2008).
Rooming In
Neonates who room-in with their mothers have a greater likelihood to be put at the breast
to suck, leading to more continual breastfeeding and less supplementation. Mothers were able to
identify feeding cues sooner, and the infants cried less and weighed more after the first week.
When an infant stayed with the mother 24 hours a day, she produced more milk and her
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confidence in both parenting and bonding with her infant increased (Bystrova et al., 2007; Keefe,
1987; Yamauchi & Yamanouchi, 1990b). Infants have a better quality of sleep when they roomin compared to those in the nursery, and interestingly mothers sleep the same amount of time
whether they room-in or not, with rooming-in mothers reporting higher scores measuring quality
of sleep (Keefe, 1987, 1988).
Studies conducted on rooming-in have not been rigorous in their methods; however the
practice has been shown to have a positive association with breastfeeding outcomes (PerezEscamilla, Segura-Millan, Pollitt, & Dewey, 1992; Scott, Landers, Hughes, & Binns, 2001) with
even partial rooming-in having a positive influence (Buxton et al., 1991).
Breastfeeding on Demand
It is now accepted that fixed or set breastfeeding schedules lead to insufficient milk supply
and breastfeeding problems. BFHI acknowledges that breastfeeding does not occur at scheduled
time points and places no restriction on the amount or duration of breastfeeding. Allowing a
neonate unrestricted breastfeeding allows them to self-regulate their own feedings by indicating
their readiness. A recent study examined the volume and fat content of breast milk over a 24
hour period and found there is variation in feeding patterns between infants and from day to day
(Kent et al., 2006). Unrestricted breastfeeding increased volume of milk intake on day 3,
lactogenesis occurred earlier, meconium passed earlier, neonates glucose levels stabilized, higher
weight nadir day 3-4 with increases in the rate of weight gain, less supplementation, and lower
rates of hyperbilirubinemia (De Carvalho, Klaus, & Merkatz, 1982; De Carvalho, Robertson,
Friedman, & Klaus, 1983; Hawdon, Ward Platt, & Aynsley-Green, 1992; Yamauchi &
Yamanouchi, 1990a). Increased breastfeeding frequency was also shown to decrease breast
soreness, nipple pain, and engorgement (Hill & Humenick, 1996).
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Rooming-in from birth enables and encourages mothers to pursue a baby-led demand
feeding schedule and allow them to successfully initiate breastfeeding.
Breastfeeding Support
Women may need breastfeeding support from healthcare providers in the immediate
postpartum in assisting the mother to position and attach their babies at the breast. In a study
using focus groups to determine factors mothers felt contributed to their decision to wean early,
the dominant themes that emerged were overworked nurses or lack of nurses, lack of skill of
nursing staff to assist with breastfeeding and getting the infant to latch on, conflicting advice,
lack of privacy, and noise (Vogel & Mitchell, 1998). The main problem the women identified
was that the infant was unable to latch on and suck. The mothers attributed this to the lack of
nurse's skill.
Another study reported five variables associated with breastfeeding success and duration.
They included the time of breastfeeding initiation, the mother’s experience of breastfeeding
during her hospitalization, whether the mother was upset with her hospital stay, the attitudes of
the professional staff and her significant other about her decision to breastfeed, and the
availability of help from the nursing staff to breastfeed (Tarkka et al., 1998). The main source of
the mother’s unhappiness was the infant’s inability to latch on and feed. When the staff was
unable or unavailable to remedy the situation, her ability to cope decreased and she became
unhappy with her hospital care. She was more likely to quite breastfeeding if she was coping
poorly.
The primary cause of sore nipples is thought to be due to incorrect breastfeeding
mechanics, such as improper positioning, dysfunctional or disorganized sucking, improper latch
or failure of the infant to form a teat, i.e., the ability of the infant to draw the nipple and part of
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the areola into the mouth (Righard, 1998; Righard & Alade, 1992; Tait, 2000; Walker, 2007).
Limiting the time at breast has no effect on nipple soreness, but correct latch and position are
crucial. It is important to address the nipple pain and implement corrective action as up to a third
of these mothers will switch to formula feeding postpartum (Briggs, 2003). Many women are
surprised and the intensity and extent of the pain they experience which can result in unwanted
rejection toward the infant, inability to trust their body and early cessation of breastfeeding
(Kelleher, 2006).
Maternal Satisfaction with Breastfeeding
Maternal dissatisfaction with breastfeeding may lead to early cessation. The top reasons
that a mother stops breastfeeding in the early postpartum is her perception that her infant is not
satisfied by her breast milk alone (Li, Fein, Chen, & Grummer-Strawn, 2008; Murray et al.,
2007), concern she is not producing enough milk (Murray et al., 2007), and nipple pain
(Morland-Schultz & Hill, 2005). In another study (O'Leary, Kopsell, & Haller, 1997), the main
reasons for formula supplementation was the mother’s perception that she did not have enough
milk, and the formula was easier to give. A further study similarly reported that the main reasons
mothers supplemented with formula was the perceived inadequacy of their milk supply, sore
nipples, frequency of night feedings, and the baby's preference for formula (Chapman & PerezEscamilla, 1999). Upon further analysis of these themes, the mothers determined that lack of
milk supply was related to infant behaviors such as fussiness, slow weight gain, rashes, and the
infant's rapid consumption of formula with sound sleep afterwards, whereas when breastfed, the
infants were fussy and discontented.
Consistently reported as a reason of early of weaning is insufficient milk supply (Meedya,
Fahy, & Kable, 2010; Thulier & Mercer, 2009). Despite the fact 50% of women report they
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perceive their milk supply to be insufficient, only 5% actually suffer from a physiological
insufficient milk supply (Meedya et al., 2010; Thulier & Mercer, 2009). Many women
supplement with infant formula in response to their perception of having insufficient milk
supply. The reduction in demand for the breast milk decreases the maternal supply, multiplying
the problem. There is a strong psychological component to this biologically factor as perception
of insufficient milk supply is associated with low maternal self-efficacy for breastfeeding
(Meedya et al., 2010).
Specific infant behaviors valued by the mother have been linked to maternal satisfaction
(Vandiver, 1997). Fifty primigravida who had given birth to term healthy infants completed
questionnaires on infant temperament, caregiver flexibility, and their perception of breastfeeding
in their third trimester and then again when their infants were 12 weeks old. Thirty of the
mothers were additionally watched in their homes for 2 hours while interacting with their infants
at 2, 6, and 12 weeks postpartum. Significantly longer duration of breastfeeding was correlated
with higher rates of mothers’ interactive behaviors with their infants and their perception that the
infants had an easy temperament.
This led researchers to examine the relationship between infant fussiness, discontent
behavior and poor weight gain, and the mother’s perception of poor milk supply and sore
nipples. Two researchers independently concluded that it was correct infant position and sucking
of the breast that avoided the majority of problems that led to early breastfeeding cessation
(Fisher, 1981; K. B. Frantz & Fleiss, 1980). They determined that the infant had an oral search
reflex which is stimulated when the lips are close to the nipple. The reflex allows correct sucking
at the breast which they defined as the infants mouth is wide open, tongue under the areola with
the milk expressing in slow deep sucks. The determined manipulation of the nipple into the
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infant’s mouth led to faulty sucking, and once the infant learned faulty sucking, it was
problematic to retrain the infant to suck correctly at the breast. The introduction of artificial
nipples on formula supplement bottles or pacifiers contributed to the infant learning faulty
sucking technique (Fisher, 1981; K. B. Frantz & Fleiss, 1980).
Maternal self-efficacy in the prenatal period has been examined in relation to breastfeeding
outcomes. A longitudinal study conducted in the United States evaluated 64 minority women 2
months postpartum (Ertem, Votto, & Leventhal, 2001). The women who during the prenatal
period were not confident about breastfeeding were 12 times more likely to stop breastfeeding
than those who were confident. Lack of confidence in breastfeeding was associated with
mothers’ perception of insufficient milk supply, which led to a decrease in breastfeeding and an
increase in formula supplementation (Dennis, 2002). In another study, lower breastfeeding rates
were found at 6 weeks postpartum in women who perceived their milk production to be
insufficient who also scored lower on maternal confidence (Hill & Humenick, 1996).
Maternal Perception of Infant Behavior
Breastfeeding requires mother and infant fully participate in an interactive process each
learning to fulfill their new roles. The maternal task of initiating and facilitating breastfeeding
has been recognized. However, it has only recently been acknowledged that the infant plays a
part in this process. Research in past decades established that newborns are interactive, proactive
and individualized in their reaction to the world (Klaus & Klaus, 1998).
Studies of mother-infant interaction have highlighted the role of infants perceptual,
communicative, and interactive competency (Brazelton, Cramer, Kreisler, Schappi, & Soule,
1983). The bi-directionality of the mother-infant interaction is characterized by synchrony and
reciprocity (Tronick & Cohn, 1989). The infant’s behavior is not only influenced by the mother
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but it may also affect the mother’s behavior. In this way, the infant’s signals may affect the
quantity and quality of caregiver exchanges (Mazet & Stoleru, 1993). If this interaction is
interrupted due to the direct effects of epidural medication, and the baby is less alert, less able to
orient, and less able to show organized movement, this may interfere with the mother-infant
relationship (A.D. Murray et al., 1981; Sepkoski, Lester, Ostheimer, & Brazelton, 1992).
Research has demonstrated how these infant behaviors are useful for breastfeeding.
Mothers appear to associate certain infant behaviors with satisfaction with breastfeeding. In one
study (Lothian, 1995), a group of mothers who—regardless of support, motivation or intent—
continued breastfeeding only if they believed their newborn was satisfied and “attached easily,
sucked well and appeared content” (p.333). In related studies, maternal satisfaction with
breastfeeding was associated with competent infant feeding behaviors (Matthews, 1991), and an
infant demonstrating attachment behaviors (Brandt, Andrews, & Kvale, 1998). Both of these
studies established satisfied infants breastfed longer than an infant perceived to be unsatisfied.
Descriptions of their newborn’s satisfaction by the mother were related to behavioral state
organization. The behaviors described included the infants’ ability to come to a quiet alert state
(Brandt et al., 1998), calm themselves (Leff et al., 1994; Lothian, 1995), make eye contact and
maintain a mutual gaze with the mother (Lavelli & Poli, 1998) and exhibit cuddliness and
consolability without irritability (R. B. Hughes, Townsend, & Branum, 1988; Karl, 2004).
Infants who were able to organize their behavioral states breastfed more effectively and for a
longer duration than those who were not (R. B. Hughes et al., 1988; Lothian, 1995). The early
infant behaviors at the breast may affect the mother’s decision to continue to breastfeed based on
the mother’s perception of whether or not her infant enjoys breastfeeding.
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Demographic and Socioeconomic Factors
A number of demographic and socioeconomic factors may decrease incidence and duration
of breastfeeding. Such factors include returning to work (Brand, Kothari, & Stark, 2011;
Johnston & Esposito, 2007), lack of social support (Brand et al., 2011), racial minority, level of
education high school or less (Chin, Myers, & Magnus, 2008), low socioeconomic status (Chin
et al., 2008), parity (Lind, Perrine, & Ruowei, 2014), marital status (Lind et al., 2014), biological
and physiological conditions (Chin et al., 2008), and smoking (Lind et al., 2014). Research has
shown that mothers who are married (Avery, Duckett, Dodgson, Savik, & Henly, 1998), are
older than age 30 years (Bolton, Chow, Benton, & Olson, 2009; Brand et al., 2011), have a high
income (Avery et al., 1998; Dennis, 2002), and are well educated (Avery et al., 1998; Haas et al.,
2006; Wen, Baur, Rissel, Alperstein, & Simpson, 2009) had higher incidence of breastfeeding
initiation and duration. Elevated maternal body mass index was also found to negatively
influence the initiation, intention, and duration of breastfeeding significantly (Guelinckx,
Devlieger, Bogaerts, Pauwels, & Vansant, 2012).
Infant’s Ability to Latch and Suck
In order for the infant to effectively breastfeed, the infant must be correctly positioned at
the breast to stimulate the neonate’s oral searching reflex. While mothers must develop the skills
for successful breastfeeding, the infant is born with two specific innate reflexes to assist him in
taking in the nutrients required for survival. The first of these is the rooting reflex, which is
initiated by the mother. The rooting reflex has two components (1) tactile stimulation of the skin
around the infant’s mouth will cause the infant to turn his head in that direction and (2) his
mouth gapes in preparation of the nipple (Woolridge, 1986). When the infant’s mouth gapes, the
mother must take the initiative to bring infant and breast together so that the second reflex—the
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sucking reflex—can be elicited (Woolridge, 1986). The infant should be supported to open the
tongue wide, thrust the tongue forward to take the breast, then with the tongue under the areola
express milk from the breast with deep slow sucks (Righard, 1998; Righard & Alade, 1992). The
nipple and surrounding breast tissue is drawn into a teat by suction created in the infant’s mouth.
The teat is 3 times as long as the nipple is at rest, and extends back into the infants mouth to the
junction between the soft and hard palates (Ardran et al., 1958). At its base it is held between the
upper gum and the tongue, which covers the lower tongue (Woolridge, 1986). The lateral
margins of the tongue cup around the nipple crating a central trough in which the nipple lies
(Weber et al., 1986). Milk is expressed from lactiferous sinuses and is propelled toward the back
of the mouth by a posterior directed peristaltic action of the tongue (Ardran et al., 1958; Weber
et al., 1986). The cycle of sucking is initiated by an upward curving of the anterior tongue,
followed closely by pressure from the lower gum caused by elevation of the jaw (Woolridge,
1986). The raising of the tongue continues to move the milk into the pharynx. If the volume of
milk is sufficient to trigger swallowing, the soft palate rises and closes off the nasal cavity. The
larynx, which separates the trachea from the esophagus, moves up to close the trachea, which is
aided by a downward movement of the epiglottis resulting from pressure from the fluid bolus
and rear portion of the tongue (Woolridge, 1986). The pharyngeal space is progressively reduced
until it is obliterated propelling the milk into the esophagus (Logan & Bosma, 1967).
There are two features of normal sucking that deserve a closer look because their
disturbance can lead to sore nipples. The first is that normal sucking is devoid of frictional
movement. If a significant amount of breast tissue has been formed into a “teat,” then there
should be very little movement of the teat in and out of the infant’s mouth; there should be a
unidirectional exchange of milk into the infant’s mouth (Woolridge, 1986). Thus, there should be
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minimal friction from the tongue and gums against the skin of the breast. This picture is
consistent with reports made by cineradiographic and ultrasound observation (Ardran et al.,
1958; W. Smith, Erenbery, Nowak, & Franken, 1985; Weber et al., 1986). The second feature is
that the application of positive pressure on the nipple by the tongue surface is the primary force
in evacuating milk from the nipple and into the esophagus.
The infant also generates a negative pressure in his mouth during the process of milk
removal. The role of negative pressure has not been determined, but the two most likely
functions are 1) to retain the nipple and breast in the mouth in the correct position (countering
the natural retractile nature of the tissue), thereby retaining the teat shape of the nipple and breast
tissue; and 2) to aid in the refilling of the nipple by sinuses and ducts (Woolridge, 1986).
Evidence for the former suggestion can be seen in Ardran’s cineradiographic films (Ardran et al.,
1958).
Survival of the newborn is reliant on establishing effective feeding. Effective and efficient
feeding requires coordination of breathing with sucking and swallowing and involves the
functional interaction of lips, jaw, palate, tongue, larynx, pharynx, and esophagus (Bu'Lock et
al., 1990; A. Miller, 1982). To accomplish this, the neonate uses cerebral and brainstem
structures, 6 of the 12 cranial nerves (V, VII, IX, X, XI, and XII), 22 bones connecting at 34
sutures, and 60 voluntary and involuntary muscles in a process that occurs at 40 to 60 cycles/per
minute, 10-30 minutes at a time, 8-16 times a day (Smyth, Alldred, & Markham, 2007).
Newborns must have oropharyngeal muscle patterns with the coordination and strength to obtain
milk from the breast, as well as the psychomotor ability to cue that they are ready to feed (L.
Smith, 2010). The muscles that control the sucking, opening and closing of the mouth during
breastfeeding are innervated by motor fibers. If compromised, this may interfere with the
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neonate’s ability to root, latch, and suck adequately (L. Smith, 2010). An intact CNS is essential
for the infant to physiologically latch and feed (Radzyminski, 2005).
Methods for Assessment of Breastfeeding
Very few studies have used an objective breastfeeding assessment scoring tool (J. J.
Henderson, Dickinson, Evans, McDonald, & Paech, 2003; Volmanen, Valanne, & Alahuhta,
2004; Wiklund, Norman, Uvnas-Moberg, Ransjo-Arvidson, & Andolf, 2009; Wilson et al.,
2010). There is no standardized method to assess the breastfeeding encounter, but several tools
have been developed for breastfeeding assessment. These include the LATCH scoring system,
Infant Breastfeeding Assessment Tool (IBFAT), and the Mother Baby Assessment Tool (MBA).
The LATCH scoring system (D. Jensen et al., 1994) is used extensively by nurses at birthing
centers and hospitals and is the breastfeeding assessment tool used at Yale New Haven Hospital
(YNHH). It has been used by researchers (Baumgarder, Muehl, Fischer, & Pribbenow, 2003b;
Chang & Heaman, 2005) in their assessment of the effects of labor analgesia on breastfeeding
and was used for the current study. LATCH is a breastfeeding charting system that assesses
individual breastfeeding sessions using a systemic model to gather information (D. Jensen et al.,
1994). The LATCH score includes all aspects of latching behavior by providing a score of 0, 1,
or 2 for key components of breastfeeding. L= is the infants ability to latch onto the breast, A= is
the audible sound of swallowing, T=Type of nipple the mother has, C= Comfort of the mothers
breast and nipple, H=Holding which is the amount of assistance the mother needs to hold the
neonate. To obtain the score all the areas of assessment are added to get a total for that
breastfeeding session. For example a mother with previous breastfeeding experience, everted
nipple, and an alert and vigorous infant could get a score of 9 or 10 (D. Jensen et al., 1994).
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Successful breastfeeding defined by LATCH is a score >7 at two feeds in 24 hours (Baumgarder
et al., 2003b; Bramson et al., 2010).
The interrater reliability of the LATCH tool was high and ranged from 85.7%-100% and
strong construct validity (Adams & Hewell, 1997; J. M. Riordan & Koehn, 1997). Riorden and
Koehn (1997) found a significant correlation between nurses’ and mothers’ assessment scores,
and both assessment scores positively correlated with duration of breastfeeding. These findings
support previous research that assessed the validity and reliability of LATCH tool (Adams &
Hewell, 1997; Matthews, 1988). Matthews (1988) found interrater reliability between raters’
scores and mothers’ scores to be 91%. A more recent study (Altuntas et al., 2014) found positive
and significant correlations between researchers' scores for 46 observations using the IBFAT,
MBA, and LATCH. They reported that all three assessment tools were compatible in the
assessment of breastfeeding performance.
Methods for Assessing Infant Well-being
One of the primary concerns of obstetrical anesthesia is neonatal well-being. The greatest
challenge for researchers has been how to accurately measure neurobehavior. Clinical and
laboratory measurement scales, including Apgar scores (Apgar, 1953), umbilical blood venous
and arterial acid-base balance analysis (Bax & Nelson, 1993), and neonatal neurobehavioral
testing scales have been developed to assess neonatal well-being (Als, Tronick, Lester, &
Brazelton, 1977).
Apgar Scores
Early studies used Apgar scores at 1 and 5 minutes, cord blood pH, and respiratory
depression to evaluate the effects of epidural analgesia on the neonate. Whereas these tests
evaluate depression of vital function, they are not sensitive to the subtle differences in neonatal
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neurobehavior, such as variation in muscle tone, motor movements, and sleep cycles, which may
be differentially influenced by narcotics, resulting in impairment of the neonate’s ability to
breastfeed effectively.
Nearly every infant born in the developed world is assigned an Apgar at 1 and 5 minutes
with virtually all studies on epidural analgesia and neonatal outcomes including Apgar scores. Dr
Virginia Apgar, an anesthesiologist, developed a scoring system in 1952 to rapidly assess the
status of the newborn after delivery and the need for prompt intervention to establish breathing
(Apgar, 1953). The Apgar score is comprised of five components: Heartrate, respiratory effort,
muscle tone, reflex irritability, and color, each of which is given a score of 0, 1, or 2. The score is
reported at 1 and 5 minutes after birth, and higher scores indicate optimal condition of the
neonate in the transition to extrauterine life.
Apgar and her team established the relationship between blood gas data and Apgar scores,
verifying that newborns with low scores were acidotic and hypoxic and needed treatment. Once
the mechanism of low Apgar scores was understood, she then applied them to assess labor,
delivery, and the effects of anesthetics given to the mother on the baby. She and her colleagues
demonstrated that cyclopropane, which was commonly used for cesarean and vaginal deliveries
at that time, caused depression of babies and low Apgar scores when given to the mother. On the
basis of their data, they concluded that epidural analgesia provided the best outcomes for mother
and newborn (Apgar, Holaday, James, Prince, & Weisbrot, 1957), starting the trend toward
regional anesthesia in obstetrics.
The 5 minute Apgar score has been shown to be more predictive of survival than the 1
minute score (Apgar, 1966; Drage, Kennedy, & Schwarz, 1964). A report from the Collaborative
Study of Cerebral Palsy, which involved 17,221 babies at 13 institutions, showed that the Apgar
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score, especially the 5-minute score could predict neonatal survival and neurologic development
(Drage et al., 1964). Several large cohort studies since then have documented that a 5-minute
score <7 is associated with increased risk of neonatal death (Casey, McIntire, & Leveno, 2001;
Moster, Lie, Irgens, Bjerkedal, & Markestad, 2001; Nelson & Ellenberg, 1981; ThorngrenJerneck & Herbst, 2001) and cerebral palsy in term infants (Drage, Kennedy, Berendes, Schwarz,
& Weiss, 1966; Thorngren-Jerneck & Herbst, 2001). This is significant because labor epidural
analgesia administered to the mother has been shown to produce a mild but significant decrease
in Apgar scores at 1 and 5 minutes (Greenwell et al., 2012; Herrera-Gomez et al., 2015). In a
population study of 1 million term births in Sweden (Thorngren-Jerneck & Herbst, 2001),
epidural analgesia was found to be a risk factor for Apgar scores <7, along with several other
obstetric risk factors. The authors concluded that 5-minute Apgar scores <7 are associated with
an increased risk of neonatal morbidity, infant mortality, and neurologic impairment (ThorngrenJerneck & Herbst, 2001).
Neonatal Neurobehavior Tests
Neonatal neurobehavior scales describe the individual infants’ autonomic, motor, state, and
social-attentional systems as they interact with each other and become integrated, how the
neonate is affected by environmental factors, and what the neonate contributes to the
development of the emerging parent-child relationship (Brazelton & Nugent, 2011). Such tests
can assess the neonatal depressant effects of drugs given to the mother intrapartum. Various
neurobehavioral tests have been designed to capture these subtle aspects the Apgar score cannot
detect. Three assessment tools have been used to examine the association between epidural
analgesia and neonatal behavior: the Brazelton Neonatal Assessment Scale (NBAS) (Brazelton,
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1973), the Scanlon Early Neonatal Neurobehavioral Scale (ENNS) (Scanlon, Brown, Weiss, &
Alper, 1974), and the NACS (Amiel-Tison et al., 1982b).
The NBAS, which takes the longest to administer (30-45 min) and requires significant
training to carry out, has been described as the most comprehensive neonatal neurobehavior
examination (Kuhnert, Linn, et al., 1985).
The ENNS was developed by an anesthesiologist to examine neurobehavioral changes that
occur with anesthetic drugs. The test takes 10 minutes to perform and places more emphasis on
muscle tone, reflexes and decrement to stimulation than the NBAS because it is believed these
would be most affected by anesthesia drugs (Kuhnert, Linn, et al., 1985). It covers many of the
same areas as the NBAS, including assessment of state and interaction so it provides a general
evaluation.
The NACS was specifically designed to detect CNS depression of the neonate from drugs
and to differentiate those effects from birth trauma and perinatal asphyxia (Amiel-Tison et al.,
1982a, 1982b). This test does not specifically assess breastfeeding but uses 20 criteria to assess 5
general areas: adaptive capacity, passive tone, active tone, primary reflexes, and general
neurologic status (Amiel-Tison et al., 1982b). The NACS was proposed as a simple, noninvasive,
5 minute neurobehavior exam to assess subtle effects of drugs and distinguish drug effects from
birth trauma. No special training is required to perform the NACS. It has been widely embraced
by the obstetrical anesthesia community and is used worldwide, despite criticism of its reliability
and validity (Brockhurst, Littleford, Halpern, & Fisher, 2000; M. D. W. Camann & Brazelton,
2000) and its ability to differentiate effects among different drugs (Kuhnert, Linn, et al., 1985).
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Labor Pain
Pathophysiology of Childbirth Pain
To understand the nature of labor pain it starts with understanding how nociceptive stimuli
that is centrally received by the parturient called pain. During the first stage of labor dilation)
visceral pain predominates, with pain (nociceptive) stimuli arising from mechanical distention of
the lower uterine segment and cervical dilation (McDonald, 2001; Ward, 1997). High-threshold
mechanoreceptors in the myometrium may also generate nociceptive stimuli in response to
uterine contractions, particularly in long protracted labors (Faure, 1991). The increasing intensity
of pain commonly observed in the progression of dilation may be partially attributed to lower
activation threshold in the mechanoreceptors, and to chemoreceptor stimulation produced by the
repeated stimulation of uterine contractions (Bonica & McDonald, 1990; Brownridge, 1995).
These nociceptive stimuli of the dilation phase are predominately transmitted to the posterior
root ganglia at T 10 through L1 (McDonald, 2001; Ward, 1997). Similar to other types of
visceral pain, labor pain may be progressively referred to the abdominal wall, lumbosacral
region, iliac crests, gluteal areas and thighs (McDonald, 2001). Although virtually all laboring
women experience lower abdominal pain during contractions, 15-74% may also experience
contraction-related low back pain, which for some is continuous even between contractions
(Labrecque, Nouwen, Bergeron, & Rancourt, 1999; Melzack & Schaffelberg, 1987). Some
women experience very widespread and diffuse pain sensations, whereas others feel very
localized pain in specific well defined areas (Melzack, Kinch, Dobkin, Lebrun, & Taenzer,
1984). As the pelvic or descent phase of labor advances (first stage and second stage), somatic
pain predominates from distention and traction on pelvic structures surrounding the vaginal vault
and from distention of the pelvic floor and perineum. Sharp and generally well localized, these
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stimuli are transmitted via the pudendal nerve through the anterior rami of S2 through S4
(McDonald, 2001; Ward, 1997).
In the dorsal horn of the spinal cord, the nociceptive stimuli are processed and transmitted
via the spinothalamic tract to the thalamus, brain stem, and cerebellum, where spatial and
temporal analysis occurs, and to the hypothalamic and limbic systems where emotion (affect)
and autonomic responses originate (Terman & Bonica, 2000). At the level of the dorsal horn,
motor and sympathetic relax activity is stimulated, and modulation of nociceptive impulse
transmission may occur through several complex inhibitory systems activated at many
supraspinal levels of the CNS.
Knowledge of the anatomy of labor pain defines the current treatments of labor pain with
epidural analgesia. The visceral pain of the first stage of labor and sacral somatic pain caused by
descent of the fetus in the birth canal can be completely blocked by epidural analgesia, resulting
in decreased maternal stress response.
The local anesthetics widely used in labor epidurals work by blocking voltage-gated
sodium channels preventing conduction of an action potential in afferent C and A delta fibers
(Lirk, Picardi, & Hollmann, 2014). During the first stage of labor unmyelinated C fibers transmit
slow, dull, poorly localized, visceral pain. Myelinated A delta fibers transmit the rapid, sharp
well localized somatic pain seen in the second stage of labor. Spinal opioid receptors are
positioned to modulate noxious afferent input in the central/spinal axis. Opioids work on the
dorsal horn of the spinal cord, binding with mu, delta, and kappa opioid receptors, causing Gcoupled proteins to activate, and inhibiting the release of Ca++, and K channels. Activation of
the kappa receptor directly inhibits the release of substance P, by blocking Ca++ influx required
for transmitter release at primary afferent terminals. Mu and delta receptors are coupled to
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voltage-dependent K channels and inhibit depolarization of the nerve. Central/ spinal pain
modulation occurs by inhibiting excitatory neurotransmitters such as glutamate and substance P,
from presynaptic afferent nerve terminals that ascend the spinal cord to the brain.
Physical and Psychological Factors Affecting Perception of Pain
The severity and duration of labor pain and suffering are influenced by a number of
physical and psychological factors. Physical factors such as maternal age and parity, maternal
condition, condition of the cervix at the onset of labor, and the relationship of the size and
position of the fetus to the size of the birth canal (Sheiner, Sheiner, & Shoham-Vardi, 1998).
Many of these factors are interrelated. Generally, older nulliparas experience longer and more
painful labors than younger nulliparas (Melzack et al., 1984). The parous cervix begins to soften
before the onset of labor and is less sensitive than the nullipara cervix. The intensity of uterine
contractions in early labor tends to be greater in nulliparas than parous women, whereas the
reverse is true as labor progresses (Wong, 2009). Dystocia caused by a contracted pelvis, a large
baby, or abnormal presentation or position is likely to cause more pain. Women who go on to
have a cesarean delivery after labor have more breakthrough pain during epidural analgesia and
require higher opioid doses during systemic analgesia than women who deliver vaginally
(Alexander, McIntire, & Leveno, 2001; Hess, Pratt, Soni, Sarna, & Oriol, 2000). A history of
dysmenorrhea, maternal fatigue, and general debility are associated with higher levels of pain
(Melzack, 1984).
Psychological factors, including fear, apprehension, and anxiety, and the presence of
family members or birthing companions, also influence pain and suffering during childbirth
(Henneborn & Cogan, 1975; Kennell, Klaus, McGrath, Robertson, & Hinkley, 1991; Lang,
Sorrell, Rodgers, & Lebeck, 2006). Education, intense motivation, and cultural factors influence
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the affective and behavioral dimensions of pain, although they probably affect actual pain
sensation minimally. For example, Bonica observed that women who had predelivery training in
psychoprophylaxis manifested little or no pain behavior during childbirth, although when
questioned the next day, most of them indicated the process had been quite painful (Bonica,
1969).
Labor Pain and Its Effects on Mother and Fetus
During the first stage of unmodified labor, maternal respiration increases by 75-100%
(Hagerdal, Morgan, Sumner, & Gutsche, 1983). Maternal hyperventilation in response to pain
has long been known to have negative effects on the fetus (Huch, 1986; Motoyama, Rivard,
Acheson, & Cook, 1966). This leads to hypocarbia and respiratory alkalosis, which can disrupt
placental transfer of oxygen (Reynolds, 2010). A compensatory metabolic acidosis becomes
progressively more severe as labor advances, and is conveyed to the fetus (Thalme, Belfrage, &
Raabe, 1974). Episodes of hypoventilation that occur between contractions lead to oxygen
desaturation (Minnich, Brown, Clark, Miller, & Thompson, 1990). Maternal hyperventilation
causes vasoconstriction which affect the uterine arteries (Huch, 1986). There is a shift in the
oxygen disassociation curve. It was demonstrated years ago in sheep that maternal
hyperventilation resulted in reduced oxygen content in umbilical venous blood, and restoring the
carbon dioxide to normal reversed this effect (Levinson, Shnider, DeLorimier, & Steffenson,
1974). The adverse effects of hypocarbia at first were harder to demonstrate in humans (Huch,
1986). However, a reversal of this phenomenon could explain the reduction of metabolic acidosis
seen in regional anesthesia. Maternal hyperventilation lowers the partial pressure of carbon
dioxide (pCO2) of the umbilical artery, but as labor progresses this change is overcome by an
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increased severity of metabolic acidosis to the extent that the longer the second stage of labor
(pushing to delivery) the lower the cord pH will be at birth (Pearson & Davies, 1974b).
Maternal stress and pain adversely affect the fetus. The stress of labor also leads to the
release of maternal cortisol and catecholamines and prolongs labor (Lederman, Lederman, Work,
& McCann, 1978; J. Moore, 1993; Myers, 1975). Painful labor activates the stress response with
release of β lipotropin and ACTH thus β endorphin and cortisol with the βendorphin having very
little analgesic effect. The increased sympathetic/ adrenal activity can lead to uncoordinated
uterine movement and decreased uteroplacental perfusion (Loo & Irestedt, 2000). The metabolic
outcome of the stress response is hyperglycemia with poor insulin response, lipolysis with
release of free fatty acids, ketones and lactate (Reynolds, 2010). Catecholamines, along with the
metabolic acids, readily cross the placenta, increasing the oxygen requirement of the fetus,
another outcome of maternal metabolic acidosis compounded in the fetus (Thalme et al., 1974).
Although the maternal stress response is relatively counterproductive, it can be suppressed
by epidural analgesia. In contrast, the fetal stress response is beneficial for adaptation to
extrauterine life and is not suppressed by maternal epidural analgesia (Irestedt, 1993; Westgren
et al., 1986). Particularly during the second stage (complete cervical dilation to delivery of
neonate), labor induces a massive catecholamine (epinephrine and norepinephrine) surge in the
fetus, which helps to preserve blood flow to brain, heart, and adrenals and to promote postnatal
adaptive circulatory changes and surfactant release (Reynolds, 2010).
The amount of pain a woman feels when she is in labor is influenced by a number of
physical factors, including oxytocin augmentation, dysfunction of labor, and the duration and
progress of the labor. Women experience pain in a variety of ways, and the way a woman copes
with the pain is influenced by psychological and environmental factors, the circumstance of her
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labor, her cultural background, the support available to her, and her preparation for labor (AnimSomuah et al., 2011). Suffering during labor can have a negative effect on her psychologically,
lead to labor dysfunction and postpartum depression which all can influence breastfeeding
negatively (Montgomery et al., 2012). The overwhelming physiologic stress in labor experienced
by the mother can cause physiologic stress to the fetus which may affect breastfeeding initiation
at birth (Montgomery et al., 2012).
Labor induces a massive catecholamine (epinephrine and norepinephrine) surge in the
fetus, particularly in the second stage, which helps to preserve blood flow to brain, heart, and
adrenals and to promote postnatal adaptive circulatory changes and surfactant release (Reynolds,
2010). Although this stress response is advantageous to the fetus, unmedicated labor produces
maternal physiological changes that can affect the fetus adversely. Maternal hyperventilation in
response to pain has long been known to have negative effects on the fetus (Hutch, 1986;
Motoyama et al., 1966). This leads to respiratory alkalosis and a left shift in the oxygen
disassociation curve which can disrupt placental transfer of oxygen (Reynolds, 2010). A
compensatory metabolic acidosis, which becomes progressively more severe as labor advances
and is conveyed to the fetus (Thalme et al., 1974), episodes of hypoventilation between
contractions leading to oxygen desaturation (Minnich et al., 1990) and uterine vasoconstriction
(Hutch, 1986). Additionally the stress of labor also leads to the release of maternal cortisol and
catecholamine's, which may prolong labor and impair placental flow (Lederman et al., 1978;
Ohno et al., 1986; Segal & Wang, 2008). Stress hormones also bring about lipolysis (with release
of free fatty acids that readily cross the placenta) and hyperglycemia, which exacerbate fetal
hypoxia (Reynolds, 2010). All these changes tend to intensify fetal metabolic acidosis which
becomes progressively worse as labor progresses (Thalme et al., 1974).
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History of Labor Analgesia
On January 19, 1847, James Young Simpson used diethyl ether to anesthetize a woman
with a deformed pelvis for delivery of her child. The era of obstetrical anesthesia had begun.
Simpson was highly criticized for his etherization of childbirth. The medical community,
including obstetricians, believed that uterine pain was inseparable from contractions, and any
drug that abolishes pain would alter contractions (Caton, 2014). Clergy argued that childbirth
pain is God’s punishment to Eve and her descendents for disobedience in the garden of Eden,
and it was wrong to avoid the pain of divine punishment (Caton, 2014). The controversies
continued until 1853 when John Snow administered chloroform to Queen Victoria during the
birth of her 8th child, Prince Leopold. Queen Victoria's decision to use an anesthetic during labor
shattered the clergy’s argument and empowered women. Women lost their skepticism,
announced they wanted anesthesia, and essentially forced their physicians to provide it to them.
By 1860, because of the demands of women, anesthesia for childbirth became part of medical
practice. Physicians used obstetric anesthesia sparingly until the early twentieth century, when
suffragettes recognized that they could not participate fully in the economic and political life of
the country unless they were healthy. For this reason they made obstetric care, including
anesthesia, part of their campaign for political party (Caton, 2014).
Early feminists had a good reason to be concerned about obstetric care. Despite many
improvements to medicine, maternal morbidity and mortality hardly changed between 1830 and
1930. Women were debilitated by the sequelae of poorly managed deliveries and exhausted by
frequent pregnancies and management of large families. Accordingly feminists sought care by
obstetricians rather than midwives, deliveries in hospitals rather than at home, and adequate time
for recuperation before returning to their normal responsibilities (Caton, 2014).
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They also campaigned for obstetric anesthesia. Feminists and physicians alike believed
that the pain of childbirth, in and of itself, contributed to the disability of women later in life. To
improve the quality and availability of anesthesia, feminists founded two organizations. The
National Twilight Sleep Association began in the US just before the beginning of World War I,
and The National Birthday Trust Fund started in Great Britain in 1928. Both organizations
influenced the practice of obstetric anesthesia. Physicians explored new ways to manage labor
pain, including use of rectal ether and intravenous opioids. They also performed many important
studies on the use of regional anesthesia (Caton, 2014).
A major development in obstetric anesthesia occurred around 1910 with the development
of Dämmerschlaff or “twilight sleep.” It combined opioids and scopolamine to make women
amnestic and provide some comfort during labor while they remained awake. However, it left the
women disoriented and uncoordinated where they were no longer actively involved in the birth
of their infant. Recovery was long after these medications, preventing mothers from caring for
their infants. Hence, they were taken to the nursery and cared for by nurses. The infants would
subsequently be fed formula. The period from 1860 through 1940 was referred to as the “dark
ages of obstetric anesthesia and analgesia,” with minimal progress in obstetric analgesia and
anesthesia (Bonica, 1995). The introduction of regional anesthesia would be the next major
change in obstetric anesthesia.
In 1885, Leonard Corning, a new York neurologists inadvertently performed the first
epidural analgesia by injecting cocaine in the lower back of a gentleman with the intention to
cure him of his complaint of masturbation (Corning, 1885). Based on the description of the
results and the manner of onset of analgesia, there is little doubt that this was an epidural. In
addition, it was a “walking epidural”; the man experienced dizziness but his motor function was
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intact, and he displayed no observable uncoordinated movements. He left an hour after his
injection. After this account, Corning introduced the term “spinal anesthesia” (Brill, Gurman, &
Fisher, 2003).
The first papers describing obstetric applications of spinal and lumbar epidural appeared
between 1900 and 1930 (Caton, 2014). The origin of epidural analgesia began with Jean Enthuse
Sicard, a neurologist who treated sciatica and tabes by injecting cocaine through the sacral
hiatus. Known as caudal anesthesia, this method was used to provide surgical anesthesia. Fidel
Pages-Mirave, a Spanish surgeon, first used the lumbar approach to the epidural space for
surgical anesthesia in 1921. He introduced the idea of “segmental anesthesia,” where loss of
sensation is limited to an area supplied by one or two spinal nerves. This was a huge contribution
to the field because it eliminated the side effects of complete spinal anesthesia blocks. Sadly,
Pages-Mirave died in a motor vehicle collision before he could publish his findings. In 1931,
Achille Dogliotti independently identified the epidural space and described its anatomy and
physiology in detail. Dogliotti developed the modern “loss of resistance” technique used to find
the epidural space. He also published a report on the introduction of local anesthetics into the
epidural space. The technique at this time involved a single bolus of local anesthetic, limiting the
duration of anesthesia provided by epidural anesthesia (Dogliotti, 1931). This dilemma was
solved in 1947, when Manuel Martinez Curbelo of Cuba used a Tuohy needle and a small
ureteral catheter to provide "continuous lumbar epidural infusion for analgesia” (Curbelo, 1949).
Major change in obstetric anesthesia and analgesia came when John Bonica, who later
became the first chairman of the Department of Anesthesiology at the University of Washington,
took over his wife’s pain management during her labor in 1943. She had a close to fatal
complication with open-drop ether, and his management of her anesthesia probably saved her
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life. From the moment he intervened to save his wife’s life, he devoted his career to pain
management and advancing anesthesia care of the mother and fetus (Chadwick, 2005).
Caudal anesthesia was the primary means of providing labor pain relief when Bonica was
chief of anesthesia. In 1943, Hingson and Edwards published a method for continuous caudal
analgesia for labor in which a malleable needle remained in the sacral canal throughout labor and
tetracaine (Pontocaine) was introduced (Hingson & Edwards, 1943). In 1970, small flexible
catheters replaced the needles. Only when commercially produced catheters became readily
available in the 1970s did labor epidural analgesia become more popular (H. S. Chadwick,
2005).
For obstetricians, regional anesthesia had many advantages. First, it appeared safe and easy
to manage, which was important because qualified anesthesia providers were in short supply.
Second, regional anesthesia allowed obstetricians to make more liberal use of operative
techniques for vaginal delivery (e.g., episiotomy, use of forceps), which were just coming into
vogue. No less important, regional anesthesia appeared to satisfy the desires of women who
wanted more comfortable deliveries. These motives prompted the use of more regional blocks,
including presacral, paravertebral, spinal lumbar epidural, and caudal epidural anesthesia.
In 1967, the first volume of Bonica’s classic textbook Principles and Practice of Obstetric
Analgesia and Anesthesia was published (Bonica, 1967). The book was a comprehensive
discourse on almost everything known in obstetric anesthesia. It examined the anatomy and
physiology of uterine function and childbirth pain, including the neurologic pathways involved
in the perception of childbirth pain. It brought together studies of placental structures and
function pointed to the transmission of drugs and the effects the drugs may have on the infant.
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The studies of the anatomy and physiology of the uterus worked to identify the effects of
inhalation and regional anesthesia on the labor process.
In 1978, Philip Bromage published the book Epidural Analgesia, which took the practice
of epidural analgesia to the modern era and played an essential role in the acceptance and use of
epidural analgesia in obstetrics and pain management (Bromage, 1978). Subsequent problems
with the use of epidurals during labor stimulated detailed and accurate studies of the effects of
anesthesia with modifications of techniques. The introduction of opioids to either the spinal or
epidural space was a significant development in obstetric anesthesia, making labor and delivery
even less painful. This stirred practitioners in the 1980s and 90s to reexamine the effects of drugs
on the fetus, neonate, mother, and the labor process. As a result of these studies, a number of
modifications were made to minimize adverse effects.
Systemic Analgesia
Systemic opioids are still the most widely used medication for labor analgesia worldwide
(Pandya, 2010). Systemic analgesia is dependent upon an effective concentration of drug in
maternal circulation and any drug that affects the maternal CNS crosses the blood-brain barrier
and also the placenta. Drugs given systemically over time affect the mother as well as the fetus.
Because of the effects the doses of these medications are limited and pain relief is insufficient to
reduce any of the adverse effects of labor pain.
The most common parenteral opioids used for labor pain relief are morphine and pethidine
(Demerol), administered IV or intramuscularly (IM). Respiratory depression of the neonate is a
common and the most serious adverse effect of intrapartum opioid administration (B. A.
Lieberman et al., 1979; Schnider & Moya, 1964; Wiener, Hogg, & Rosen, 1979). Studies have
demonstrated systemic opioids decreased neonatal alertness (Belsey et al., 1981), lower neonatal
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neurobehavior scores (Hodgkinson, Bhatt, & Wang, 1978), impairing mother-infant interaction
(Moreau & Birch, 1974; Richards & Bernal, 1972; Scanlon et al., 1974; Standley, Soule, Copans,
& Duchowny, 1974), inhibition of sucking (Kron, Stein, & Goddard, 1966; Nissen et al., 1995;
Righard & Alade, 1990), and a delay in effective feeding (Crowell, Hill, & Humenick, 1994;
Matthews, 1989). The neonatal behavior variables measured at delivery and found to be affected
were reduced alertness, more likely to cry when handled, and decreased measures of
consolability which is the ease with which the tester could quiet the infant (Belsey et al., 1981).
CNS depression affects the infant’s tone, with fewer and less well directed movements, less
spontaneous motor activity when awake, impaired success in the infants ability to move the hand
to mouth all impairing the infants ability to breastfeed (Belsey et al., 1981; Kraemer, Korner, &
Thoman, 1972). Drug exposure reduced the infant’s ability to quiet himself after arousal, with
frequent state changes from sleep through wakefulness to crying (Belsey et al., 1981; Emde,
Swedborg, & Suzuki, 1975).
The majority of studies on maternal systemic opioid and its effects on the fetus/neonate
have focused on pethidine (meperidine) because it has been in frequent use worldwide for a long
time. Detrimental effects could last up to 72 hours postpartum due to the accumulation of
norpethidine (normeperidine) (Kuhnert, Kuhnert, Philipson, & Syracuse, 1985). Maximal fetal
exposure of respiratory depression (Belfrage, Boreus, Hartvig, Irestedt, & Raabe, 1981; Hamza
et al., 1992), and metabolic acidosis (Sosa et al., 2006) were seen when pethidine was given 3 to
5 hours before delivery; however, if administration was 1 hour before delivery, effects were
barely noticeable. Infants whose mothers received pethidine during labor sucked at significantly
lower pressures and rates and consumed less milk than those whose mothers received no
medication (Kuhnert, Kuhnert, et al., 1985).
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In summary, the adverse effects on the neonate of parenteral opioids given during labor are
well documented, and there is no evidence to support their continued use.
Epidural Medications
The most common drugs used for epidural analgesia contain combinations of local
anesthetics with an opioid and are set on a continuous infusion, often for many hours.
Bupivacaine is the mainstay local anesthetic used and is commonly combined with fentanyl. The
dosage frequently used in this setting for continuous labor epidural infusions is 0.125%
bupivacaine with 2-3 µg/mL fentanyl. At Yale New Haven Hospital, the standard protocol for
otherwise healthy parturients who request epidural analgesia for vaginal delivery calls for a
continuous infusion of 0.05% bupivacaine with 3 g/mL hydromorphone instead of fentanyl.
Low-Dose Local Anesthetic Epidurals
In the early years of labor epidurals, bupivacaine doses of 0.2-0.25% were used to maintain
labor pain relief by blocking both somatic and visceral pain. The high concentration of local
anesthetics produced very dense pain relief but also caused many unwanted side effects, such as
motor block, hypotension, extreme sensory deficit, and rarely toxicities to the fetus. The
discovery of opioid receptors on the dorsal horn of the spinal cord changed epidural analgesia.
Opioids administered in the epidural space bind directly on the opioid receptors on the spinal
cord without the effects seen when administered intravascular. Intrathecal opiates could relieve
the visceral pain of the first stage of labor but to relieve the somatic pain of the late first stage to
second stage of labor a local anesthetic needed to be combined.
When combined, epidurally administered local anesthetics and lipid-soluble opioids work
together to provide analgesia (Lyons, Columb, Hawthorne, & Dresner, 1997; Polley, Columb,
Wagner, & Naughton, 1998; Vercauteren & Meert, 1997). During the past 10 years,
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concentrations of local anesthetics have decreased to 0.0625 %- 0.125%, lowering the total
amount of local anesthetic used and eliminating many of the side effects, such as motor
blockade, associated with the higher doses of local anesthetics. In addition, the lower doses of
opioid needed for analgesia reduce the side effects seen with systemic absorption of high doses
of opioids. An important aspect of labor analgesia is latency. The supplement of a lipid-soluble
opioid to long acting/long latency local anesthetics shortens latency (Justins, Francis, Houlton, &
Reynolds, 1982). Hence, present day labor epidural analgesia usually combines a low-dose long
acting local anesthetic with an opioid. Bupivacaine is the mainstay local anesthetic used and is
commonly combined with fentanyl. Bupivacaine is highly protein bound, so placental transfer is
low with a duration of analgesia of 2 hours.
Ropivacaine is a homologue of bupivacaine with a latency and duration similar to that of
bupivacaine (J. A. Katz, Bridenbaugh, Knarr, Helton, & Denson, 1990) without the cardio
toxicity bupivacaine. Studies on potency have suggested that ropivacaine is 40% less potent than
bupivacaine (Polley, Columb, Naughton, Wagner, & van de Ven, 1999). However, clinical
studies have shown no difference in terms of sensory blockade between low-concentration
epidural infusions of ropivacaine and bupivacaine (Beilin et al., 2007; Lee, Ngan Kee, Ng, Lau,
& Wong, 2004). When equal potent sensory doses were compared ropivacaine may be associated
with less motor blockade than bupivacaine (Beilin et al., 2007; Lacassie, Habib, Lacassie, &
Columb, 2007). This characteristic is probably not clinically significant when low doses of
bupivacaine are used (Wong, 2009).
A 2013 meta-analysis (Sultan, Murphy, Halpern, & Carvalho, 2013) that included 15
articles involving 1,997 patients compared the effect of low-concentration epidural bupivacaine
(≤0.1%) or ropivacaine (≤0.17%) versus high concentration of local anesthetics on obstetric and
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anesthetic outcomes. Although 1-minute Apgar scores <7 favored the high concentration group,
low concentrations of labor epidural solutions improved obstetric outcomes (decrease in
frequency of assisted vaginal delivery, shorter duration of second stage of labor) and reduced
maternal side effects (less motor blockade, better ambulation, and decreased urinary retention)
without compromising analgesia. The authors recommended the use of low concentrations of
local anesthetics for epidural analgesia to optimize obstetric outcome.
Properties of Epidural Opioid Analgesia
Lipid solubility of an opioid is one of the most important factors in determining its
individual effects (Wagemans, Zuurmond, & de Lange, 1997). Lipid solubility determines how
the drug is absorbed into local tissue, traverse the dura and gain access to the cerebral spinal fluid
(CSF) or be absorbed systemically (Brose, Tanelian, Brodsky, Mark, & Cousins, 1991). Once the
drug is administered in the epidural space, the pharmacology and pharmacodynamics of the drug
allocate its unique profile of analgesia and side effects.
Pharmacokinetic studies have shown that highly lipophilic opioids such as fentanyl and
sufentanil diffuse freely from the epidural space into the maternal blood and across the placenta
(de Barros Duarte et al., 2009; Desprats et al., 1991). Because fentanyl is so frequently used in
this setting, it has been well researched and its effects documented. The side effects of fentanyl,
such as sedation, vomiting, pruritus, and, although rare, neonatal respiratory depression, are
known (Carrie, O'Sullivan, & Seegobin, 1981; M. Kumar, Chandra, Ijaz, & Senthilselvan, 2014;
M. Kumar & Paes, 2003; Noble, Morrison, Brockway, & McClure, 1991, 1994). Most studies
have focused on neonatal outcomes in the delivery room, ignoring the possibility of lateoccurring side effects that can arise up to several hours after exposure because of the longer
terminal half-life of fentanyl in neonates. Because it is bound principally to albumin and
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becomes unbound during the first day of life, increasing the free concentration of fentanyl,
secondary peaks in plasma drug concentration can occur (R. Katz & Kelly, 1993; Koehntop,
Rodman, Brundage, Hegland, & Buckley, 1986; Leighton & Halpern, 2002; E. Lieberman &
O'Donoghue, 2002; McClain & Hug, 1980; Reynolds, 2011). A 2014 case-control study showed
a positive association between exposure to traditional fentanyl-bupivacaine infusate in maternal
epidural analgesia and respiratory distress in neonates at ≥34 weeks gestation within 24 hours of
life who required supplemental oxygen ≥2 hours and/or positive pressure in the neonatal
intensive care unit (M. Kumar et al., 2014).
Neonatal Drug Exposure After Epidural Analgesia During Labor
Placental Drug Transfer by Diffusion
Most drugs, including those used for analgesia and anesthesia cross the placenta by passive
diffusion. Diffusion is dependent on a concentration gradient across the placenta with drugs
passively moving from areas of high concentration to low. The placenta is a lipid membrane and
lipophilic molecules diffuse readily across lipid membranes. Drugs with a molecular weight of
<500 Da readily diffuse across the placenta. Most drugs used in anesthesia, including opioids and
local anesthetics have molecular weights <500 Da.
Only the non-ionized portion of a partially ionized drug crosses the placenta (Griffiths &
Campbell, 2014). The pH of maternal blood and the pKa of the drug determine the degree to
which the drug is ionized. Most drugs used in anesthesia are poorly ionized in blood therefore
un-ionized unbound drug readily crosses the placenta. If the pH of maternal blood changes, such
as in labor, then changes in the degree of ionization of the drug and placental transfer can occur.
The transplacental distribution of lipophilic substances whose unbound and un-ionized
particles readily cross the placenta is influenced by the transplacental gradient for protein
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binding and pH. Fetal pH is lower than maternal pH, therefore free bases tend to stay on the fetal
side due to ion trapping, and weak acids to the reverse (Reynolds, 2010). If the fetus becomes
acidotic basic drugs such as local anesthetics and opioids can accumulate in the fetus called “ion
trapping” (Griffiths & Campbell, 2014). Ion trapping occurs when the lower pH of the fetus
produces an increased portion of ionized drug, which is then unable to cross the placenta
increasing the exposure to the drugs.
Acidic drugs bound mainly to albumin do not diffuse across the placenta. Only the
unbound portion of the drug is free to cross the placenta. For most basic drugs, the major binding
protein is α1-acid glycoprotein, the concentration which is always higher in maternal than fetal
plasma (Krauer, Dayer, & Anner, 1984). For drugs that are mainly bound to α1-acid
glycoprotein, higher maternal than fetal binding reduces the equilibrium fetal/maternal ration
(Reynolds, 2010).
Placental Transfer of Epidural Medications
Bupivacaine, the local anesthetic most frequently used in labor epidural analgesia has a
high degree of protein binding in maternal and fetal circulation. It has been established there is
excessive bupivacaine binding to maternal α1-acid glycoprotein (90%) compared to fetal protein
binding (50%) and that the difference in protein binding affects placental transfer of bupivacaine
(R. F. Johnson et al., 1995; Mather, Long, & Thomas, 1971). When both maternal and fetal
plasma have normal physiologic serum protein levels, the maternal-to-fetal bupivacaine transfer
ratio decreased and the fetal-to-maternal transfer increased (R. F. Johnson et al., 1995). This
difference in transfer is due to the amount of free (un-ionized) drug available for placental
transfer. It has been definitely established in these studies that drugs that are demonstrate more
protein binding potentials express these elements in the maternal-fetal gradient. For example
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placental bupivacaine transfer increased as the amount of protein in the receiving perfusate was
increased (Hanshaaw-Thomas & Reynolds, 1985). Increased bupivacaine clearance across the
placenta is also related to the maternal-fetal gradient of unionized bupivacaine. This is clinically
significant under pathological conditions when maternal and fetal plasma levels of protein are
not normal. For instance, in severe pre-eclampsia maternal protein binding is reduced leading to
greater transfer of bupivacaine across the placenta to the fetus.
Using pregnant rabbit (Gaylard, Carson, & Reynolds, 1990) and ewe (Biehl, Shnider,
Levinson, & Callender, 1978; Pickering, Biehl, & Meatherall, 1981) models, researchers found
increased bupivacaine concentration in the umbilical vein related to lower pH of fetal circulation.
It has been proposed decreased fetal pH results in ion trapping leading to the higher fetal
bupivacaine concentration. It has further been determined that the increases in fetal bupivacaine
concentration may also be due to the decreased ability of the fetus to clear the drug and changes
in tissue distribution (Finster, Ralston, & Pedersen, 1993). Regardless this information is
extremely important to the safety of the fetus. Researchers have established increased sensitivity
of the fetus during times of hypoxia and fetal acidosis to the harmful effects of bupivacaine (R.
F. Johnson et al., 1995; Morishima & Covino, 1981; Morishima et al., 1989). During fetal
acidosis, bupivacaine transfer may be increased by a large factor.
The transfer of lipophilic drugs by diffusion across the placenta and equilibrium takes
longer in fetal than maternal tissue because the fetal compartment is deep. Fetal exposure is
dependent on blood flow on both sides of the placenta (flow-dependent transfer), duration of
exposure and equilibrium ratios (Reynolds, 2010). The immediate effect of the drug is related to
the concentration of free unbound drug however a large albumin-bound portion is a storehouse
for the neonate (Reynolds, 2010). During the first days after delivery, albumin binding declines,
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increasing free concentrations of drugs such as fentanyl and diazepam (Nau, Luck, Kuhnz, &
Wegener, 1983).
Bader et al. (1995) evaluated umbilical vein and maternal vein concentrations of fentanyl
and bupivacaine after continuous epidural infusion during labor (Bader et al., 1995). In their
study, 21 parturients received 0.125% bupivacaine and 2 g/mL fentanyl at a constant rate of 10
mL/h (12.5 mg/h bupivacaine and 20 g/h fentanyl). Maternal vein (MV) and umbilical vein
(UV) concentrations were measured at birth. Length of infusion ranged from 1 to 15 hours. The
mean value of bupivacaine in MV was 0.50 ± 0.16 and UV 0.15 ± 0.06 with an UV/MV ratio
0.03. Bader et al. (1995) did not find a statistically significant relationship between duration of
infusion and accumulation of either drug but did suggest rapid placental transfer and
equilibration of fentanyl between maternal and neonatal blood and a maternal-neonatal gradient
for bupivacaine concentration, attributed to placental deposition and protein binding (Bader et
al., 1995).
Data from the study by Bader et al (1995) are consistent with those of Abboud and
colleagues (Abboud et al., 1984), who observed patients receiving 0.125% bupivacaine at a rate
of 14 mL/h. Their data showed a MV bupivacaine concentration of 0.54±0.10 and a UV
concentration of 0.18 ± 0.04, with a UV/MV ratio of 0.33. The low UV/MV ration is reflective
of bupivacaine high protein binding and lipid solubility. In vitro studies examining isolated
human placental cotyledons support these theories, showing a fetomaternal concentration
gradient mean of 0.58 (Ala-Kokko, Plenimaki, Hollmen, & et al., 1993). Although bupivacaine
rapidly crossed from the MV to the fetal reservoir, the fetomaternal concentration was low,
suggesting placental deposition of this extremely lipid-soluble drug. These two studies showed
no correlation with cord blood level of bupivacaine and duration of infusion. Radzyminski did
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find a significant correlation between bupivacaine concentration in cord blood and length of
infusion time (Radzyminski, 2005). The dose of bupivacaine in that study was 0.044% at a
continuous infusion of 14 mL/h. The longer the epidural infusion ran, the greater the
concentration of bupivacaine in cord blood at delivery. However, the levels of bupivacaine were
low when compared to the amount of drug infused, and she found no difference in breastfeeding
or neurobehavior between the epidural group and the nonmedicated group.
Fentanyl is also detectable in the cord blood after birth. Bader and colleagues reported MV
concentration of 0.17 ± 0.10 ng/mL, UV concentration 0.16 ± 0.09 ng/mL, and a UV/MV ratio of
0.94 (Bader et al., 1995). The UV/MV ratio was quite high, suggesting placental transfer was
rapid, and UV concentration quickly reached equivalence with MV concentration. Fentanyl is
highly lipid soluble and it would be expected to cross the placenta rapidly. Animal studies
support this theory. An early animal study examined maternal and fetal fentanyl concentrations
1-60 minutes after a bolus of medication was given (Craft et al., 1983). There was a rapid decline
in maternal concentration, demonstrating rapid redistribution and uptake in maternal tissue, with
the fetal concentration profile running parallel to maternal decline. The UV/MV ratio in both
studies remained equal over time not changing with longer infusion times. In addition, an in vitro
human placental study that examined uptake and distribution of fentanyl reported equal M→F,
F→M clearance of fentanyl (Zakowski, Schlesinger, Dumbroff, & et al., 1993). They found that
the transfer of fentanyl reached a plateau within 40-80 minutes of continuous infusion, alluding
to passive transfer of fentanyl across the placenta. They also found a high amount of fentanyl in
placental tissue, suggesting the placenta serves as a storehouse for fentanyl. To date there have
been no studies that have examined whether there is an interaction between bupivacaine and
fentanyl facilitating or inhibiting transfer of either drug. The results of these three studies show
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MV and UV fentanyl concentrations are low and fentanyl levels did not correlate with infusion
time.
Fetal Tissue Uptake
UV samples do not mirror fetal tissue uptake. In animal studies fentanyl showed a large
distribution to all tissue and a clearance rate dependent on dose (Murphy, Hug, & McClain,
1983). Clearance rate for the neonate is slow due to immature liver enzymes, and may at first
distribute to the brain or heart (Gauntlett et al., 1988). Maternal half-life of fentanyl is
approximately 8 hours (Moises et al., 2005); however, fetal half-life is difficult to measure
quantitatively after exposure to maternal epidural analgesia because of the fetal tissue uptake
(Desprats et al., 1991; Paech, Westmore, & Speirs, 1990). Therefore, because of the unknown
amount of fentanyl accumulation in fetal tissue of this highly lipophilic drug, UV measurements
of fentanyl may not be accurate (Capogna & Camorcia, 2004).
The importance of fetal tissue accumulation of bupivacaine is unknown. Tissue uptake by
the nonvital organs of the fetus may impede increased bupivacaine levels in fetal heart and brain.
It has been suggested that the fetus metabolizes and excrete bupivacaine like an adult (Mango,
Berlin, Karlsson, & et al., 1976). Small amounts of bupivacaine metabolites have been found in
neonatal urine 36 hours after delivery (Kuhnert, Zuspan, Kuhnert, Syracuse, & Brown, 1987). In
the absence of observable neurobehavioral deficits, it would convey that there is not enough
bupivacaine accumulation to impair CNS function in the neonate.
Epinephrine
Epinephrine is frequently added to the local anesthetic to slow the vascular uptake of the
local anesthetic and opioids from the spinal space. The addition of epinephrine to bupivacaine
has been shown to reduce plasma levels of bupivacaine by approximately 17% in the fetus and
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30% in maternal circulation (Abboud et al., 1989). Some studies suggest the effects of
epinephrine on fetal drug levels were smaller than the effect on maternal plasma levels;
therefore, the fetal/maternal concentration gradients were higher for bupivacaine plus
epinephrine than for bupivacaine alone (Beazley, Taylor, & Reynolds, 1972; Belfrage, Berlin,
Raabe, & Thalme, 1975; Belfrage, Raabe, Thalme, & Berlin, 1975; Reynolds & Taylor, 1971).
Other studies did not confirm the increased fetal/maternal ratios following co-administration of
epinephrine. Hence, most authors regard the addition of epinephrine to the local anesthetic as
unnecessary, especially since the duration of anesthesia was not prolonged (Jouppila et al., 1978;
Nesheim, 1983), and epinephrine can alter uterine blood flow leading to uteroplacental
insufficiency and prolong labor (Nesheim, 1983).
Epidural Hydromorphone
Hydromorphone is a mu receptor agonist with pharmacokinetic properties intermediate
between highly hydrophilic morphine and highly lipophilic opioids such as fentanyl and
sufentanil (Reisine & Pasternak, 1996). After epidural administration, the amount of drug that
penetrates dura and pia-arachnoid to enter the CSF and spinal compartments is inversely
proportional to its lipid solubility and polarity (Chrubasik, Chrubasik, & Martin, 1993; Herz &
Teschemacher, 1971; Plummer, Cmielewski, Reynolds, Gourlay, & Cherry, 1990; Sinatra et al.,
2000; Yaksh, Al-Rodhan, & Jensen, 1988). For example, high lipid solubility increases systemic
absorption and reduces availability of the drug in the dorsal horn of the spinal cord thereby
continually needing more drug to extend their limited duration of action (Bernards et al., 2003;
Sinatra et al., 2000). Hydrophilic opioids have more difficulty traversing neural and vascular
membranes, staying in the spinal compartment, increasing the availability of drug on the dorsal
horn of the spinal cord, and ensuring lower concentration of drug needed for continued receptor
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site activity (Sinatra et al., 2000). Placental transfer of hydrophilic opioids is impeded and they
therefore diffuse across slowly and are unlikely to attain effective concentration in the fetus
(Reynolds, 2011; Syme, Paxton, & Keelan, 2004).
This gain in opioid-mediated analgesic effect provides a local anesthetic dose-sparing
effect, allowing the use of bupivacaine as an adjunct rather than primary analgesic where
infusions are 2-2.5 times as dilute as those traditionally seen in continuous labor epidural
infusions (Sinatra et al., 2000).
Quality of pain relief for continuous epidural infusion containing 0.05% bupivacaine plus 3
g/mL hydromorphone was evaluated in 1830 parturients requesting analgesia during labor and
delivery (Sinatra et al., 2002). The infusion provided rapid and effective analgesia and minimal
adverse events for patients whom differed in parity and at varying stages of labor. Pain relief was
maintained in most patients without need for epidural reinforcement (Sinatra et al., 2002).
Clinically significant adverse events including excessive maternal sedation, profound
hypotension, respiratory depression, clinically significant motor blockade, and severe fetal
bradycardia were not observed (Sinatra et al., 2002). The fact that patients report highly effective
pain control with epidural doses comparable to fentanyl is significant, considering that
intravenous doses of fentanyl are 10-12 times more potent than hydromorphone.
The author of this dissertation and colleagues conducted a prospective observational study
in 2012 at Yale New Haven Hospital to determine neonatal and maternal exposure to
hydromorphone and bupivacaine in the epidural solution (Shah, French, Dai, & Snegovskikh,
unpublished data, 2012). Ten healthy parturients with uncomplicated pregnancies received an
initial bolus of 100 g hydromorphone and 9 mL 0.25% bupivacaine, followed by continuous
infusion of 0.05% bupivacaine and 3 g/mL hydromorphone at 14 mL/h (0.7 mg/h bupivacaine
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and 42 g/h hydromorphone), which is the standard protocol at Yale New Haven Hospital. If
necessary, additional boluses of 0.25% bupivacaine were given to maintain analgesia. As
mentioned above, Sinatra and colleagues (Sinatra et al., 2002) had previously found that this
protocol achieved a level of analgesic efficacy comparable to that with 0.125% bupivacaine 2
g/mL fentanyl, despite earlier findings that the IV potency of hydromorphone is only 1/10 to
1/12 that of fentanyl (Reisine & Pasternak, 1996). Umbilical vein and maternal vein blood
samples were obtained within 15 minutes of delivery to determine hydromorphone and
bupivacaine concentrations. The umbilical/maternal vein ratio was calculated for each sample.
Table 1 compares the results of our study with those of Bader et al. (1995) and with those
of another study by Abboud et al., who observed patients receiving 0.125% bupivacaine at a rate
of 14 mL/h (Abboud et al., 1984).
Table 1.

Drug Concentration Data in Maternal Vein (MV) and Umbilical Vein (UV)
MV
concentration

UV
concentration

UV/MV
ratio

Bupivacaine, μg/mL

0.23±0.18

0 (0-0)a

0 (0-0.06)

Hydromorphone, ng/mL

0.26±0.09

0.23±0.09

0.88±0.11

Bupivacaine, μg/mL

0.50±0.16

0.15±0.06

0.30

Fentanyl, ng/mL

0.17±0.10

0.16±0.09

0.94

0.54±0.10

0.18±0.04

0.33

Shah et al (unpublished data)

Bader et al. (1995)

Abboud et al. (1984)
Bupivacaine, μg/mL
MV = maternal vein; UV = umbilical vein.
Data are expressed as mean ± SD unless otherwise noted.
a

Median (interquartile range). The UV concentration was 0 μg/ml in 8 of 10 neonates, 0.10 in one, and 0.16 μg/ml in
one.
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Consistent with the results of the Bader et al. study, we found that maternal and umbilical
vein concentrations were independent of duration of epidural infusion/total amount of infusate.
Maternal venous concentrations of hydromorphone and bupivacaine were highly correlated,
consistent with maternal vascular absorption of the infusate from the epidural space. The overall
concentration of bupivacaine needed to achieve efficacy was much lower when bupivacaine was
combined with hydromorphone rather than fentanyl, resulting in lower maternal vein
concentrations of bupivacaine in our study than in the other two studies. Furthermore, whereas
all 21 UV samples in the Bader et al. study had detectable levels of bupivacaine in the umbilical
vein, only two umbilical vein samples had detectable levels of bupivacaine in our study, and
these were from patients who had required more than one additional bolus.
The infusion concentration and total amounts of hydromorphone infused in our patients
were higher than those of fentanyl in the Bader et al (1995) study: 3 g/mL hydromorphone (42
g/h) versus 2 g/mL fentanyl (20 g/h). However, the overall concentration of hydromorphone
in the umbilical vein was comparable to that of fentanyl, possibly because of the greater
hydrophilicity of hydromorphone compared with fentanyl. This is significant because other
studies have found incidences of neonatal respiratory depression with the fentanyl umbilical vein
concentrations that were found in the Bader et al. study (Carrie et al., 1981; M. Kumar et al.,
2014; M. Kumar & Paes, 2003; Nikkola, Ekblad, Kero, Alihanka, & Salonen, 1997; Noble et al.,
1994). Thus, although the potency of hydromorphone is only 1/10 to 1/12 that of fentanyl, the
fetus is exposed to a lower opioid dose while achieving comparable pain relief. The use of
hydromorphone in the epidural solution may therefore be more favorable with respect to limiting
neonatal exposure to foreign substances.
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Effects of Epidural Analgesia on Mother and Neonate
The effects of epidural analgesia on the fetus may be direct by placental transfer and fetal uptake
with CNS depression or indirect as a result of a change in maternal homeostasis that results in a
change to the fetal intrauterine environment or both (Bonica & McDonald, 1990). The direct
effects are potentially more important for drugs that act systemically, where it is dependent on
the presence of the drug in maternal circulation to exert its effects and placental transfer more
relevant. Epidurally administered drugs do not require presence in maternal blood to work
effectively. Therefore, indirect effects of epidural analgesia may be more prominent than direct
placental transfer.
Positive Effects
Epidural analgesia preserves the beneficial stress response of the fetus to labor and
reverses the negative maternal physiological and biochemical changes of labor. Analgesia
reduces stress hormones such as epinephrine, cortisol, ACTH, peptide hormones and angiotensin
II (Shnider et al., 1983) (Cascio, Pygon, Bernett, & Ramanathan, 1997; Eberle, Kinsella, &
Arrison, 1995; Westgren et al., 1986), reduces hyperventilation (Thalme et al., 1974), maintains
uterine dilation due to sympathetic blockade (Hollmen, Jouppila, Jouppila, Koivula, & Vierola,
1982), reduces episodes of hemoglobin oxygen desaturation (Arfeen, Armstrong, & Whitfield,
1994; Deckardt, Fembacher, Schneider, & Graeff, 1987; R. P. Griffin & Reynolds, 1995), and
provides better quality pain relief and higher maternal satisfaction than systemic opioids or
nitrous oxide (L. Jones et al., 2012).
Neonatal Acid-Base Status
Three studies published in the 1970s examined intrapartum acid-base changes with or
without epidural analgesia (Pearson & Davies, 1973a, 1973b, 1974a, 1974b; Thalme et al., 1974;
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Zador & Nilsson, 1974), one of which was randomized (Thalme et al., 1974). The studies
demonstrated that labor epidural analgesia reduced maternal hypocarbia and maternal and fetal
metabolic acidosis and lactate (Zador & Nilsson, 1974), while notably reducing the drop in fetal
pH that normally occurs during stage 2 of labor (Reynolds, 2011).
These findings were confirmed by the end 1990’s, when the epidural cesarean and
backache controversies prompted a number of randomized studies comparing epidural analgesia
with systemic opioids, allowing for a meta-analysis of acid-base status in over 2000 babies in 12
studies (Reynolds, Sharma, & Seed, 2002). This confirmed that umbilical artery pH and base
excess were significantly better in babies born to mothers who received epidural analgesia for
labor. A Canadian study comparing Apgar scores and need for neonatal resuscitation between
PCEA (Patient-Controlled Epidural Analgesia) containing bupivacaine and fentanyl with PCIA
(Patient-Controlled Intravenous Analgesia) showed an improvement in neonatal pH and base
excess in the epidural group (Halpern et al., 2004). To show that the differences between the
groups were not simply due to adverse effects of systemic opioids, Schocket and colleagues
conducted a case-controlled study comparing umbilical artery acid-base status in 110 matched
pairs of women who had either received epidural analgesia or no analgesia (Schocket, Garrison,
Wiley, & Sharma, 2005). There were no differences in umbilical artery pH, but both pCO2 and
base excess were significantly higher in the epidural group suggesting epidural analgesia had a
beneficial effect on metabolic acidosis rather than an adverse effect of systemic opioids.
Maternal Stress Reduction
It has been hypothesized the stress of labor can have long-term behavioral effects on the
neonate (Taylor, Fisk, & Glover, 2000). Studies in animal models also found an association
between peripartum stress and long-term behavioral outcomes (W. C. Griffin, 3rd, Skinner,
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Salm, & Birkle, 2003; Hayashi et al., 1998; Kapoor & Matthews, 2005; Schneider, Roughton,
Koehler, & Lubach, 1999). Prolonged antepartum maternal stress has been linked to adverse
neurobehavioral outcomes in children (Van den Bergh, Mulder, Mennes, & Glover, 2005;
Weinstock, 2005). It is uncertain whether a single stress episode such as one that occurs during
labor and delivery can lead to long-term neurobehavioral consequences. It is unknown at this
time if peripartum stress has a role in the development of learning disabilities. Epidural analgesia
administered for labor decreases markers of both maternal and fetal stress such as cortisol
(Abboud, Sarkis, Hung, et al., 1983; N. M. Miller, Fisk, Modi, & Glover, 2005; Taddio, Katz,
Ilersich, & Koren, 1997). If fetal stress has a role in decreased neurobehavioral outcomes, it
could be that neuraxial analgesia might also affect long-term outcomes after vaginal delivery.
Negative Effects of Maternal Labor Analgesia on Neonatal Neurobehavior
Neurobehavior tests have been used in various studies of the effects of maternal analgesia
on the neonate. These studies introduced the clinical importance of neonatal neurobehavior on
breastfeeding initiation. However, failure to provide information and inconsistencies in
medication regimens, definition of variables, sample sizes, and research methods make it
difficult to draw conclusions.
Morikawa and colleagues reported a significant relationship between bupivacaine dose and
neonatal neurobehavior as assessed with the NACS (Morikawa et al., 1990). Abboud and
colleagues found no relationship between epidural bupivacaine and NACS scores (Abboud et al.,
1984). In a study by Radzyminski and colleagues, infants born to mothers who received epidural
analgesia with low-dose bupivacaine and fentanyl showed no differences in NACS scores
compared to infants of mothers who received no pain medication for labor (Radzyminski, 2003).
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In a second study, the same author found a relationship between bupivacaine passive tone, active
tone, and total score on the NACS at 1 hour but not at 24 hours (Radzyminski, 2005).
Abboud and colleagues used the ENNS to compare neurobehaviors differences in 170
infants; 50 mothers received 2% epidural 2-chloroprocaine, 50 with 0.5% epidural bupivacaine,
50 with 1.5% lidocaine and 20 in an unmedicated control group (Abboud, Khoo, Miller, Doan, &
Henriksen, 1982). Patients were randomly assigned to local anesthetic groups. Analysis of
variance showed no differences in ENNS scores among the groups. In another study, Abboud
and colleagues found no adverse effects of lidocaine on the early neurobehavioral status of the
neonate as assessed with the ENNS (Abboud, Sarkis, Blikian, et al., 1983).
In one study using the NBAS exam, neonatal behavior in a group of infants whose mothers
received pethidine during labor was assessed at delivery and during the first six weeks of life by
means of the NBAS. Higher cord blood levels of pethidine were associated with depressed
attention and social responsiveness, but the changes observed were relatively subtle, and
comparison of these infants with a control groups whose mothers had received no drugs revealed
no between-group differences in behavior (Belsey et al., 1981). In another study, the same
authors found that visual skills and alertness decreased significantly with increases in the cord
blood concentration of bupivacaine, particularly on the first day of life but also throughout the
next six weeks. Adverse effects of bupivacaine levels on the infants’ motor organization, ability
to control their own state of consciousness, and physiological response to stress were also
observed (Rosenblatt et al., 1981).
Three studies using the NBAS exam found a marked difference between the groups (B. A.
Lieberman et al., 1979; A.D. Murray et al., 1981; Sepkoski et al., 1992). Lieberman and
colleagues described the fewest differences between the groups, finding that the epidural-
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exposed infants responded less to human voice in the delivery room (B. A. Lieberman et al.,
1979). Murray and colleagues compared 15 control infants whose mothers received no analgesia
for pain relief, 20 infants exposed to bupivacaine 0.25%, and 20 infants exposed to bupivacaine
and oxytocin (A.D. Murray et al., 1981). The infants in the epidural groups had lower NBAS
scores at 1 and 5 days and identified marked differences in motor control, response to stress and
state control. The largest differences were in state control; only 13% of nonmedicated infants had
poor state control compared with 50% of the epidural-exposed infants. The difference remained
despite controlling for forceps delivery and there was no dose-response effect seen. Even on day
5 the state control scale remained significantly different. There were no differences in NBAS
scores between the groups after 1 month. However, at 1 month, mothers who had had epidural
analgesia viewed their infants less favorably and in general found them more difficult to care for
compared with unmedicated mothers (E. Lieberman & O'Donoghue, 2002). Sepkoski and
colleagues compared 38 epidural-exposed (bupivacaine 0.5%) infants to 20 nonmedicated infants
using the NBAS at 3 hours, and on day 3, 7, and 28 (Sepkoski et al., 1992). The infants were
matched for potentially confounding factors such as maternal ponderal index, parity, the number
of maternal and fetal non-optimal conditions and induction of labor. The epidural group received
significantly more oxytocin, had longer labors and more forceps deliveries. The infants that were
exposed to epidural were less alert, had difficulty orienting, and exhibited poor motor function in
the first month of life. Multivariate analysis examining the dose of bupivacaine demonstrated a
dose response for both orientation and motor effects similar to those reported by Murray et al.
(1981).
The early bupivacaine studies were performed when high concentrations of local anesthetic
solutions were common. Although the higher concentration of local anesthetic provided dense
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pain relief, it created many of the unwanted side effects such as motor blockade, hypotension,
excessive sensory loss, and toxicities (Hess, Pratt, & Oriol, 2006). With the addition of opioids to
the epidural infusions, the local anesthetic concentration can be decreased, still providing
effective analgesia with fewer side effects (Breen, Shapiro, Glass, Foster-Payne, & Oriol, 1993;
S. E. Cohen, Tan, Albright, & Halpern, 1987; Cousins & Mather, 1984).
It is difficult to determine why there is so much variability in study conclusions. Early
differences in infant behavior might be attributed to a direct effect of the medication on the infant
(A.D. Murray et al., 1981; Sepkoski et al., 1992). This explanation can be supported by the doseresponse effect, which only one study was able to establish (Sepkoski et al., 1992). However,
differences up to 1 month later cannot be attributed to a direct effect of the drugs. Brazelton
hypothesized that early interactions with a baby who is less alert, less able to orient, and less able
to show organized movement may interfere with the development of the mother-infant
relationship (Brazelton, 1973; A.D. Murray et al., 1981; Sepkoski et al., 1992). There may be
individual characteristics of the mother that determine both how she will interact with her infant
and what she will choose for pain relief when in labor.
Indirect Negative Effects of Labor Epidural Analgesia
Effects of Physical Changes in the Mother
If the mother develops respiratory depression with hypoxemia from systemic absorption of
epidurally administered opioids, fetal hypoxemia and hypoxia will follow (Ferouz, Norris, &
Leighton, 1997). Hypotension in the mother caused by epidural medications may reduce
uteroplacental perfusion and oxygenation of the fetus (Wong, 2009). Fetal bradycardia can occur
without maternal hypotension 15-45 minutes after epidural initiation. There is an acute drop in
maternal plasma epinephrine associated with the onset of analgesia (Shnider et al., 1983).
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Epinephrine is a tocolytic and it has been postulated that the acute drop in epinephrine results in
a short term imbalance of uterine tocolytic/tocodynamic forces that result in uterine hypertonus,
decreased uterine perfusion and subsequently fetal bradycardia (Clark, Smiley, & Finster, 1994;
Wong, 2009). Although the bradycardia usually resolves by fluid bolus, ephedrine, and/or
suspension of oxytocin infusion, it still has potential to disrupt the labor process.
Effects of Epidural-Related Maternal Fever on Neonatal Outcomes
Intrapartum maternal fever complicates one-third of all deliveries and is defined as a
maternal temperature increase of 37.5-38ºC. Women develop fever during labor for various
reasons, with the most common causes related to infection such as chorioamnionitis. However,
epidural analgesia has been consistently associated maternal fever or temperature increase in a
number of prospective and observational studies in the absence of infection (W. R. Camann,
Hortvet, Hughes, Bader, & Datta, 1991; Fusi, Steer, Maresh, & Beard, 1989; E. Lieberman et al.,
1997; Macaulay, Bond, & Steer, 1992; Philip et al., 1999; Ramin et al., 1995; Yancey, Zhang,
Schwarz, Dietrich, & Klebanoff, 2001). The exact cause of epidural-related fever is unknown,
but it thought to be associated with an inflammatory state or altered thermoregulation and not
due to an infectious process (de Orange, Passini, Amorim, Almeida, & Barros, 2011; Fusi et al.,
1989; Goetzl, Evans, Rivers, Suresh, & Lieberman, 2002; Negishi et al., 2001; Yancey et al.,
2001).
Even when the fever is not related to infection, it can still have significant consequences to
the neonate which may ultimately affect the success of breastfeeding. As maternal temperature
increases, the transfer of heat can cause fetal hyperthermia. Primate studies conducted in the
1970s assessed the effects of maternal fever without infection by artificially warming pregnant
baboons to 42ºC to evaluate fetal outcomes (Morishima, Glaser, Niemann, & James, 1975). The
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extreme increase in temperature was associated directly with fetal hypoxia, hypotension, and
metabolic acidosis. However, because this level of elevation in temperature is rarely seen in
clinical practice, the relevance to practice remains uncertain.
Although no data are available on the specific effects of increased maternal temperature on
breastfeeding, the many studies showing a negative effect of maternal fever on neonatal
outcomes make it logical to assume a negative effect on breastfeeding. Therefore, early
identification of maternal fever is imperative to prevent neonatal consequences. Furthermore,
maternal fever is related to other factors, such as separation of mother and infant, which may
compound the effect. For example, in one study(E. Lieberman et al., 1997), although no
difference in the actual rate of sepsis was observed, neonates born to mothers with epiduralrelated fever were more frequently evaluated for sepsis (34%) than neonates of mothers who did
not receive epidural analgesia (10%) and who had a much lower rate of fever. Another study of
1100 women showed that evaluations for sepsis were more frequent when the mother had
epidural analgesia even when the mother was afebrile (Goetzl et al., 2001). The immediate
postpartum period is a crucial time to initiate breastfeeding, and each minute of skin-to-skin
contact during the first 3 hours after delivery increases the likelihood of exclusive breastfeeding
(Bramson et al., 2010). Because the neonate is often separated from the mother for an extended
period of time during such evaluations, this separation may increase the negative effect on
initiation of breastfeeding.
Epidural Analgesia and Oxytocin Regulation in Relation to Breastfeeding
Oxytocin Mechanism During Labor and After Birth.
Endogenous oxytocin during labor and birth is necessary for the development of maternal
behavior that facilitates the process of breastfeeding. Large amounts of oxytocin are released
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during labor and delivery, leading to more forceful contractions, which are necessary for delivery
of the neonate, detachment of the placenta, and keeping the uterus contracted to prevent
postpartum hemorrhage. Additionally, as noted in the section on skin-to-skin contact above,
maternal oxytocin is released by skin-skin contact as the infant exhibits the instinctual behavior
by rooting, finding the breast, and sucking at approximately 1 hour of age (Nissen et al., 1998),
and this results in milk ejection and the release of prolactin, which is linked to milk production
(Dawood et al., 1981).
Oxytocin and prolactin are also pivotal to breastfeeding and are associated with behavioral
and physiological adaptations in breastfeeding women (Jonas et al., 2009; Jonas, Nissen, RansjoArvidson, Matthiesen, & Uvnas-Moberg, 2008; Nissen et al., 1998; Uvnas-Moberg, Widstrom,
& Nissen, 1990). Animal studies show that oxytocin levels immediately after birth may be
integral to the development of maternal behavior and the interaction between the mother and
infant (Jonas et al., 2008; Keverne & Kendrick, 1994). Oxytocin promoted maternal behavior
and mother/newborn interaction in animal experiments (Keverne & Kendrick, 1994; Pedersen,
Ascher, Monroe, & Prange, 1982; Williams, Gazal, Leshin, Stanko, & Anderson, 2001) and
promoted maternal behavior adaptations in human experiments (A. G. Frantz, 1978; Jonas et al.,
2009; A. Levine, Zagoory-Sharon, Feldman, & Weller, 2007; Pedersen et al., 1982; Poulain &
Wakerley, 1982; Richard, Moos, & Freund-Mercier, 1991; Theodosis, Poulain, & Vincent,
1981). Thus, it can be concluded that the mother’s endogenous oxytocin facilitates the
mother/infant interaction and breastfeeding.
Effects of Synthetic Oxytocin on Breastfeeding.
The physiology of labor and onset of lactation is clearly understood, but little research has
been conducted on the effects of synthetic oxytocin on breastfeeding or newborn neurobehavior,
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although induction and augmentation of labor with synthetic oxytocin is used in the majority of
births in the United States and is the most frequent medical intervention in childbirth (R. K.
Freeman & Nageotte, 2007). Another study found a previously unsuspected association between
reduction in breastfeeding rates and oxytocin administered either alone or combined with
ergometrine (Jordan et al., 2009). Synthetic oxytocin used during labor was found to disturb
onset and duration of breastfeeding in women who received higher doses of oxytocin
experiencing difficulties with neonatal reflexes necessary for breastfeeding (Garcia-Fortea et al.,
2014; Olza Fernández et al., 2012). Oxytocin infusions cause serum levels of oxytocin to be
much higher than seen naturally. This may interfere with the mother’s endogenous oxytocin
release and/or sensitivity of oxytocin receptors, which could interfere with maternal/infant
bonding postpartum (Garcia-Fortea et al., 2014; Jordan et al., 2009).
Newborn neurobehavior feeding cues in 47 healthy term infants exposed to synthetic
oxytocin demonstrated a low level of feeding organization, significant for brief and sustained
hand-to-month cues compared to an unexposed group (Bell, White-Traut, & Medoff-Cooper,
2010). In another study, the administration of oxytocin was associated with delayed initiation of
breastfeeding and increased use of formula during the hospital stay (Wiklund et al., 2009).
Synthetic oxytocin crosses the placenta and reaches the fetus (Melek, Blann, & Mattison,
1996; M. R. Odent, 2013). Approximately 80% of the blood traveling from the umbilical vein to
the fetus bypasses the liver, going directly to the vena cava through the patent ductus venosus
and quickly to the brain. The fetal blood-brain barrier is very immature and permeable. The
developing brain is exposed to a large amount of oxytocin during labor infusions. Oxytocin
receptor desensitization induced by oxytocin is well documented (M. Odent, 2010; Phaneuf,
Rodriguez Linares, TambyRaja, MacKenzie, & Lopez Bernal, 2000; C. Robinson, Schumann,
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Zhang, & Young, 2003). It seems plausible that interfering with the oxytocin system in the
developing brain of the fetus at this critical phase may alter neonatal behavior and contribute to
difficulties with breastfeeding (M. R. Odent, 2013). Furthermore, oxytocin administration causes
uterine contractions that are much stronger and more painful than natural contractions. Oxytocin
can cause hyperstimulation of the uterus, producing fetal distress and hypoxia (Simpson &
James, 2008; Wei, Luo, Xu, & Fraser, 2009).
Epidural Analgesia and Oxytocin Regulation.
There is no evidence that oxytocin administration increases epidural use (Bugg, Siddiqui,
& Thornton, 2011; S. Wei et al., 2009), although in one study, women in whom labor was
augmented or induced with oxytocin requested an epidural earlier than women who went into
spontaneous labor (A. R. Moore, Shan, & Hatzakorzian, 2013). When oxytocin infusions and
amniotomy were implemented together, the rate of epidural use did increase, and this occurred
earlier in labor (S. Wei et al., 2009). This finding is significant because epidural analgesia
combined with oxytocin for labor has been associated with negative birth outcomes (Roberts,
Algert, Douglas, Tracy, & Peat, 2002; Tracy, Sullivan, Wang, Black, & Tracy, 2007).
Women who receive epidural analgesia for labor pain have higher rates of oxytocin
augmentation than those who do not receive epidural analgesia (Anim-Somuah et al., 2011;
Chang & Heaman, 2005; Wiklund et al., 2009). Circulating maternal plasma levels of
endogenous oxytocin decrease with the use of epidural analgesia during labor (Goodfellow, Hull,
Swaab, Dogterom, & Buijs, 1983; Rahm, Hallgren, Hogberg, Hurtig, & Odlind, 2002). Research
with sheep and heifers showed that epidural analgesia inhibited maternal oxytocin immediately
postpartum in the blood and the brain, leading to hindered acceptance and recognition by the
mother (Krehbiel, Poindron, Levy, & Prud'Homme, 1987; Williams et al., 2001). Epidural
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analgesia impedes the binding of oxytocin to receptors located on the uterus, which leads to
desensitization of the uterine oxytocin receptors, reducing uterine contractility (Phaneuf et al.,
2000; C. Robinson et al., 2003). Subsequently, augmentation with synthetic oxytocin (Pitocin,
Syntocinon) is required in increasing amounts to maintain labor in women who have received
epidural analgesia (Anim-Somuah et al., 2011; Chang & Heaman, 2005; E. Lieberman &
O'Donoghue, 2002; Wiklund et al., 2009). As the concentration of the exogenous oxytocin
infusions continue to rise, it interferes with the mother’s endogenous oxytocin release and uptake
via a negative feedback mechanism (Goodfellow et al., 1983; Rahm et al., 2002). Women who
had both an epidural and an oxytocin infusion for labor had significantly lower mean endogenous
serum oxytocin levels in response to sucking on the second day postpartum in a dose-dependent
fashion (Jonas et al., 2009). The shortened breastfeeding duration shown in women who received
epidural analgesia (Beilin et al., 2005; J. J. Henderson et al., 2003; Torvaldsen, Roberts,
Simpson, Thompson, & Ellwood, 2006) may be a result of decreased maternal milk production
due to low levels of maternal oxytocin at birth, which may interfere with the pattern of oxytocin
secretion for milk production and impact maternal-infant bonding at birth (Jordan et al., 2009).
Although more than 70% of women in the United States use epidural analgesia during
labor (Cambic & Wong, 2010), and almost all labors use oxytocin infusions to increase labor
contractions (R. K. Freeman & Nageotte, 2007), the long-term consequences of these two
interventions are largely unknown. Animal research has demonstrated perinatal manipulation of
the oxytocinergic system can have enduring effects on feeding, attachment, and social and sexual
behavior (Carter, 2003; Olza Fernández et al., 2012). Further research in this area is needed to
ascertain the effects of intrapartum oxytocin combined with epidural analgesia on breastfeeding
success and maternal and neonatal behavior.
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Epidural Analgesia with Instrumental Vaginal Delivery and Breastfeeding
Epidural analgesia is associated with a significantly higher rate of instrumental vaginal
delivery (forceps and vacuum) (Anim-Somuah et al., 2011; Nyuyen et al., 2010). Two large
cohort studies found that the use of epidural analgesia in nulliparous women was associated with
a 4-fold increase in instrumental vaginal deliveries (Hawkins, Hess, Kubicek, Joyce, & Morrow,
1995; Paterson, Saunders, & Wadsworth, 1992). Instrumented vaginal delivery can have serious
ramifications for the neonate and mother. It has been associated with an increase in severe
maternal perineal lacerations (J. N. Robinson, Norwitz, Cohen, McElrath, & Lieberman, 1999)
and neonatal birth injuries (L. M. Chadwick, Pemberton, & Kurinczuk, 1996; Gebremariam,
1999; Gilbert, Nesbitt, & Danielsen, 1999; C. A. Hughes, Harley, Milmoe, Bala, & Martorella,
1999; M. G. Levine et al., 1984). Women who had epidural analgesia, forceps delivery, and
episiotomy have been reported to have a 40% higher incidence of anal sphincter tears (Fitzgerald
et al., 2007). In another study (J. H. Johnson, Figueroa, Garry, Elimian, & Maulik, 2004),
neonates delivered by forceps showed a significantly greater risk for marks and bruising,
whereas neonates delivered by vacuum showed significantly more cephalohematoma and caput
and molding. Epidural analgesia was used frequently in both groups, with more in the forceps
group, but the study classified according to delivery mode and not epidural use. This study also
found a statistical significance with epidural and pudendal analgesia and episiotomy, vaginal
lacerations, and third- and fourth-degree perineal lacerations with forceps, whereas in vacuumassisted deliveries periurethral lacerations were most significant (J. H. Johnson et al., 2004).
A retrospective case-control study was designed to evaluate the relationship between
epidural analgesia, labor length, and perinatal outcomes in 350 women who received epidural
compared with 1400 patients without epidural. Epidural analgesia was associated with longer
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labors and increased rates of vacuum deliveries due to dystocia or fetal distress was higher than
the control (Hasegawa et al., 2013). The results also demonstrated that Apgar scores and
umbilical artery pH were significantly lower in the neonates delivered by vacuum, whether they
had an epidural or not. The instrument delivery adversely affected the neonate more than the
epidural.
Lieberman and colleagues evaluated 1233 nulliparous women in spontaneous labor who
were afebrile at admission to investigate whether there was an association between intrapartum
temperature elevation and assisted vaginal delivery (E. Lieberman, Cohen, Lang, Frigoletto, &
Goetzl, 1999). They found that women who had a temperature ˃37.5ºC were three times more
likely to experience an assisted vaginal delivery (25.2 % vs. 8.5%) in both epidural users and
nonusers. Even after adjusting for potentially confounding factors such as length of labor,
women who had an elevated temperature intrapartum were still two times as likely to require an
assisted vaginal delivery. With more frequent intrapartum temperature elevations in women who
receive epidural analgesia, perhaps this may be one factor to explain the higher assisted vaginal
delivery rates in women who use epidural analgesia
Epidural analgesia causes a longer stage 2 labor (Anim-Somuah et al., 2011) and a fourfold increase in the risk of fetal occiput position (E. Lieberman, Davidson, Lee-Parritz, &
Shearer, 2005). This combination can expose the fetal vertex to excessive molding (caput
succedaneum) (Akmal & Paterson-Brown, 2009; Tamagawa & Weaver, 2012). The extra tension
and stretch of the cranial nerves caused by the increased molding on the fetal vertex can cause
hemorrhage when tension is added during instrumental delivery. This substantially increases the
risk of postpartum complications.
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Instrument deliveries cause pain during delivery from the episiotomy and perineal
lacerations. When a repair is needed with stitches, this can create even more discomfort for the
mother. The tissue damage caused by episiotomies and lacerations can take a long time to repair,
and this can delay immediate skin-to skin contact between the infant and mother. During early
skin-to-skin contact, the neonate initiates breastfeeding, inducing the production of maternal
oxytocin necessary for milk production, uterine contraction, and maternal and neonatal
behaviors. When delivery is difficult, the baby may need medical assessment, thereby delaying
immediate skin-to-skin contact during the crucial time. Being in pain may prevent the mother
from getting breastfeeding off to a good start. The baby may have pain from bruising and facial
injury caused by the forceps or vacuum delivery which inhibits movements of the baby’s head
and neck, making it difficult for the baby to get into the breastfeeding position and to latch on
effectively. Longer stage 2 labor caused by epidural analgesia tires mothers and stresses babies,
making breastfeeding even more difficult. The delay in breastfeeding that this cascade of events
creates requires extra support and postpartum follow-up for the mother and neonate.
Instrument-assisted delivery, longer labor, and maternal-infant separation after delivery
may lead to increased difficulties in breastfeeding (Rajan, 1994) (Patel, Liebling, & Murphy,
2003; Tamminen, Verronen, Saarikoski, Goransson, & Tuomiranta, 1983). Labor epidural
analgesia affects these labor and delivery outcomes, thereby secondarily affecting breastfeeding
initiation in conjunction with the direct effects of the medications (Anim-Somuah et al., 2011;
Montgomery et al., 2012).
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Effects of Epidural Medications on Breastfeeding
It has been theorized that labor analgesia reduces a mother’s probability of successfully
breastfeeding her child. One proposed mechanism by which intrapartum labor analgesia may
decrease breastfeeding success is that women who remain unmedicated during labor experience a
higher acute stress level, which subsequently prompts their neonate to organize neurobehavior
including those tied to feeding, more rapidly and effectively during the immediate postpartum
period (Bell et al., 2010). Those infants who feed most vigorously during the first few days of
life are more likely to still be breastfeeding at 3 or 6 months (Mizuno, Fujimaki, & Sawada,
2004). Epidural opioids are known to cross the placenta potentially depressing neonatal CNS
function (Loftus et al., 1995). The neonatal depression may prevent development of good feeding
behavior in the initial hours of life predisposing the mother to quit breastfeeding prematurely
(Wieczorek et al., 2010).
Empirical Studies on Labor Epidural Analgesia and Breastfeeding
A review of the literature found 23 empirical studies that were specific to labor epidural
analgesia and measured a breastfeeding outcome (French et al., in press). Results were
conflicting: 11 studies found that epidural analgesia was not implicated in adverse breastfeeding
outcomes (10 found no effect and 1 found a positive effect) and 12 studies showed negative
associations between epidural analgesia and breastfeeding success.
Of the 11 studies showing epidural analgesia was not implicated in adverse breastfeeding
outcomes, 10 showed no effect (Albani et al., 1999; Armani et al., 2013; Bell et al., 2010; Chang
& Heaman, 2005; Chen, Li, Wang, & Wang, 2008; Halpern et al., 1999; Radzyminski, 2003;
Rajan, 1994; Wang, Li, & Hu, 2005; Wieczorek et al., 2010; Wilson et al., 2010), and only one
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reported positive results on initiation of breastfeeding and quantity of milk in a comparison of
continuous epidural with no analgesia (Wang et al., 2005).
One study (Wieczorek et al., 2010) recruited 87 multiparas who had previously breastfed
and who delivered vaginally after receiving continuous labor epidural infusion with various
doses of fentanyl. A telephone questionnaire was administered during the immediate postpartum
period and at 1 week and 6 weeks postpartum by an investigator blinded to the total fentanyl
dose. No dose-response relationship was found. However, because of the high rate of
breastfeeding (95.4% at week 6), the study did not have sufficient power to detect a difference
between high and low doses of fentanyl. Another study (Radzyminski, 2003) evaluated
breastfeeding behaviors using the Preterm Infant Breastfeeding Behavior Scale in 56 healthy
mother-infant pairs and found no difference in neonatal rooting, latching, or sucking at 1 hour
and at 24 hours after delivery between neonates born to mothers who received epidural analgesia
and those whose mothers had no analgesia. They also measured the levels of bupivacaine and
fentanyl in cord blood and found no significant effects on breastfeeding variables.
In addition, no dose-response effect was found in a secondary analysis of data from a
randomized trial in the United Kingdom that assessed the effect of epidural analgesia on mode of
delivery. A total of 1054 primiparas were randomized to receive high-dose epidural analgesia
with bupivacaine alone or one of two mobile epidural techniques with low-dose bupivacaine and
fentanyl, either a combined spinal epidural with a mean fentanyl dose of 107 µg, or a low-dose
infusion with a mean fentanyl dose of 163 µg (Wilson et al., 2010). A matched comparison
group of women who did not receive regional analgesia was also recruited. The women were
interviewed postpartum and mailed a postal questionnaire 12 months after delivery. The authors
found no differences among the groups with regard to initiation rates or duration of
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breastfeeding. However, the breastfeeding initiation rate was significantly lower in a subset of
women in the non-epidural group who received pethidine than in the other groups.
In a study reported in Chinese with an English abstract, 124 women with vaginal delivery
were randomly divided into labor analgesia group (n = 75) and control group (n = 49). No
significant differences in the initial time of lactation, the rate of abundant lactation, or newborn
weight reduction between mothers receiving epidural analgesia and a control group (Chen et al.,
2008). In another study reported in Chinese with an English abstract, healthy women
hospitalized for vaginal delivery without obstetric complications were observed, and 96 women
who received continuous epidural anesthesia were compared with 74 women who did not (Wang
et al., 2005). The epidural group had a shorter starting time of lactation, a larger quantity of milk
secretion, and higher prolactin level 48 h after delivery. The women in the epidural group also
reported better analgesia and postpartum mental state than the control group.
Twelve studies found adverse effects of epidural analgesia on breastfeeding, either in
comparisons of women with and those without epidural analgesia (Baumgarder et al., 2003b;
Dozier et al., 2013; Gizzo et al., 2012; J. J. Henderson et al., 2003; Jordan et al., 2009; RansjoArvidson et al., 2001; J. Riordan, Gross, Angeron, Krumwiede, & Melin, 2000; Torvaldsen et al.,
2006; Volmanen et al., 2004; Wiklund et al., 2009) or in analyses of dose-response relationships
of epidural medications and breastfeeding (Beilin et al., 2005; Jordan et al., 2005).
In contrast to the three studies finding no effects of fentanyl dose level, a retrospective
cohort study in the UK, in which midwife and obstetric case notes were analyzed in a random
sample of 425 healthy primiparas identified from a birth registry (Jordan et al., 2005), found a
dose-response relationship between fentanyl and bottle feeding. Higher fentanyl doses decreased
breastfeeding rates even after demographic confounders of breastfeeding had been accounted for.
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However, women who had decided antenatally to bottle feed did so regardless of fentanyl dose.
In addition, a randomized double-blind study (Beilin et al., 2005) found an adverse effect of
fentanyl dose on neurologic variables at 24 hours after birth but not on breastfeeding behavior
observed by a lactation consultant. At 6 weeks, more women with high-dose than with low-dose
fentanyl had discontinued breastfeeding.
In a prospective cohort study of 1280 women in Australia who responded to mailed
questionnaires regarding breastfeeding at 1, 8, 16, and 24 weeks postpartum (Torvaldsen et al.,
2006), women with epidural analgesia had an increased likelihood of breastfeeding difficulties
and partial breastfeeding in the first week postpartum and were more likely to stop breastfeeding
in the first 24 weeks compared with women who had no analgesia. In another prospective
observational study conducted in Australia (J. J. Henderson et al., 2003), 992 primiparas were
enrolled to investigate effects of labor epidural analgesia (n = 690) on breastfeeding duration by
a self-reported postal questionnaire at 2 and 6 months. Women with labor epidural analgesia had
a shorter breastfeeding duration and a 1.4-times greater risk of breastfeeding cessation in the first
6 months postpartum when compared to women who had no analgesia. Similar results were
found in a retrospective study of 164 primiparas with spontaneous vaginal delivery in Finland
(Volmanen et al., 2004). Questionnaires were mailed a median of 2.4 years after delivery.
Women who had epidural analgesia were more likely to report problems of “not having enough
milk,” and reported more partial breastfeeding or formula feeding during the first 6 months
postpartum than women who had no epidural.
A retrospective cohort study was performed in a large obstetric data set from Wales to
investigate the associations between drugs given routinely in labor and breastfeeding at 48 hours
(Jordan et al., 2009). Regression analysis confirmed the association between epidural analgesia
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and lower breastfeeding rates, even after accounting for confounding variables such as age,
parity, and social class. The authors did not name the epidural medications used.
A prospective study assessed the effects of different types of analgesia during labor on
spontaneous breastfeeding movements and behavior (Ransjo-Arvidson et al., 2001). The authors
videotaped 28 neonates placed skin-to-skin with the mother immediately after birth. Analysis of
the video tapes blinded to type of analgesia or no analgesia showed that neonates whose mothers
had received labor analgesia had less frequent infant hand massage–like movements and sucking
at the breast than infants whose mothers had received no analgesia, with almost half of the
infants in the analgesia group not breastfeeding within the first 2.5 hours after birth. However,
some patients receiving epidural analgesia also had parenteral pethidine or multiple types of
analgesia, and only two patients had only epidural analgesia. Another prospective study of 129
women in the United States examined labor analgesia and its effect on neonatal sucking and
breastfeeding duration (J. Riordan et al., 2000). The researchers measured suckling using the
IBFAT and found reduced neonatal suckling scores in women who had labor analgesia, although
there was no difference in duration of breastfeeding through 6 weeks postpartum compared to
women who had no analgesia. Similarly, a study in the United States of 52 mixed-parity healthy
women with spontaneous vaginal delivery found that epidural analgesia (n = 34) was associated
with reduced sucking among the female neonates during their first feed compared with the
nonmedicated group (Armani et al., 2013; Bell et al., 2010).
In a retrospective comparative study carried out in Sweden (Wiklund et al., 2009), all
maternity records of women who received epidural analgesia for labor between January 2000
and April 2000 were assessed. After exclusions, 351 charts were included. Each epidural chart
was matched to a control record similar in age, parity, and gestational age. Compared to matched
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controls, neonates born to mothers who had epidural analgesia during labor had significantly
lower rates of suckling at the breast during the first 4 hours after delivery, were given formula
more often while in the hospital, and fewer were fully breastfeeding at discharge.
Discussion of Studies on the Effects of Epidural Analgesia on Breastfeeding
Studies on the relationship between epidural analgesia and breastfeeding success yielded
conflicting results, with 1 study showing a positive association, 12 studies yielding negative
associations, and 10 studies finding no effect of epidural analgesia on breastfeeding. The level of
evidence was evaluated using the criteria shown in Table 2.
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Table 2.

Criteria for Evaluating Levels of Evidence
Therapeutic Studies—Investigating the Results of Treatment

Level I

1. Randomized controlled trial
a. Significant difference
b. No significant difference but narrow confidence intervals,
2. Systematic review of Level I randomized controlled trials (studies were
homogeneous)

Level II

1. Prospective cohort study,
2. Poor-quality randomized controlled trial (e.g., <80% follow-up)
3. Systematic review
a. Level II studies
b. Nonhomogeneous Level I studies

Level III

1. Case-control study
2. Retrospective cohort study
3. Systematic review of Level III studies

Level IV

Case series (no, or historical, control group)

Level V

Expert opinion

Source: Wright, J. G., Swiontkowski, M. F., & Heckman, J. D. (2003). Introducing levels of evidence to the journal.
The Journal of Bone and Joint Surgery. American volume, 85-A(1), 1-3.

The studies are summarized in Table 3. The level of evidence ranged from II to IV.
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Table 3.

Studies on the Effects of Epidural Analgesia on Breastfeeding
Type of Study

EDA
(n)

Comparison
Group
(n)

Assessment Methods

Findings

Rajan,
1994

Retrospective
study –
secondary
analysis of
UK survey of
pain relief in
labor
(n = 1064)

Lignocaine
(Lido)

No EDA

Questionnaire mailed No negative effects of EDA, but
at 6 weeks asked
breastfeeding rate decreased
whether mother was
when mothers received
breastfeeding
pethidine

Retrospective study; not
able to separate use of
lignocaine in EDA
from use as local
anesthetic; doses
unknown; pethidine
used in some EDA
patients; chi-square
analyses

III

Albani et al.,
1999

Prospective
cohort study;
vaginal
delivery (n =
1920); mixed
parity

Drugs unknown

No analgesia

Recorded feeding
modality at
discharge

Article in Italian, only
abstract in English;
unknown medication
and doses; chi-square
analyses

II

Halpern et al.,
1999

Prospective
cohort study,
mixed parity
(n = 189)

Combined
No EDA (n =
spinal/EDA
76)
(Bupi + Suf) (n
= 79) or pure
EDA (Lido or
Bupi) (n = 34);
maintained
with Bupi or
Fent if needed.
Total EDA
n =113

Study included only
women intending to
breastfeed; EDA was
combined with spinal
and/or IM opioid in
some patients

II

No difference in breastfeeding
rate between EDA and no
analgesia in women with
vaginal delivery

Breastfeeding
No significant effect of EDA or
assessment at 6
other types of labor analgesia
weeks by structured
on breastfeeding when leaving
telephone interview; hospital or 6 weeks later; 74%
multivariate logistic
were fully breastfeeding at 6-8
regression analysis
weeks
(n = 171)

Limitations

Evidence
Level
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Riordan et al.,
2000

Type of Study

EDA
(n)

Comparison
Group
(n)

Prospective
multisite
cohort study;
unknown
parity

Assorted drugs,
usually Bupi +
Fent or Suf
(n=27) in
varied doses

No medication
(n=37); IV
opioids
(n=52); both
IV opioids
and EDA
(n=13)

Assessment Methods

Findings

Limitations

Evidence
Level

Sucking (IBFAT)
Multiple medication and
Significant negative effect of
during hospital stay; medication vs no medication
doses; unclear whether
duration of
IBFAT assessment was
on IBFAT (suck scores,
breastfeeding
properly blinded; post
LATCH. No difference
assessed by
hoc analysis of EDA vs
between EDA and IV opioids
telephone at 6
IV opioids
but mothers with both had
weeks; ANCOVA
significantly lower scores.
Medication diminished sucking
but not duration of
breastfeeding, although
duration shorter with low
IBFAT scores

II

Ransjo-Arvidson Prospective
et al.,
cohort study;
2001
parity
unknown

Bupi via EDA or Pudendal block Video recordings of
Negative effect of EDA:
Small sample size, some
parenteral
with
immediate PP skinMedicated babies had less
patients with EDA had
pethidine or 2-3 mepivacaine
to-skin (assessed
frequent hand movements than
parenteral pethidine or
types of
(n=6) or no
blindly) - rooting,
nonmedicated babies. Nearly
multiple types of
analgesia
analgesia
latch on, sucking,
half of the medicated group did analgesia; only 2
(n=12)
(n=10)
swallowing, activity
not feed in the first 2.5 hours of patients had EDA alone
state, and
life, had higher temps (p =
neurobehavior. Age
0.03) and cried more (p=0.05)
at and duration of
first suck and
number of sucks

II

Radzyminski
2003, 2005

Bupi + Fent +
Epinephrine in
an ultralowdose infusion
(n=28)

II

Randomized
trial

No analgesia
(n=28)

PIBBS/NACS at birth No significant difference
Small sample size,
and 24 hours;
between EDA and no analgesia randomization method
high NACS =
in PIBBS/NACS scores. No
not truly random
increased
significant relation between
breastfeeding
levels of bupivacaine or
success. Measured
fentanyl in cord blood and
duration of epidural
breastfeeding variables
infusion and amount
of drug in cord
blood at birth
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Type of Study

EDA
(n)

Comparison
Group
(n)

Assessment Methods

Findings

Henderson et al., Prospective
CSE with PCEA
2003
observational
Bupi + Fent
(cohort) study; (n=690)
primiparas

Continuous
midwifery
support
group, N2O
and/or
pethidine
(n=302)

Time and quality of
first breastfeed and
self-report at 2 and
6 months

Baumgarder et
al.,
2003

Prospective
Drugs not
cohort study
specified
(consecutive
(n=115)
breastfeeding
mothers
receiving
EDA
compared with
next
breastfeeding
mother
without EDA);
mixed parity

No analgesia
(n=116)

2 successful
Negative effect of EDA, with
breastfeeding
69.6% of mothers with EDA
sessions in 24 hours
and 81% of nonmedicated
as defined by
mothers achieved successful
LATCH
breastfeeding in 24 hours; OR
0.53; p=0.04 by LATCH

Volmanen et al.,
2004

Retrospective
survey,
primiparas,
vaginal
delivery

Bupi +
No EDA
occasional Fent
(n=34)
(n=30)

Negative effect of EDA: EDA
associated with shorter
duration of breastfeeding.
Factors that favored longer
breastfeeding were higher
education, older mothers, nonsmokers and no EDA

Limitations

Evidence
Level

Intended as a randomized
clinical trial, but
analyzed as a
prospective
observational study
because of high
crossover rates
(43.4%), pethidine used
in some EDA patients;
self-report biased and
unreliable

II

Medications used not
stated

II

Mailed questionnaire Negative effect of EDA. Full
Doesn't address
2-3 years after
breastfeeding: 33% with EDA,
breastfeeding in
delivery asking
71% with no EDA; “not
immediate PP, recall
about breastfeeding
enough milk” was reported as
after 2-3 years may be
success or failure in
reason more often with EDA
faulty, failed to control
the first 12 weeks
for confounding
variables after
discharge

III
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Type of Study

EDA
(n)

Comparison
Group
(n)

Assessment Methods

Findings

Limitations

Chang &
Heaman,
2005

Prospective
cohort study;
mixed parity

Bupi or Ropi
No analgesia
with Fent or
(n=63)
occasionally
epinephrine; no
other analgesia
(n=52)

Assessed at 8-12
No differences between EDA
hours PP LATCH
and no analgesia regarding
and NACS
LATCH and NACS. Positive
telephone; phone
correlation between infant
interview at 4 weeks neurobehavior and
PP
breastfeeding effectiveness
(p=0.01)

Jordan et al.,
2005

Retrospective
sample from
birth register,
primiparas

Neuraxial
analgesia
(n=232)
containing
opioid (n=158)
or local
anesthetic
(n=74)

Infant feeding at
discharge as
recorded in case
notes: proportion
with exclusive
bottle feeding or
breastfeeding (total
or partial)

Beilin et al.,
2005

Randomized
doubleblinded study
of different
doses of Fent
in EDA;
multiparas
who had
previously
breastfed

Bupi with
EDA with Bupi PP day 1, mother and Negative effect of high-dose Fent No control group without II (for dose
intermediateonly (no
lactation consultant
EDA, breastfeeding
compariat 24 h on NACS scores but no
dose Fent
Fent) (n=60)
each assessed
assessed at 6 weeks
son)
difference in consultant
(n=59) or highbreastfeeding
assessment. Negative effect of
dose Fent
separately using “B- increasing Fent dose at 6
(n=58)
R-E-A-S-T” feeding weeks, 17% of PP women in
observation form,
the high-dose Fent group, 5%
NACS and 6 weeks
with the interim dose, and 2%
PP telephone
with no Fent reported stopping
interview
breastfeeding (p=0.005). Highdose Fent group reported
significantly more difficulty
with breastfeeding than other
groups

Nitrous oxide
or IM opioid
(n=570)

No mention of
breastfeeding hospital
practices, no definition
of exclusive
breastfeeding, no
mention of total EDA
infusion time

Evidence
Level

Possible negative effect of EDA: IM pethidine used in
Bottle feed: N2O+O2 (32%);
some EDA patients; No
IM opioids + N2o+O2 (42%);
formal breastfeeding
Neuraxial LA (44%); neuraxial
assessment in discharge
+opioid (54%) with Fent (55%) summary; exclusive
and morphine (64%). Main
breastfeeding not
determinants of bottle feed:
separately analyzed, no
maternal age, occupation, feed
neurobehavior
intention, cesarean, and Fent in
assessment
a dose-response relationship

II

III

105

Type of Study

Wang et al.,
2005

Prospective
observational
study;
unknown
parity

EDA
(n)

Comparison
Group
(n)

Continuous EDA, No EDA
drug unknown
anesthesia or
(n=96)
postpartum
analgesia

Assessment Methods

Starting time of
lactation, milk
quantity, feeding
times in 24 h,
prolactin level 48 h
after delivery

Torvaldsen et al., Prospective
Bupi + Fent
2006
cohort,
PCEA ± IM
primiparas and pethidine or
multiparas
N20 (n=416)
either
intending or
not intending
to breastfeed
(not
differentiated)

No analgesia,
Questionnaire on day
N2O,
4 and mailed at 8,
pethidine
16, and 24 weeks
(with or
PP. Breastfeeding
without N2O), categorized as full,
or general
partial or not
anesthesia
breastfeeding
(n=762)

Chen et al.,
2008

No analgesia
(n=49)

Randomized
study

Ropi PCEA
(n=75)

Findings

Limitations

Evidence
Level

Positive effects of EDA: EDA
Article in Chinese –only
group had earlier starting time
abstract available in
of lactation, larger quantity of
English
milk secretion, higher prolactin
levels 48 h after delivery, better
analgesia and PP mental state
than control

II

Possible negative effect of EDA: Not possible to determine
at week 1, EDA ± pethidine
effects of EDA alone
group had higher risk of partial
because no EDA
instead of full breastfeeding
patient had vaginal
compared with N2O, pethidine,
birth without pethidine
and no analgesia groups. At 24
(all EDA patients
weeks, both EDA and
without pethidine had
pethidine groups had higher
cesarean birth)
risk of breastfeeding cessation
than no analgesia group (p =
<0.0001)

III

No differences between EDA
Article in Chinese – only Not clear if
Starting time of
and
no
analgesia
in
starting
abstract available in
I or II
lactation, rate of
time of lactation, rate of
English
abundant lactation,
abundant lactation, or newborn
newborn weight
weight reduction
reduction, and
prolactin were
recorded during first
24 hours
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Type of Study

EDA
(n)

Comparison
Group
(n)

EDA drugs not
No analgesia
specified, with
or without IM
opioid or spinal

Assessment Methods

Findings

Breastfeeding or not Negative effect of EDA:
at 48 hours PP; as
Regression analysis showed
recorded in maternal breastfeeding rate was
notes. Regression
significantly lower with EDA
analyses
than with no EDA (p<0.001),
even when adjusted for parity

Limitations

Jordan et al.,
2009

Retrospective
analysis of
survey data;
(n=48,366)

Wiklund et al.,
2009

Retrospective
Bupi+Suf ±
matched casepudendal or
controlled
paracervical
study
block (n=351)

No analgesia
+/- pudendal
or
paracervical
block
(n=351)

Wilson et al.,
2010

Prospective
High-dose Bupi
cohort study –
(n=353); CSE
secondary
with low-dose
outcome
Bupi+Fent
measure from
(n=351); lowrandomized
dose Bupi and
trial
Fent infusion
comparing
(n=350)
different types
of EDA
(COMET
trial)

Nonrandomize Interviewed 24-48 hrs No difference between EDA and Maternal report of
d matched
PP. Postal
non-EDA groups in
breastfeeding may not
comparison
questionnaire 12
breastfeeding initiation; women be accurate, sample
group with no months PP asked
with pethidine in non-EDA
size estimates not
EDA
duration of
group reported lower
determined by
(n=351);
breastfeeding
breastfeeding initiation rates
breastfeeding initiation
pethidine
(p=0.002). Older age (p<0.001) or duration, and no data
(n=151)
and non-white ethnicity
on additional
(p<0.026) predicted
breastfeeding support
breastfeeding. Duration of
women may have had
breastfeeding similar across all
EDA groups

Breastfeeding
assessed at 1 and 4
hrs after birth,
bottle-fed in hosp,
breastfeeding at
discharge; as
recorded in
maternity record

Drugs and doses not
specified; incomplete
coding for social class.
Retrospective design
cannot separate effects
of confounding
variables

Negative effect of EDA: Fewer Retrospective study
babies of mothers who received
EDAs suckled breast within
first 4 hours (p<0.0004); babies
with EDAs were more likely to
receive supplement (p<0.0012),
and fewer had exclusive
breastfeeding at discharge
(p<0.0430)

Evidence
Level

III

III

II
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Type of Study

EDA
(n)

Comparison
Group
(n)

Prospective
cohort study

EDA Bupi+Fent
(n=34)

No medication
(n=18)

Wieczorek et al., Prospective
2010
observational
cohort study;
multiparas
who had
previously
breastfeeding
successfully

Bupi+Fent
(n=87).
Compared
high-dose Fent
(>150 g,
n=47) vs lowdose Fent
(<150 g, n =
40)

No control
Immediate PP
without EDA
questionnaire and
telephone interview
at 1 and 6 weeks
with degree of
breastfeeding
classified

Gizzo et al.,
2012

Bolus Fent+Ropi, No medication Within 2 hours of
booster boluses
(n=64).
birth midwife
as need (n=64)
Controls
completed grid
randomly
follow-up and
selected from
recorded data
larger group
who met
inclusion
criteria but
did not
receive EDA

Bell et al.,
2010

Prospective
cohort study;
primiparas

Assessment Methods

Findings

Limitations

Neonatal
No difference in number of
Groups were selfneurobehavior
sucks; sucking pressure not
selected. Missing data
organization
related to EDA exposure
on 4 neonates due to
measured within 1
overall, but unmedicated girls
video recorder
hour after birth with
had more sucks (p=0.027) than
problems/ and 1 infant
sucking apparatus
girls in EDA group. Overall
needing observation, no
girls had stronger suck pressure racial/ethnic diversity,
than boys (p=0.042)
and small sample size
No significant correlation
Comparison was only
between Fent dose and
high vs low dose of
breastfeeding success.
Fent. High
Breastfeeding success rate of
breastfeeding rates
>95% PP; cessation rate at 6
resulted in insufficient
weeks PP was much lower than power to detect a true
in previously quoted literature
difference between
doses if one existed

Negative effect of EDA:
Abstract states
Duration of first breastfeeding
“randomized” but
was significantly shorter in the
assignment to study
EDA group than in the
group was not random;
nonmedicated group (p<0.001), narrow patient selection
and length of labor was longer
(patients with potential
in epid vs. nonmedicated
confounding factors
(p<0.001)
excluded)

Evidence
Level

II

II (for dose
comparison
)

II
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Type of Study

EDA
(n)

Comparison
Group
(n)

Armani et al.,
2013

Retrospective
case-control
study

Bupi or Ropi
combined with
opiates
administered as
EDA top-up
(n=287)

Dozier et al.,
2013

Retrospective
EDA (any type, No EDA
analysis of
drugs not
(n=290)
data from 2
specified,
cohort studies
excluded local,
of
spinal, or
breastfeeding
general
support: 1
anesthesia)
prospective in- (n=437)
hospital and 1
retrospective
perinatal;
primi- and
multiparas

No analgesia
(n=1676)

Assessment Methods

Gathered data on
neonatal and
obstetric outcomes,
rates of
breastfeeding,
supplemental
formula, and full
formula

Findings

Limitations

No difference between EDA and Retrospective design; not
no analgesia in breastfeeding
possible to draw
rate or supplementation. EDA
conclusions about
had higher rates of instrument
duration of
deliveries (p<0.01; occiput post breastfeeding
position (p<0.05, neonatal
cephalohematoma (p=0.01) and
lower 1 minute Apgar
(p=0.016); more women with
EDA had fever (p=0.003)

Data abstracted from Negative effect of EDA: Mothers Medications not
birth certificate +
with EDA more likely to
specified; breastfeeding
EMR; breastfeeding
discontinue breastfeeding
data relied on maternal
cessation within
during first 30 days (Kaplanself-report; results
first month assessed
Meier analysis with log-rank
applicable only to
by maternal selftest), even considering BFH
vaginal deliveries, fullreport (mailed
status and other factors (p<0.04 term singleton infants;
survey)
for BFH; p<0.01 for non-BFH)
secondary analysis –
(Cox proportional hazards).
data not available for
Mothers with EDA + oxytocin
certain relevant
most likely to stop
variables; different data
sources may introduce
bias

Evidence
Level

III

II-III

ANCOVA = analysis of covariance; BFH = Baby-Friendly Hospital; Bupi = bupivacaine; CSE = combined spinal epidural; EDA =
epidural analgesia; EMR = electronic medical record; Fent = fentanyl; IBFAT = Infant Breastfeeding Assessment Tool; IM =
intramuscular; LATCH = breastfeeding assessment tool; Lido = lidocaine; NACS = Neonatal Neurologic and Adaptive Capacity Score;
PCEA = patient-controlled epidural analgesia; PIBBS = Preterm Infant Breastfeeding Behavior Scale; PP = postpartum; Ropi =
ropivacaine; Suf = sufentanil.
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Only two randomized studies comparing epidural analgesia to no analgesia were found,
and neither study justified classification at level I. One of these (Radzyminski, 2003; J. G.
Wright, Swiontkowski, & Heckman, 2003) showed no difference in breastfeeding behaviors
between infants of women who received epidural analgesia and those whose mothers received no
analgesia, but the method of treatment allocation was not truly random. The second randomized
trial (Chen et al., 2008) showed no difference between epidural analgesia and no pain-relieving
measures. However, the number of patients in the two groups differed, and it was not possible to
evaluate the study design because only the abstract was available in English. One problem with
studies that find no differences between groups is that they are not always powered to detect a
true difference, even if one did indeed exist.
Another study (J. J. Henderson et al., 2003) was intended as a randomized trial, but
breastfeeding outcomes were analyzed as a prospective observational study because of high
crossover rates (43.4%). This study found an association between epidural analgesia and
shortened duration of breastfeeding. A further randomized study compared different doses of
epidural fentanyl without a non-epidural group and found a negative effect of increasing doses
(Beilin et al., 2005).
If epidural medications have a physiological effect on breastfeeding, and the half-life of
epidural fentanyl in the maternal circulation is 2 to 2.5 hours, then breastfeeding should be
studied the first few hours after delivery, before the drugs are cleared. However, breastfeeding
was measured at time points ranging from immediate postpartum to 6 months, or assessed
retrospectively through questionnaires mailed up to 2 or 3 years after delivery. Especially after
so much time has elapsed, maternal self-report carries the risk of recall bias. After hospital
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discharge, many new factors may confound the picture of breastfeeding success; for example,
lack of social support, presence of siblings, or the mother’s need to return to work or school. In
addition, studies did not always take into account maternal factors that may influence
breastfeeding, such as the mother’s intention to breastfeed, level of education, marital status,
BMI, and smoking behavior.
Numerous differences among studies make it difficult to draw conclusions. Different
definitions of breastfeeding success were used. In some studies, breastfeeding was considered
successful only if exclusive, whereas other studies grouped partial and full breastfeeding
together. Many of the studies did not consider other factors that may influence breastfeeding
success, such as hospital practices in regard to provision of breastfeeding support, availability of
supplemental formula, and the timing of breastfeeding initiation after delivery. A hospital
environment strongly supportive of breastfeeding may be able to at least partially offset the
potential negative effects of epidurals on breastfeeding (Halpern et al., 1999; Wieczorek et al.,
2010).
To assess reflexes needed for rooting and swallowing, standardized breastfeeding
assessment tools such as LATCH (D. Jensen et al., 1994), the IBFAT (Matthews, 1988), or the
Preterm Infant Breastfeeding Behavior Scale (PIBBS) (Nyqvist, Rubertsson, Ewald, & Sjoden,
1996) should be used. However, only a few studies reported such measures (Baumgarder et al.,
2003b; Beilin et al., 2005; Chang & Heaman, 2005; Radzyminski, 2003; J. Riordan et al., 2000).
The drugs and doses used in labor epidural analgesia varied among study sites, but all
contained a local anesthetic (usually bupivacaine) and an opioid (generally fentanyl or
sufentanil). However, some studies failed to mention the exact name and/or dose of the
medications used in the epidural. Furthermore, in several studies, women in the epidural
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analgesia groups also received other medications, including pethidine, which has been shown to
have an adverse effect on breastfeeding (Rajan, 1994; Wilson et al., 2010). This makes it very
difficult to determine whether the observed breastfeeding outcome was associated with the
pharmacokinetics of a specific epidurally administered drug given at a specific dose at a certain
time or with some other variable related to the epidural.
It is unclear whether and to what extent epidural medications exert a direct or indirect
effect on breastfeeding. For example, epidurally administered local anesthetic and opioid drug
combinations readily cross the placenta and fetal blood-brain barrier and may depress necessary
neonatal reflexes needed for rooting, swallowing, or sucking (Chang & Heaman, 2005). A
depressed neonate not responsive to sucking may prompt the mother to quit breastfeeding too
soon. Because an intact and functioning central nervous system is necessary for an infant to latch
on and feed, several studies have used the NACS (Amiel-Tison et al., 1982b) to address the
association between epidural opioids and neonatal neurobehavior. Infants who score high on
breastfeeding behaviors tend to have high NACS scores (Chang & Heaman, 2005; Radzyminski,
2005). For example, Beilin et al. randomized 177 multiparas who had previously breastfed into
three groups, with epidural bupivacaine and either no fentanyl, or fentanyl at <150 g or >150
g (Beilin et al., 2005). More than 150 g of fentanyl was associated with significantly lower
NACS scores compared to bupivacaine without fentanyl. Thus, it can be concluded that
depression of the neonate’s tone by epidural opiates impedes the neonate’s ability to latch on to
the breast. Such factors may result in a vicious circle, preventing good feeding behaviors in the
first 24 hours of life, which may prompt the mother to quit breastfeeding too soon.
Epidural analgesia has been consistently associated with maternal fever or temperature
elevation. This may also affect breastfeeding, because the transfer of heat can cause fetal
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hyperthermia. In one study (Greenwell et al., 2012), when the temperature of all women who
received epidural analgesia was evaluated, a significant linear correlation was found between
maximum maternal temperature and the infant’s Apgar scores, hypotonia, early-onset seizures,
and need for assisted ventilation. Infants born to women with maternal fever ˃38.3ºC had a twoto six-fold increase in all the neonatal outcomes evaluated. Although no data are available on the
specific effects of increased maternal temperature on breastfeeding, the many studies showing a
negative effect of maternal fever on neonatal outcomes make it logical to postulate a negative
effect on breastfeeding.
Furthermore, it is not clear to what extent the combination of epidural analgesia with other
intrapartum interventions has an indirect effect on breastfeeding (Montgomery et al., 2012).
Recent emphasis has been placed on research involving the potential lowering effect of epidural
analgesia on oxytocin levels in the maternal plasma during labor and birth and the relationship of
epidural analgesia to the mother's endogenous release of oxytocin. Oxytocin use has been
associated with delayed initiation of breastfeeding (Wiklund et al., 2009), and combined
administration of epidural analgesia and oxytocin during labor has been negatively associated
with breastfeeding success. The shortened breastfeeding duration shown in women who received
epidural analgesia (Beilin et al., 2005; J. J. Henderson et al., 2003; Torvaldsen et al., 2006) may
be a result of decreased maternal milk production due to low levels of maternal oxytocin at birth,
which may interfere with the pattern of oxytocin secretion for milk production and impact
maternal-infant bonding at birth (Jordan et al., 2009). Further research in this area is needed to
ascertain the effects of intrapartum oxytocin combined with epidural analgesia on breastfeeding
success.
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Epidural analgesia is also associated with a significantly higher rate of instrumental
vaginal delivery (Anim-Somuah et al., 2011; Nguyen et al., 2010). Two large cohort studies
found that the use of epidural analgesia in nulliparous women was associated with a 4-fold
increase in instrumental vaginal deliveries (Hawkins et al., 1995; Paterson et al., 1992).
Instrumental vaginal delivery can have serious ramifications for the neonate and mother. A
retrospective case-control study was designed to evaluate the relationship between epidural
analgesia, labor length, and perinatal outcomes in 350 women who received epidural analgesia
compared with 1400 patients without epidural. Epidural analgesia was associated with longer
labors and increased rates of vacuum deliveries due to dystocia or fetal distress was higher than
the control (Hasegawa et al., 2013).
The tissue damage caused by episiotomies and lacerations due to instrumental delivery can
take time to repair, which can delay immediate skin-to skin contact between the infant and
mother. During early skin-to-skin contact, the neonate initiates breastfeeding, inducing the
release of maternal oxytocin necessary for milk production and maternal and neonatal behaviors.
When delivery is difficult, the baby may need medical assessment, thereby delaying immediate
skin-to-skin contact during the crucial time. Being in pain may prevent the mother from getting
breastfeeding off to a good start. The baby may have pain from bruising and facial injury caused
by the forceps or vacuum delivery which inhibits movements of the baby’s head and neck,
making it difficult for the baby to get into the breastfeeding position and to latch on effectively.
Longer stage 2 labor caused by epidural analgesia tires mothers and stresses babies, making
breastfeeding even more difficult. The delay in breastfeeding that this cascade of events creates
requires extra support and postpartum follow-up for the mother and neonate.
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This literature review demonstrates that the relationship between epidural analgesia and
breastfeeding remains inconclusive. This is not surprising, considering that the available studies
varied in design, outcome definition, sample size, control group, inclusion of many potential
confounders, and rigor, making any statistical conclusion difficult. Poor study design is common.
Few studies are able to use randomized treatment allocation, most do not use a breastfeeding
assessment tool. Some studies have not mentioned the names of medications that were used, at
what dose or concentration of the epidural infusion, making it difficult to determine whether any
effects are caused by the specific drugs in the epidural infusate or the condition that the epidural
analgesia itself has created (Szabo, 2013).
Despite concern regarding adverse effects on breastfeeding, epidural analgesia and other
intrapartum interventions are frequently used because of the benefits they confer. Therefore, it is
important to find ways of ameliorating any adverse consequences. Hospital practices and
providers can lend additional breastfeeding support to women who are at a higher risk of not
initiating breastfeeding or for early cessation. Various strategies may be tried, but one promising
way to achieve this goal is for hospitals to offer breastfeeding support by promoting unlimited
skin-to-skin contact between mother and neonate. Skin-to-skin contact between the neonate and
the mother during this sensitive period enhances the long-term interaction between mother and
neonate. When this contact occurs, mothers have been shown to be more likely to be
breastfeeding at 1 and 4 months after delivery and for a longer duration (Bystrova et al., 2009;
Salariya et al., 1978; Wiberg et al., 1989)
Building on the considerations discussed in this chapter, the current study attempts to
provide more information on the relationship between epidural analgesia and breastfeeding
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success. The next chapter discusses the methods used in this study to answer the research
questions.
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Chapter 3: Methods
This prospective, observational study investigated whether breastfeeding would be less
effective in infants whose mothers received epidural analgesia with hydromorphone compared
with those whose mothers received no analgesia, and whether the total amount of drugs given or
the presence of multiple stressful events or interventions during labor would be related to the
effectiveness of breastfeeding. Chapter 3 presents the specific hypotheses, discusses the study
design, and describes the selection of subjects, the setting of the study, the type of epidural
analgesia used, the study variables and procedures (including procedures used to ensure rigor of
the study and protection of human subjects), the risks and benefits of the study, and the methods
used for statistical analysis.
Hypotheses
Based on the research questions posed in Chapter 1, the following hypotheses were
formulated:
H1: Compared with healthy term infants whose mothers received no analgesia, healthy
term infants of mothers who receive epidural analgesia with hydromorphone will exhibit
significantly less effective breastfeeding behaviors at 3, 12, and 24 hours of age.
H2: Duration of infusion/amount of infusate will be significantly negatively related to
breastfeeding behaviors at 3, 12, and 24 hours of age in healthy term infants whose mothers
receive epidural analgesia with hydromorphone for labor pain.
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H3: When multiple stressful events or interventions are present during labor or
immediately after birth, healthy term infants will demonstrate significantly less effective
breastfeeding behaviors at 3, 12, and 24 hours of age, whether or not labor analgesia was used.
Study Design
To test these hypotheses, a prospective, observational, single-blinded cohort design was
used to compare breastfeeding behaviors of infants whose mothers chose to receive epidural
analgesia containing hydromorphone with breastfeeding behaviors of infants whose mothers
chose to receive no analgesia. An observational cohort design rather than a randomized
controlled trial was necessary because it was not ethically possible to randomly assign
participants to either receive an epidural or to be in a control group receiving no medication for
labor pain. It would be unethical to withhold labor pain medication to someone who requests it
or to give pain medication to someone who does not want it and would prefer to try nonpharmacological methods. In an attempt to minimize bias due to differences between the study
groups, the eligibility criteria were designed to make the study population as homogeneous as
possible. For example, to reduce the likelihood of a prolonged labor, only women who had
previously labored and delivered a viable infant were included. In addition, to increase the
homogeneity of the sample, only multiparas who had previously breastfed were included.
The time points of 3, 12, and 24 hours were selected because the plasma elimination halflife of hydromorphone in the circulation is approximately 2-3 hours (Felden et al., 2011;
Inturrisi, 2002). If epidurally administered medications do affect breastfeeding and
neurobehavior, the first assessment should occur before the drugs have been cleared from
maternal and neonatal circulation. Therefore, first breastfeeding assessment and neurobehavior
tests were to be done within 4 hours after delivery. The 12-hour time point was selected because
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8-24 hours is considered the crucial time for the establishment of breastfeeding, and the drugs
would be expected to have been metabolized and cleared from mother and neonate. The 24-hour
time point was selected to address breastfeeding status at time of discharge.
Subjects
The study population consisted of an unmedicated group (control group) of 51 motherinfant dyads in which the mother did not receive any pain medication or CNS depressants and 51
mother-infant dyads in which the mother elected to receive epidural analgesia for labor pain.
Sample Size
Sample size was determined for comparative analysis using repeated-measures analysis of
variance. The minimum difference between groups that would be worth detecting was
determined using Cohen’s d set at 0.5 (i.e., medium effect) (J. Cohen, 1988; Lakens, 2013).
Assuming 80% power and an  value at 0.05, a sample size of 51 cases per group was needed to
detect a true difference if it exists. Recruitment continued until the required number of subjects
was achieved in each group.
Selection Criteria
Mother-infant dyads were included when the mother met the following criteria: (a) aged 18
years or older; (b) used only epidural analgesia (continuous infusion) or no medication during
labor and delivery; (c) had breastfed after previous deliveries; (d) intended to breastfeed again;
(e) allowed breastfeeding to be observed at 3, 12, and 24 hours postpartum; (f) was English
speaking; (g) had a singleton pregnancy; (h) had an infant ≥37 weeks and ≤42 weeks gestation;
and (i) delivered vaginally. Exclusion criteria comprised (a) any complication of pregnancy such
as pregnancy-induced hypertension or insulin-dependent gestational diabetes; (b) any
complication of labor; (c) obesity (BMI ≥40); (d) alcohol or substance abuse; (e) infant with
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congenital anomalies; (f) infant receiving antibiotics or intravenous therapy for hypoglycemia ;
(g) infection as evidenced by maternal fever during labor; (h) infant with an Apgar score less
than 8 at 5 minutes; (i) infant having resuscitation after delivery; (j) mother has undergone any
type of procedure that required anesthesia or analgesia within 24 hours postpartum; (k) abnormal
fetal presentation such as occipital posterior or breech.
Setting
The study took place at the Labor and Birth Unit and the Postpartum Unit of YNHH, a
1500-bed teaching facility in New Haven, Connecticut. YNHH has a delivery rate of
approximately 5,500 babies per year and is a major obstetrical referral center for physicians
throughout the region. YNHH is located in a culturally, economically, and socially diverse
neighborhood. Although many of the hospital patients live within the area surrounding the
hospital, many come from cities throughout the state of Connecticut.
YNHH is in the process of becoming Baby Friendly and has implemented The Ten Steps
to Successful Breastfeeding. To control for delivery room practices known to have an influence
on the neonate’s ability to suck and establish breastfeeding, the following steps were followed in
the same way for all mother-infant dyads in this study. It was expected that all neonates would be
placed skin-to-skin immediately after birth, and breastfeeding initiated within the first hour. This
is the standard of care at this institution. If the neonate could not be placed immediately skin-toskin because of a complication with the mother, neonate, or delivery, the mother-infant dyad was
excluded from the study. Thus, all babies were placed on the mother’s chest in a similar manner.
Vitamin K and eye care were provided 24 hours postpartum.
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Treatment - Epidural Analgesia
Epidural analgesia was administered according to the standard protocol of Yale New
Haven Hospital for healthy parturients who request epidural analgesia for vaginal delivery: The
protocol called for 1.5% lidocaine with 1:200,000 epinephrine as a test dose and/or 0.25%
bupivacaine with 1:200,000 epinephrine as a bolus, and 100 µg hydromorphone followed by a
continuous infusion of 0.05% bupivacaine with 3 µg/mL hydromorphone at a rate of 14
mL/hour.
Study Variables
Demographic and Clinical Characteristics
At the time the participant signed the informed consent form, the study team filled out a
patient information sheet related to labor, delivery, and medication received during labor
(Appendix A: Patient Information Sheet). Clinical factors such as oxytocin (Pitocin, Syntocinon)
use, instrument delivery, maternal temperature, and duration of labor were also recorded.
Epidural Medications
Data were collected regarding the continuous epidural infusion (extent of cervical dilation
at the time of epidural placement, dose of the components, infusion rate, and total volume), type,
and dose of local anesthetics, and any additional doses for breakthrough pain.
LATCH Breastfeeding Assessment Tool
The LATCH Breastfeeding Assessment Tool (D. Jensen et al., 1994) was used to measure
breastfeeding effectiveness. Permission for its use was obtained from the copyright owner (John
Wiley & Sons, Inc., Appendix B: Copyright Permission for LATCH Breastfeeding Assessment
Tool).
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LATCH is a breastfeeding charting system that assesses individual breastfeeding sessions
using a systemic model to gather information (D. Jensen et al., 1994). The LATCH score
includes all aspects of latching behavior by providing a score of 0, 1, or 2 for each key
component of breastfeeding: L = the infant’s ability to latch onto the breast, A = the audible
sound of swallowing, T = type of nipple the mother has, C = comfort of the mother’s breast and
nipple, H = holding, which is the amount of assistance the mother needs to hold the neonate. To
obtain the score for a particular breastfeeding session, the total of all the scores for the areas of
assessment is calculated. A score of 2 on each item meets the criterion for effective
breastfeeding. Thus, for this study, effective breastfeeding was defined as a total LATCH score
of 10.
The scales are described below:


L indicates how well the neonate latches on to breast during breastfeeding. A score of 2 is
given if the neonate’s gum line is placed well over the mother’s lactiferous sinus, the lips
are flagged outward, the infant’s tongue is positioned over the areola, and there is
rhythmic sucking. If a neonate is too sleepy or reluctant to feed and repeated attempts are
needed to meet the criteria, or a staff member must hold the nipple in the infant’s mouth,
the score will be less than 2. A score of 2 means effective breastfeeding.



A indicates the audible swallowing of the infant during breastfeeding. Swallowing is an
indicator of milk intake. A short forceful expiration of air should be heard for a score of
2. During the first 24 hours of life, several bursts of intermittent sucking may be heard
before the swallow.
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T stands for the mother’s nipple type. If the nipple is everted (project outward) after
stimulation and rest, a score of 2 is given. An inverted or flat nipple receives a score less
than 2. Effective breastfeeding is defined as a score of 2.



C stands for the mother’s comfort. Pain in the nipple area and breast will interfere with
let-down and the mother’s willingness to continue to breastfeed. An assessment score of
2 is given if the nipples have no visible signs of blisters, redness, bruising, cracking, or
bleeding, and the breast is soft and tender. A score of 1 is given for moderate discomfort
with reddened, small blisters, or bruising. A score of 0 is for severe discomfort and sore
breasts. Effective breastfeeding is defined as a score of 2.



H indicates the mother’s positioning and holding of the neonate during breastfeeding and
the amount of help she requires from staff. A score of 2 is given if the mother cradles the
neonate like a football or side laying against the breast, head aligned with the mother’s
trunk facing the breast, supporting her breast with a cupped hand.
The interrater reliability of the LATCH tool was high among lactation consultants and

ranged from 85.7% to 100% (Adams & Hewell, 1997). In a test of the validity of the LATCH
tool, significant Spearman correlations were found between nurses’ assessment of LATCH
scores and mothers’ ratings of how well they thought breastfeeding had gone (J. Riordan, Bibb,
Miller, & Rawlins, 2001). Findings also showed total LATCH score and mothers’ assessment
scores positively correlated with duration of breastfeeding. These findings support the construct
validity of the LATCH tool.
Because Yale New Haven Hospital uses the LATCH instrument to guide breastfeeding
education of mothers, both the PI and the lactation consultant have used the LATCH tool
extensively and have spent approximately 1 year in preparation for this study. Both were also
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involved in LATCH training of nurses on the Postpartum Unit. Therefore, it was not deemed
necessary to conduct an interrater reliability pilot study.
Neurologic and Adaptive Capacity Score (NACS)
The second assessment planned for evaluation of neonates in this study was the NACS.
Permission for use was obtained from the copyright holder, Wolters Kluwer Health (Appendix
C: Copyright Permission for the Neurologic and Adaptive Capacity Score [NACS]). The NACS
was specifically designed to detect central nervous system depression of the neonate from drugs
and to differentiate those effects from birth trauma and perinatal asphyxia (Amiel-Tison et al.,
1982b). The scale has been widely used by obstetric anesthesia researchers since it was
developed in 1982.
The NACS contains portions of the Brazelton Neonatal Behavior Assessment Scale
(NBAS), the Amiel-Tison neurologic exam, and the Scanlon ENNS (Amiel-Tison et al., 1982b).
The criteria chosen for the NACS were from those used in standard clinical and neurologic
behavioral testing. Items chosen for the NACS were those that had been shown to be affected by
perinatal asphyxia, birth trauma, or obstetric medications. The test does not specifically assess
breastfeeding but uses 20 criteria to assess 5 general areas: adaptive capacity, passive tone, active
tone, primary reflexes, and general neurologic status. Each of the 5 general areas is given a score
of 0 = absent or grossly abnormal; 1 = mediocre or slightly abnormal; or 2 = normal, with a
maximum total of 40. The total score of 35-40 to indicate a vigorous response, scores of 34 or
below are low enough to detect neonates with possible problems. The neonatal neurobehavior
was evaluated at 3, 12, and 24 hours after birth using the NACS test.
Birth trauma, obstetric medications, neurologic disease, and perinatal asphyxia all
demonstrate abnormalities in tone; therefore the NACS uses 8 separate tests for tone. There are 4
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tests of passive tone in the upper and lower extremities equally that enable detection of
hypotonia, which is indicative of birth trauma or perinatal asphyxia if observed in one side of the
body or only seen in the upper body (Amiel-Tison, Sureau, & Shnider, 1988). Drugs and
anesthetics frequently show a more general mediocre tone presenting as more general
depression. The test does not require any special equipment, it is not noxious to the neonate, and
it is simple to perform and score, with an interrater reliability of 92.8% (Amiel-Tison et al.,
1982b).
The PI attended the Brazelton Institute at Harvard Medical School and met all the
requirements for certification to administer the Brazelton NBAS (Appendix D: Brazelton
Institute Certification). The NBAS is a 45 minute thorough neurobehavior exam. The study site
would not allow a 45-minute neurobehavior exam. Therefore, the NACS was used, as it contains
some of the items from the NBAS but takes only 5 minutes to perform. Prior to data collection,
the PI reviewed NBAS training films and completed training exercises for the NACS. The
correct method of scoring the infant during an examination was to be observed by a pediatrician
at Yale New Haven Hospital who was familiar with the NACS, and the PI was to perform 10
NACS sessions simultaneously with the pediatrician prior to data collection for this study.
However, as described in the Results section, because of difficulties in execution, evaluations
with the NACS had to be discontinued.
Study Procedures
Procedures Prior to Recruitment


Approval for the research study was obtained from the Yale University Human
Investigations Committee and the Institutional Review Board of the University of
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Connecticut (Appendix E: Protocol Approval, IRB Approval, and IRB Authorization

Agreement).


Letters were sent to physicians, midwives, unit managers, and nursing staff in the Labor
and Birth Unit and the Postpartum Unit to inform them about the study (Appendix F:
Study Information for Physicians, Midwives, etc.).



An in-service training session was held to educate registered nurses, lactation consultants,
nurse anesthetists, anesthesiology residents, and nurse-midwives in these units regarding
the study (purpose, inclusion/exclusion criteria, recruitment, and procedures for data
collection). The training was conducted by the PI.



Flyers (Appendix G: Information Flyer for Nurses, Midwives, and Residents) were
placed around both the Labor & Birth and Postpartum Units to keep providers aware of
the purpose and procedures of the study.
Recruitment Procedures



Recruitment of subjects was done by the study team of co-investigators, which consisted
of two CRNAs who work in labor and delivery and an anesthesiology fellow specializing
in obstetric anesthesia. They were trained in depth on study design, inclusion criteria, and
recruitment strategies.



Nurses and midwives alerted a study team member of a possible candidate for the study
based on the inclusion criteria and asked the patients if they wanted to speak with a
member of the research team who could explain the study and answer any questions they
may have (Appendix H: Text for Nurses and Midwives for Speaking With Prospective
Subjects)



The principal investigator was notified of potential subjects.
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After being notified of potential subjects, study team members provided a detailed
explanation of the study, answered questions, and obtained written informed consent if
the patient agreed to participate (Appendix I: Oral Information for Prospective
Participants). The written informed consent form is provided in Appendix J: Written
Informed Consent Form.



Prospective subjects were approached in the labor room after they had made the decision
as to whether to have epidural analgesia or within 1 hour after delivery. Women who had
decided to have epidural analgesia were approached only after placement of the
indwelling catheter. Most laboring women are competent to consent to research and other
procedures after the administration of epidural analgesia containing opioid and local
anesthesia, because the doses commonly used have little to no sedative effect, and the
decrease in pain may make patients more able to consider and discuss options in their
care.



If an unmedicated mother had consented before vaginal delivery but then decided to
receive an epidural, she could remain in the study and cross over to the epidural cohort.

LATCH and NACS Data Collection Procedure
The following procedures were to take place at approximately 3, 12, and 24 hours after
delivery. The PI was to contact the participant at these times.
If at the time of contact with the participant, the neonate was due to feed, the PI or the
lactation consultant was to conduct the NACS and record it on the NACS assessment
sheet (Appendix K: Neurologic and Adaptive Capacity Score (NACS). The PI or the lactation
consultant then observed a breastfeeding session. Breastfeeding data were recorded on the
LATCH Feeding Record (


Appendix L: LATCH Feeding Record).
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If at the time of contact the neonate was not due to feed, the NACS and breastfeeding
observation were to be postponed until the next time that infant was due to feed. The
same procedure as above was to be followed.



If the mother or infant required any help with breastfeeding the PI was to alert the
patient’s nurse.



After completion of the three breastfeeding observations and NACS assessment, the PI
informed the patients of the completion and thanked them for participation.
Blinded Observation
Observational data collection is susceptible to biases and distortions. Some of the biases

may be due to personal interest of the data collector or anticipation of what is to be observed
affecting what is actually being observed (Polit & Beck, 2010). Because scoring the LATCH and
NACS depends on observational data, it is necessary for the data collector to be blind to the
study group. Therefore, the data collectors (the PI and the lactation consultant) did not know
whether the participant received analgesia for her labor and delivery.
The consent form and patient information related to labor, delivery, and medication
received during labor were placed in a sealed envelope and then coded with the patient’s study
ID number. These envelopes were kept in a locked office in a locked file cabinet in the office of
the Chief Certified Registered Nurse Anesthetist (CRNA). To ensure that the PI did not know
which study group a subject was in during the time of data collection, these envelopes were
given to the PI only after the study was complete.
The PI also did not have access to the mother’s electronic medical record. While
performing the study observations, there were to be no discussions about how the labor and
delivery was managed. The staff was also instructed not to disclose the information. If at any
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time the principal investigator became aware of the patient’s status, the participant was to be
withdrawn from the study.
Procedures for Ensuring Patient Safety


As part of the Yale University requirements for researchers, all members of the study
team of co-investigators completed training in Human Protection for Research Subjects
and HIPAA.



A HIPAA waiver from the Yale University Human Investigations Committee was
granted to allow access to the following information during the recruitment phase of the
study: name, medical record number, and whether or not a patient was in labor. The
research could not be conducted without the waiver and without access to and use of the
protected health information. Once patients entered the study, all data was
anonymized/de-identified in the study database.



Before approaching a patient in the labor room, the PI obtained the permission of the
patient’s obstetric care provider and also involved the patient’s primary nurse in
discussions regarding the appropriateness of such an approach.



If the patient’s obstetric care provider and/or primary labor room nurse felt that a
particular patient was not in a position to comprehend the research protocol and give
informed consent, then that patient was not approached for research participation until the
circumstances changed to the satisfaction of the primary care providers.



Whenever possible, the research investigators discussed the proposed research and
obtained informed consent in the presence of one of the patient’s independent labor
support persons (if such a support person was available and the patient had no objection
to that person’s involvement).
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All conditions of the epidural were for clinical purposes only and no manipulation
occurred for the study. The epidural catheter was placed only upon patient request for
pain management.



The investigators refrained from approaching patients for research participation at certain
times during the labor and delivery process when such an approach would have been
inappropriate. During the first stage of labor (<4 cm dilation), most women were
relatively comfortable and the intervals between contractions allowed for adequate
explanation and discussion. Because the second stage of labor may be characterized by
considerable pain and exhaustion, women were not approached during this phase.



Written evidence of informed consent was obtained in all subjects.



At the time of consent, a detailed explanation of the research was given and questions
were answered.



After delivery, the medication data from the epidural group was collected by the coinvestigators: the two CRNAs, and the obstetric anesthesiology fellow.

Risks/Benefits
The study procedures presented no known risks. No experimental conditions were placed
on the subjects. The independent variable (epidural analgesia) was the hospital’s standard
treatment and was self-selected by participants prior to researcher contact. The participants had
already decided to breastfeed and were aware of the data collection. Neonates were not
awakened for study procedures. The LATCH evaluation tool was not adverse or noxious to the
neonate. The PI and the lactation consultant were strictly observers of the breastfeeding. If
assistance was needed, the patient’s nurse was contacted.
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Every measure was taken to ensure patient privacy. To minimize risks to subjects’ privacy,
patients were invited to participate in their private room. All data collection forms were coded
and the master list of names and code numbers was kept in a locked office in a locked file
cabinet. Once results were obtained, the patients’ medical record numbers were shredded and all
that remained were the study ID numbers with no identifiable data. The information was stored
on a secure network drive accessed through an encrypted computer belonging to the PI.
No particular benefits accrued to the individual participants. The general benefits of the
study were that participants could have the satisfaction of knowing they had contributed to
identification of medical interventions that may adversely affect future newborns, helped health
care providers anticipate mother-infant dyad’s breastfeeding needs, and facilitated women's
informed choices during labor and delivery.
Statistical Analysis
The IBM SPSS Statistics Software Package Version 23 (IBM Corp., Armonk, NY) was
used for data management and analysis, except for the mixed-effect regression model used to
examine the dose relationship between epidural parameters (total amounts of infusate, lidocaine,
bupivacaine, and degree of dilation) and LATCH score in the epidural group, which was
performed using SAS software, version 9.3 (SAS Institute, Inc., Cary, North Carolina).
The data were collected and then coded and examined graphically in box plots and withingroup histograms to determine whether the variables in each group were normally distributed
and free of outliers and that the spread of data was consistent across the groups. Descriptive
analyses of variables relating to demographic characteristics, obstetric history, characteristics of
labor and delivery, neonatal characteristics, epidural medications, and breastfeeding behaviors
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were performed using means, standard deviations, and ranges for continuous variables and
frequencies and proportions for categorical variables.
Group Comparisons
The purpose of this study was to examine the relationship between epidural analgesia used
for labor pain relief and effectiveness of breastfeeding in the first 24 hours postpartum. Women
who received epidural analgesia during labor and their neonates were compared with those who
used no analgesia for labor or delivery and their neonates (control). Hypothesis testing using
inferential statistics was carried out to demonstrate any differences between groups regarding
demographic and obstetric characteristics, labor variables, and neonatal variables, with
independent t tests for continuous variables. The Kruskal-Wallis test was used for non-normally
distributed data. The Pearson chi-square test or the Fisher exact test was used to test for
associations among categorical data, for example when comparing groups regarding the
proportion of women with certain characteristics, such as the percentage of women who received
oxytocin. For determination of significance of differences between groups, p < 0.05 was selected
as the level of significance.
Correlational Analyses
To test for bivariate relationships between variables, the Pearson product moment
correlation was used. The variables included duration of labor; ruptured membranes; total IV
fluids; amount of oxytocin augmentation; induction of labor; LATCH scores at 3, 12, and 24
hours postpartum; meconium suctioning of the neonate; Apgar scores at 1 and 5 minutes; and
percentage of weight loss of the neonate.
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Multivariate Analyses
Multivariate analysis refers to the modeling of data for related multiple measurements, for
example when an outcome is measured for the same individual at multiple time points (repeated
measures). If parametric assumptions were met, repeated-measures analyses of variance (RMANOVA) were used to assess differences in breastfeeding outcomes on the LATCH total score
and subscales over the three time points (3, 12, and 24 hours) and between the infants whose
mothers received analgesic medication and whose mothers did not receive medication.
We also examined the effect of epidural on the LATCH score by using a mixed-effect
regression model, which included fixed effects of the treatment (epidural versus unmedicated),
time post-labor, interaction of treatment and time, covariates that showed significant differences
between the two groups at baseline (labor duration, total amount of oxytocin used, induction of
labor type, and total fluids), and the random effect of intercept.
Multivariable Analyses
As outlined in the literature review, numerous factors can influence the initiation and
success of breastfeeding. Multiple regression and logistic regression can be used to address the
effects of potential confounding factors that may introduce bias because of the nonrandomized
nature of the study. We therefore performed multiple linear regression analyses to describe the
relationship between the LATCH score as the dependent variable and epidural analgesia as a
predictor variable, while at the same time adjusting for other predictor variables in the model.
Such analyses can predict the probability of outcomes for individuals with a certain set of
characteristics (Fields, 2013). Thus, multiple linear regression analysis was performed in the
total group to examine whether the following variables may influence total LATCH scores at the
specific time points of 3, 12, and 24 hours postpartum:
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Maternal demographic variables, such as age, race, weight, height, BMI, gravidity, parity,
and epidural placement



Neonatal variables such as Apgar scores at 1 and 5 minutes, baby’s weight at birth,
baby’s weight change, meconium stain, sex of the neonate, and whether the baby was
suctioned after delivery

To test the hypothesis that infants whose mothers had multiple stressful events or
interventions during labor would demonstrate less effective breastfeeding, independent of labor
analgesia, labor variables such as duration of labor (2nd and 3rd stage and total), whether labor
was induced, rupture of membranes, oxytocin augmentation, epidural placed, group B
streptococcus (GBS) status, perineal laceration, and total amount of IV fluids were examined
with multiple linear regression analysis.
Regression analysis was also performed in the epidural group alone, with each total latch
score at 3, 12 and 24 hours in the model with time of epidural placement to delivery, total 1.5%
lidocaine dose, total 0.25% bupivacaine dose, oxytocin for labor augmentation, induction, total
volume of epidural infusate, total duration of labor, ruptured membranes, total IV fluids,
meconium stain, and baby suctioned.
Summary of Study Methods
This chapter attempted to give the reader a clear understanding of the study design,
methodology, and analysis. Breastfeeding behaviors of infants whose mothers chose to receive
epidural analgesia containing hydromorphone were compared with those whose mothers chose to
receive no analgesia using inferential statistics. Repeated-measures analyses of variance were
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used to test differences between groups over time. Multivariable analyses were used to
investigate the effects of potential predictor variables on breastfeeding behaviors.
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Chapter 4: Results
Chapter 4 presents the findings of the study. The first section of the chapter describes the
characteristics of the overall study population and compares the characteristics of the two
cohorts. The second section describes the timing and type of medications that were used in the
cohort that received epidural analgesia. The third section presents the results for Hypothesis 1—
that healthy term infants of mothers who receive epidural analgesia with hydromorphone would
demonstrate less effective breastfeeding behaviors at 3, 12, and 24 hours of age when compared
with infants whose mothers received no analgesia. The fourth section describes the results of
multivariable analyses performed to assess the potentially confounding effects of other factors
known to influence breastfeeding. The fifth section presents the results for Hypothesis 2—that
healthy term infants of mothers who receive epidural analgesia with hydromorphone would
demonstrate less effective breastfeeding behaviors at 3, 12, and 24 hours of age in relation to the
duration of infusion and amount of drug given to the mother. The sixth section presents the
results for Hypothesis 3—that when multiple stressful events or interventions occur during labor
or immediately after birth, the infant would demonstrate less effective breastfeeding, whether or
not labor analgesia was used. The last section summarizes the study results.
Study Participants
The study participants were recruited among parturient at the Labor and Birth Unit and the
Postpartum Unit of Yale New Haven Hospital from March through April 2015. A total of 106
women were invited to participate in this study. Two women approached to participate declined
after the study was explained to them and two women were excluded because they did not meet
eligibility criteria (one used formula and the neonate of one was admitted to the neonatal
intensive care unit immediately postpartum for shoulder dystocia).
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A total of 102 mother-infant dyads met the eligibility criteria and completed the study. No
subjects were withdrawn after study entry, and no subjects in the unmedicated group asked to
receive epidural analgesia. All mothers were multiparas who had previously breastfed. Of the
102 participants, 51 mothers received epidural analgesia only and 51 mothers received no
analgesia for labor or birth. The study flow chart is presented in Figure 1.

Figure 1.

Study Flow Chart
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Data from the 102 mother-infant dyads were obtained, recorded, and coded for a total of
306 breastfeeding observation sessions. Visual inspection of normal Q-Q plots and within-group
histograms showed that the assumption of normality was satisfied, with the spread of variables
fairly consistent between the epidural and unmedicated groups.
Characteristics of the Overall Study Population
Descriptive statistics describing the demographic characteristics and obstetric history of the
overall study population are presented in Table 4.
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Table 4.

Demographic Characteristics and Obstetric History of the Overall Study
Population (n = 102)
Variable

Value

Age, years
Mean ± SD
Range

29.55 ± 4.74
21–43

Race, n (%)
White
Hispanic

66 (64)
24 (23.5)

African American

6 (5.9)

Asian

6 (5.9)

Maternal weight (kg)
Mean ± SD

79.5 ± 14.5

Range

53.6–151.8

Maternal height (cm)
Mean ± SD

163.3 ± 6.6

Range

152.4–182.9

BMI
Mean ± SD

29.6 ± 4.5

Range

19.8–50.8

Number of pregnancies
Mean ± SD
Range

2.8 ± 0.8
2–5

Number of previous live births
Mean ± SD
Range

1.4 ± 0.6
1–3

SD = standard deviation.

Labor and delivery characteristics of the overall study population are presented in Table 5.
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Table 5.

Labor and Delivery Characteristics in the Overall Study Population (n = 102)
Variable

Value

Duration of labor (min)
2nd stage
Mean ± SD
Range

20.2 ± 18.4
2–98

3rd stage
Mean ± SD
Range

7.1 ± 5.2
1–39

Total
Mean ± SD

27.3 ± 19.4

Range

6–108

Oxytocin, n (%)

35 (34.3)

Induced, n (%)

26 (25.5)

Spontaneous rupture of membranes, n (%)

47 (46.0)

Episiotomy, n (%)

7 (6.9)

Perineal laceration with vaginal delivery, n (%)

66 (64.7)

GBS+ and received antibiotics, n (%)

33 (32.4)

Total IV fluids (mL)
Mean ± SD
Range

1094.6 ± 892.1
0–3900

Type of delivery
Forceps

0 (0)

Vacuum

1 (1)

GBS+ = positive for group B streptococcus; IV = intravenous; SD = standard deviation.

Characteristics of the neonates are given for the overall study population in Table 6.
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Table 6.

Neonatal Characteristics in the Overall Study Population (n = 102)
Variable

Value

Gestational age (weeks)
Mean ± SD
Range

39.7 ± 0.9
37–41

Apgar score
1 min
Mean ± SD
Range

8.83 ± 0.37
8–9

5 min
Mean ± SD
Range
Meconium stained, n (%)
Baby suctioned, n (%)

8.98 ± 0.14
8–9
16 (15.7)
39 (38)

Sex of neonate, n (%)
Male

50 (49)

Female

52 (51)

Baby weight at birth (kg)
Mean ± SD

3.4 ± 0.48

Range

2.67–4.80

Baby weight change in 24 hours (%)
Mean ± SD

-4.52 ± 2.28

Range

-9.98 to 2.64

SD = standard deviation.

Comparisons of Participant Characteristics Across Study Groups
The unmedicated control and epidural groups were compared regarding demographic
characteristics, obstetric history, labor variables, and neonatal characteristics. No significant
differences were observed regarding age, race, weight, height, BMI, gravidity, or parity (Table
7).
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Table 7.

Demographic Characteristics and Obstetric History by Study Group
Unmedicated (n=51)

Epidural(n=51)

pa

32.5 ± 4.3

32.6 ± 5.2

0.82

Hispanic/African American/Asian

16 (31.4)

20 (39.2)

0.27

White

35 (68.6)

31 (60.8)

0.27

Maternal weight (kg), mean ± SD

79.2 ± 12.6

79.8 ± 16.3

0.82

Maternal height (cm), mean ± SD

163.3 ± 6.4

162.8 ± 6.4

0.88

BMI, mean ± SD

29.4 ± 3.8

29.7 ± 5.1

0.67

Number of pregnancies, mean ±SD

2.71± 0.78

2.82± 0.88

0.48

Number of births, mean ± SD

1.51 ± 0.70

1.37 ± 0.60

0.29

Age, mean ± SD
Race, n (%)

BMI = body mass index; SD = standard deviation
a

Means were compared with a t test, and frequencies were compared with a chi-square or Fisher exact test.

As shown in Table 8 below, the duration of the 2nd stage of labor (p = 0.001) and duration
of the entire labor process (the sum of duration of the 2nd and 3rd stages; p <0.001) were
significantly longer in the epidural group than in the unmedicated group. The percentage of
women receiving oxytocin (p = 0.002), proportion of women with induced labor (p = 0.003), and
total amount of IV fluids (lactated Ringer’s solution) administered (p <0.001) were also
significantly greater in the epidural group than in the unmedicated group. No significant
differences between the groups were observed regarding duration of the 3rd stage of labor (p =
0.28), percentage of mothers with spontaneous rupture of membranes (p = 0.43), or degree of
laceration (p = 0.35).
Four of the 51 women in the epidural group and none of the women in the unmedicated
group required corrective action for hypotension. There were no instances of fever, fetal
bradycardia, or decreased fetal heart rate variability in either group.
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Table 8.

Labor Characteristics by Study Group
Unmedicated
(n=51)

Epidural
(n=51)

pa

2nd stage

13.35 ± 12.5

27.12 ± 20.9

0.001

3rd stage

6.51 ±4.12

7.63 ±6.05

0.28

19.86 ±13.79

34.75 ±21.35

<0.001

Oxytocin, n (%)

11 (22.9)

24 (47.1)

0.002

Induced, n (%)

6 (11.8)

20 (39.2)

0.003

Duration of labor (min)

Total

Rupture of membranes, n (%)

0.43

Spontaneous rupture of membranes

26 (51.0)

21 (41.2)

Artificial rupture of membranes

25(49.0)

30 (58.8)

Degree of laceration, n (%)

0.35

0

15 (29.4)

21 (41.2)

1

17 (33.3)

17 (33.3)

2 or 3

19 (37.3)

13 (25.5)

GBS positive, n (%)

18 (35.3)

15 (29.4)

0.67

Total IV fluids (mL), mean ± SD

576 ± 704

1612 ± 750

<0.001

GBS = group B streptococcus. IV = intravenous; SD = standard deviation.
a

Means were compared with a t test, and frequencies were compared with a chi-square or Fisher exact test.

Characteristics of the 51 neonates born to mothers who received epidural analgesia and the
51 neonates born to mothers who had no analgesia are shown in Table 9. The groups were not
significantly different regarding birth weight, gestational age, Apgar scores at 1 and 5 minutes,
meconium, suction at birth, sex and weight of the baby, or percent weight loss at 48 hours
postpartum.
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Table 9.

Neonatal Characteristics by Study Group
Unmedicated (n = 51)

Epidural (n = 51)

pa

39.7 ± 0.8

39.6 ± 1.0

0.54

1 min

8.9 ± 0.35

8.0± 0.40

0.43

5 min

9.0 ± 0.14

9.0 ± 0.14

>0.99

Meconium stained, n (%)

8 (15.7)

8 (15.7)

>0.99

Baby suctioned, n (%)

15 (29.4)

24 (47.1)

0.10

Baby
Gestational age, mean ± SD
Apgar score

Sex of neonate, n (%)

0.55

Male

27 (52.9)

23 (45.1)

Female

24 (47.1)

28 (54.9)

Baby weight at birth (kg)

3.44 ± 0.71

3.33 ± 0.26

0.065

Baby weight change in 24 hours (%),
mean ± SD

-4.61 ± 2.14

-4.44 ± 2.42

0.71

a

Means were compared with a t test, and frequencies were compared with a chi-square or Fisher exact test.

Epidural Medications
Cervical dilation at the time of epidural placement in the epidural group ranged from 3 to 9
cm (Table 10). All women in the epidural group received a continuous infusion of bupivacaine
0.05% with hydromorphone 3 µg/mL at a rate of 14 mL/h. In addition to the continuous infusion,
two types of local anesthetics were administered: bupivacaine 0.25% with epinephrine at a ratio
of 1:200,000 (n = 49) and lidocaine 1.5% with epinephrine at a ratio of 1:200,000. Forty-four
subjects received both lidocaine and bupivacaine, five subjects received bupivacaine only, and
two subjects received lidocaine only. The total volumes are shown in Table 10. Fifteen of the 51
epidural subjects (29.4%) required an additional bolus of bupivacaine 0.25% with epinephrine
1:200,000 during labor for breakthrough pain.
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Table 10. Extent of Dilation at the Time of Epidural Placement, Total Amount of Epidural
Infusate, and Local Anesthetic Dose (Lidocaine or Bupivacaine)
Name

n

Mean

SD

Range

Extent of dilation at epidural placement

51

5.2

1.34

3–9

Total epidural infusate
(bupivacaine/hydromorphone), mL

51

56.38

39.96

0–170

Lidocaine 1.5%a

46

3.4

0.92

3–6

Bupivacaine 0.25%a

49

7.3

1.78

3–11

Local lidocaine and/or bupivacaine, mL

SD = standard deviation
aWith

epinephrine at a ratio of 1:200,000.

Hypothesis 1: Effects of Epidural Analgesia on Breastfeeding
The primary hypothesis was that healthy term infants of mothers who receive epidural
analgesia with hydromorphone would exhibit less effective breastfeeding behaviors at 3, 12, and
24 hours of age when compared with infants whose mothers received no analgesia. The likely
differences would correspond to the neonates’ ability to maintain an active awake state, latch on
to the breast, and coordinate the suck-breath-swallow actions necessary to remove milk from the
breast.
LATCH Assessment Tool
To test the hypothesis, breastfeeding behaviors were observed at 3, 12, and 24 hours
postpartum with the LATCH assessment tool. Repeated-measures ANOVA with independent t
tests for pairwise comparisons at each time point were performed for unadjusted scores on the
total LATCH score and individual LATCH subscales. Unadjusted total LATCH scores did not
differ between the unmedicated and epidural groups at any of the time points, F (1.712,
171.15) = 0.28, p = 0.07 (Table 11). Total scores tended to increase over time in both groups
(Figure 2).
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Table 11. Total LATCH Scores by Group at 3, 12, and 24 Hours Postpartum
Unmedicated

Epidural

Epidural vs Unmedicated

(n = 51)
Mean ± SD

(n = 51)
Mean ± SD

Mean
difference

95% CI

pa

First breastfeeding
(3 h)

8.35 ± 1.31

8.47 ± 1.34

0.12

-0.48 to 0.71

0.65

Second breastfeeding
(12 h)

8.94 ± 1.06

8.90 ± 1.06

-0.04

-0.52 to 0.44

0.85

Third breastfeeding
(24 h)

9.22 ± 0.86

9.18 ± 0.84

-0.04

-0.42 to 0.34

0.81

CI = confidence interval.
a

Repeated-measures ANOVA with independent t tests for pairwise comparisons.

Figure 2.

Total LATCH Scores in Unmedicated (Control) and Epidural Groups at Each
Time Point (1 = 3 h; 2 = 12 h; 3 = 24 h)
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The numbers and percentages of women in each group with total LATCH scores >7 also
did not differ between groups at any of the time points (Table 12).
Table 12. Proportion of Women With Total LATCH Scores >7
Unmedicated (n = 51)

Epidural (n = 51)

pa

n (%)

n (%)

First breastfeeding (3 h)

39 (76.5)

37 (72.5)

0.65

Second breastfeeding (12 h)

42 (82.4)

45 (88.2)

0.40

Third breastfeeding (24 h)

49 (96.1)

48 (94.1)

0.65

a 2
χ -test

As shown in Table 13 below, LATCH subscale scores did not differ significantly between
groups at any of the time points.
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Table 13. LATCH Subscale Scores by Group for Breastfeeding Behaviors at 3, 12, and 24 Hours Postpartum
Breastfeeding session

Unmedicated (n = 51)

Epidural (n = 51)

Mean ± SD

Mean ± SD

Mean difference

95%CI

pa

L1

1.71 ± 0.50

1.78 ± 0.46

0.08

-0.11 to 0.27

0.36

A1

1.24 ± 0.62

1.45 ± 0.70

0.22

-0.04 to 0.48

0.06

T1

2.00 ± 0.00

1.98 ± 0.14

-0.02

-0.06 to 0.02

0.32

1

C

1.92 ± 0.27

1.90 ± 0.30

-0.02

-0.13 to 0.09

0.73

H1

1.50 ± 0.61

1.33 ± 0.59

-0.16

-0.39 to 0.08

0.15

L2

1.88 ± 0.32

1.86 ± 0.35

-0.02

-0.15 to 0.11

0.77

A2

1.55 ± 0.58

1.57 ± 0.54

0.02

-0.20 to 0.24

0.94

T2

2.00 ± 0.00

1.98 ± 0.14

-0.02

-0.06 to 0.20

0.32

C2

1.96 ± 0.20

1.86 ± 0.35

-0.10

-0.21 to 0.01

0.08

H2

1.55 ± 0.58

1.63 ± 0.50

0.08

-0.13 to 0.30

0.58

L3

1.94 ± 0.24

1.96 ± 0.20

0.02

-0.07 to 0.10

0.65

A3

1.78 ± 0.41

1.73 ± 0.53

-0.06

-0.25 to 0.13

0.74

T3

2.00 ± 0.00

2.00 ± 0.00

C3

1.82 ± 0.38

1.84 ± 0.367

0.02

-0.13 to 0.17

0.80

H3

1.67 ± 0.48

1.67 ± 0.47

0.00

-0.19 to 0.19

>0.99

Breastfeeding level

Epidural vs Unmedicated

First breastfeeding (3 h)

Second breastfeeding (12 h)

Third breastfeeding (24 h)

>0.99

L = infant’s ability to latch onto the breast; A = audible sound of swallowing; T = maternal nipple type; C = comfort of the mother’s breast and nipple;
H = holding, i.e., amount of assistance the mother needs to hold the neonate.
a

Kruskal-Wallis test (all measures skewed).
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The linear regression model was used to adjust the effects of epidural on the total LATCH
score for the effects of labor duration, total amount of oxytocin used, total IV fluids (lactated
Ringer’s solution), and labor type (induction). After adjusting for these variables, we still did not
find statistically significant differences in LATCH scores between the two groups at any time
point (Table 14).
Table 14. Differences Between Neonates of Mothers With vs Those Without Epidural
Analgesia in Total LATCH Scores Adjusted for Duration of Labor, Oxytocin
Administration, Total IV Fluids, and Labor Type
Epidural vs. Unmedicated
Difference

95% CI

pa

3h

0.19

-0.37 to 0.74

0.51

12 h

0.19

-0.27 to 0.64

0.42

24 h

0.15

-0.22 to 0.52

0.43

Time

CI = confidence interval.
aMixed-effect

model.

Thus, the data from the LATCH evaluation did not support the primary hypothesis that
infants of mothers who receive epidural analgesia with hydromorphone would demonstrate less
effective breastfeeding behaviors than infants of unmedicated mothers.
NACS Assessment
The study was originally designed to conduct the NACS and the LATCH together at 3, 12,
and 24 hours after delivery. The exact times depended on the baby’s hunger and willingness to
feed. According to the developers of the NACS, the test can be performed on the neonate in any
sleep state (Amiel-Tison et al., 1982b). However, the babies performed best when the test was
performed 30 minutes before they were due to breastfeed. Thus, neonates would be observed for
signs of waking approximately 2 hours before the assessments needed to be done. This was to
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ensure the neonate could be tested when they were awake and not distressed. This became
increasingly difficult to time and babies were being tested at different states of arousal, which
altered specific items on the tool. If the babies were examined when they were crying, they
would have low active and adaptive tone scores. If the babies were sleeping, their adaptive and
active tone scores were also lower. The NACS was designed to be sensitive to the effects of
narcotics on the neonate. Therefore, those specific categories were especially important (AmielTison et al., 1982b). If the babies were distressed, they were permitted to feed, and the NACS
would have to be done before the next feed. If the baby was sleeping, the parents became upset
because they could not comfort the child or because the baby was awakened. If the LATCH was
performed before the NAC, the infant would still be skin-to-skin with the mother after feeding,
and the mothers did not want their babies tested at that time. To get the best results, it is
recommended to wait at least 1 hour after feeding before conducting a neurobehavior exam on a
neonate (Brazelton & Nugent, 2011). As part of the BFHI, it was also hospital policy to keep
babies skin-to-skin with the mother as frequently and as long as possible. The NACS was
therefore performed in only three patients (data not shown) and was then discontinued. Thus,
only data from the LATCH breastfeeding observations are available for hypothesis testing.
Effects of Confounding Variables on Breastfeeding
Multivariable analyses were performed to assess the potentially confounding effects of
other factors known to influence breastfeeding.
Maternal Demographic and Obstetric variables
Maternal demographic and obstetric variables, including maternal age, race, BMI, height,
weight, gravidity, parity, and epidural placement were examined with total LATCH scores at 3,
12, and 24 hours using multiple linear regression to test whether any of these variables could
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predict total LATCH score at the three time points (Table 15). Neither epidural placement nor
maternal demographic/obstetric history variables showed an independent effect. Table 16 shows
the R2, F, and p values as variables are added to the regression analysis. Statistical significance
was achieved for the overall model tested at 12 and 24 hours. Together, these maternal
demographic and obstetric variables contributed 20% of the variability in total LATCH scores in
the model at 3 hours postpartum, 30% at 12 hours, and 30% at 24 hours. The total LATCH score
at the first feeding (3 hours postpartum) was the only variable that significantly contributed to
the total LATCH score at the second feeding (12 hours postpartum) (p = <0.001), and the total
LATCH score at the second feeding was the only variable that significantly contributed to the
total LATCH score at the third feeding (24 hours postpartum) (p = <0.001). This indicates that
the same infant improved their LATCH score between birth and 24 hours regardless of maternal
demographic/obstetric factors and exposure to epidural analgesia medications.
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Table 15. Summary of Multiple Linear Regression Analysis of the Effects of Maternal Demographic and Obstetric Variables
as Predictors of Total LATCH Scores at 3, 12, and 24 Hours Postpartum: Total Sample (n = 102)
Total LATCH 3 h

Total LATCH 12 h

Total LATCH 24 h

Β
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

Age

0.002
(0.028)

0.943

.007
(.053-.057)

0.019
(0.022)

0.403

.056
(-.026-.063)

-0.001
(0.018)

0.977

-.003
(-.036-.035)

Race

0.000
(0.003)

0.900

-.013
(-.007- .006)

0.000
(0.003)

0.870

-.017
(-.006-.005)

-0.002
(0.002

0.292

-.107
(-.006-.002)

Maternal weight

-0.004
(0.004)

0.290

-.109
(-.013- .004)

-0.001
(0.003)

0.774

-.030
(-.008-.006)

-0.002
(0.003)

0.456

-.076
(-.007-.003)

Maternal height

0.097
(0.060)

0.106

.191
(-.021-.215)

0.039
(0.049

0.427

.094
(-.058-.135)

-0.001
(0.039)

0.978

-.003
(-.078-.076)

BMI

-0.083
(0.126)

0.511

-.285
(-.333-.167)

-0.004
(0.103)

0.969

-.017
(-.208-.200)

-0.009
(0.082)

0.912

-.048
(-.172-.154)

Gravidity

0.158
(0.162)

0.333

.100
(-.164-.480)

0.035
(0.133)

0.794

.028
(-.229-.299)

-0.078
(0.106

0.460

.007
(-.288-.131)

Parity

-0.059
(0.253)

0.816

-.029
(-.562- .444)

0.208
(0.207)

0.318

.128
(-.203-.619)

0.091
(0.165)

0.071

.071
(-.236-.419)

Epidural placed

-0.022
(0.268)

0.935

-.009
(-.554-.511)

-0.004
(0.219)

0.987

-.002
(-.439-.431)

-0.085
(0.174)

0.626

-.052
(-.432-.261)

0.251
(0.070)

< 0.001

.312
(.112-.390)

0.161
(0.066)

0.016

.250
(.030-.291)

0.425
(0.070)

<0.001

.533
(.285-.564)

Variable

Total LATCH 3h

Constant

Total LATCH 12 h

0.515
(0.116)

<0.001

.415
(.285-.745)

Constant

Total LATCH 24 h

0.381
(0.155)

0.016

.244
(.071-.688)

0.670
(0.111)

<0.001

.534
(.450-.890)

Constant
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Table 16. R2, F, and Probability for Regression Analysis of Maternal Demographic and Obstetric Variables as Predictors of
Total LATCH Scores at 3, 12, and 24 Hours Postpartum: Total Sample (n = 102)
Total LATCH 3 h

Total LATCH 12 h

Total LATCH 24 h

R2

F

p

R2

F

p

R2

F

p

Age

0.000

0.005

0.943

0.007

0.704

0.403

0.000

0.001

0.977

Race

0.000

0.011

0.990

0.007

0.362

0.697

0.011

0.562

0.572

Maternal weight

0.012

0.385

0.764

0.008

0.267

0.849

0.017

0.560

0.643

Maternal height

0.038

0.960

0.433

0.015

0.358

0.838

0.017

0.416

0.797

BMI

0.042

0.851

0.517

0.015

0.284

0.921

0.017

0.332

0.893

Gravity

0.052

0.866

0.523

0.015

0.246

0.960

0.023

0.367

0.898

Parity

0.052

0.743

0.636

0.026

0.355

0.926

0.026

0.356

0.925

Epidural placed

0.052

0.644

0.739

0.026

0.307

0.962

0.028

0.339

0.949

0.389

5.800

< 0.001

0.088

0.982

0.460

0.305

4.479

<0.001

Total LATCH 3h

Constant

Total LATCH 12h

0.220

2.881

0.005

Constant

Total LATCH 24h

0.110

1.268

0.460

0.303

Model

0.265

4.441

<0.001
<0.001

Constant
<0.001
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Neonatal Variables
Multiple linear regression analysis was also performed to assess neonatal variables shown
in the literature to be predictive of breastfeeding behaviors, including Apgar scores at 1 and 5
minutes, baby weight at birth, weight change during the first 24 hours, sex of neonate, meconium
stain, and whether the baby was suctioned after delivery (Table 17). None of the neonatal factors
had a significant effect on total LATCH scores at 3, 12, or 24 hours. Altogether, these variables
accounted for less than 10% of the variability in LATCH scores in the model at 3, 12, and 24
hours (Table 18).
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Table 17. Summary of Multiple Linear Regression Analysis for Neonatal Variables as Predictors of Total LATCH Scores at 3,
12, and 24 Hours Postpartum: Total Sample (n = 102)
Total LATCH 3 h

Total LATCH 12 h

Total LATCH 24 h

Β
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

Apgar score 1 min

-0.303
(0.375)

0.422

.375
(-1.048-.443)

0.418
(0.310)

0.181

.148
(-.198-1.033)

0.084
(0.243)

0.729

-.037
(-.567-.399)

Apgar score 5 min

1.135
(1.009)

0.263

.121
(-.868-3.139)

0.599
(0.834)

0.474

.079
(-1.056-2.255)

1.282
(0.654)

0.053

.212
(-.016-2.581)

Baby weight at birth

-0.118
(0.134)

0.381

-.090
(-.384-.148)

0.027
(0.111)

0.807

.026
(-.193-.247)

-0.056
(0.087)

0.522

-.066
(-.228-.117)

% of baby weight
change in 24 hours,

0.062
(0.059)

0.293

.108
(-.054-.178)

0.010
(0.048)

0.830

.023
(-.086-.107)

0.025
(0.038)

0.505

.069
(-.050-.101)

Meconium stained

0.561
(0.290)

0.138

.157
(-.184-1.306)

-0.227
(0.310)

0.466

-.079
(-.843-.389)

0.015
(0.243)

0.952

.006
(-.468-.497)

Sex of neonate

0.108
(0.269)

0.690

.041
(-.427-.642)

0.027
(0.223)

0.905

.013
(-.416--.469)

-0.083
(0.174)

0.635

-.049
(-.429-.263)

Baby suctioned

0.251
(0.290)

0.390

.093
(-.325-.827)

0.024
(0.240)

0.922

.011
(-.453-.500)

-0.090
(0.188)

0.633

-.052
(-.463-.283)

Variable

155

Table 18. R2, F, and Probability for Regression Analysis of Neonatal Variables as Predictors of Total LATCH Scores at 3, 12,
and 24 hours Postpartum: Total Sample (n = 102)
Total LATCH 3 h

Total LATCH 12 h

Total LATCH 24 h

R2

F

p

R2

F

p

R2

F

p

Apgar score 1 min

0.000

0.040

0.422

0.028

2.846

0.181

0.000

0.011

0.729

Apgar score 5 min

0.028

1.450

0.263

0.033

1.704

0.474

0.044

2.258

0.053

Baby weight at birth

0.031

1.044

0.381

0.033

1.124

0.807

0.050

1.731

0.522

% of baby weight change in 24
hours

0.044

1.120

0.293

0.034

0.843

0.830

0.055

1.416

0.505

Meconium stained

0.074

1.525

0.138

0.038

0.765

0.466

0.055

1.123

0.952

Sex of neonate

0.074

1.269

0.690

0.039

0.640

0.905

0.058

0.969

0.635

Baby suctioned

0.079

1.158

0.390

0.040

0.555

0.922

0.058

0.832

0.633

Model

0.334

0.790

0.563
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Hypothesis 2: Effects of Extent of Epidural Drug Exposure on Breastfeeding Behaviors
The second hypothesis was that healthy term infants of mothers who receive epidural
analgesia with hydromorphone would demonstrate less effective breastfeeding behaviors at 3,
12, and 24 hours of age in relation to the duration of infusion and amount of drug given to the
mother. This hypothesis was based on the assumption that if exposure to the drug affects the
neonate’s muscle tone and reflexes, then breastfeeding behaviors such as the necessary facial
tone to maintain latch-on would be worse with longer epidural infusions and greater amounts of
infusate.
Examination of the dose relationship between epidural medication and LATCH score in
the epidural group using the mixed-effect regression model did not show a significant effect for
total amount of epidural infusate, total dose of lidocaine, or total dose of bupivacaine (Table 19).
The degree of dilation at the time of placement of the epidural also did not significantly affect
the LATCH score (Table 19). Thus, study findings did not support the hypothesis that healthy
term infants born to mothers who received epidural analgesia would demonstrate less effective
breastfeeding behaviors with greater exposure to epidural medications.
Table 19. Mixed-effect Regression Analysis of Effects of Total Epidural Infusate, Dose,
and Extent of Dilation on Total LATCH Score (n = 51)
Name

Coefficient

95% CI

p

Total amount of epidural infusate

-0.039

-0.363 to -0.389

0.937

Total dose of lidocaine

0.116

-0.157 to 0.388

0.396

Total dose of bupivacaine

-0.026

-0.154 to 0.102

0.686

Degree of dilation at epidural placement

-0.033

-0.200 to 0.134

0.690
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Furthermore, multiple linear regression analysis in a model comprising multiple interventions
during labor also did not find significant relationships of these variables with total LATCH
scores within the epidural group (see Table 24 under Hypothesis 3: Effects of Multiple Stressful
Events or Interventions, below).
Hypothesis 3: Effects of Multiple Stressful Events or Interventions During Labor
The third hypothesis predicted that when multiple stressful events or interventions are
present during labor or immediately after birth, healthy term infants would demonstrate less
effective breastfeeding, whether or not labor analgesia was used. Such factors might include
maternal factors, e.g., long duration of labor (2nd stage, 3rd stage, or total stage 2/3), large total
amount of IV fluids administered, oxytocin administration, induction of labor, epidural
placement, group B streptococcus positive status, and perineal laceration, or neonatal factors,
e.g., meconium staining, baby suctioned, low Apgar score at 1 and/or 5 minutes, and neonatal
weight loss. Multiple linear regression analyses of these explanatory variables were therefore
performed with total LATCH score at 3, 12, and 24 hours as dependent variables tested
individually in the model. These analyses were performed both for the entire patient collective (n
= 102) and for the epidural group alone (n = 51).
Total Sample
Prior to the multiple regression analyses, Pearson’s correlation coefficients were calculated
to examine possible linear relationships between variables. The results of the correlation matrix
for the entire patient collective are presented in Table 20.
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Table 20. Correlation Matrix for Labor and Neonatal Variables and LATCH Scores in the Total Sample (n = 102)
Duration Rupture
Total IV Oxytoci
Epidural
Stage 2 membranes
fluids
n
Induction placed

Total
stage
Baby
Apgar Apgar
2&3 suctioned Meconium 1 min 5 min

Weight
loss
(%)

3h
LATCH

12 h
LATCH

Duration Stage 2
Rupture of membranes

-0.027

Total IV fluids

0.172

0.133

Oxytocin

0.023

-0.254*

-0.401**

Induction

-0.023

-0.315**

-0.301** 0.620**

Epidural placed

-0.374**

-0.098

Total Stage 2 & 3

0.964**

-0.012

0.199*

-0.009

0.061

-0.386**

Baby suctioned

-0.074

-0.039

-0.116

0.069

0.003

0.182

-0.049

Meconium

-0.048

-0.016

-0.103

-0.080

-0.131

-0.004

-0.059 0.269**

Apgar 1 min

-0.041

0.009

-0.130

-0.046

0.040

0.079

-0.053

0.189

0.167

Apgar 5 min

-0.110

0.011

-0.065

-0.102

-0.083

0.000

-0.144

0.180

0.133

Weight loss (%)

0.040

0.087

0.061

0.107

0.049

-0.037

0.043

0.075

0.017

-0.109 0.066

3 h LATCH

-0.110

-0.055

-0.172

-0.041

-0.005

-0.045

-0.114

0.124

0.183

-0.020 0.153

0.137

12 h LATCH

-0.086

-0.125

-0.042

0.025

-0.001

-0.019

-0.053

0.056

-0.037

0.166 0.124

0.007

0.421**

24 h LATCH

-0.155

-0.135

-0.031

0.095

0.083

0.023

-0.169

-0.008

0.005

0.010 0.201*

0.096

0.239*

-0.584** 0.268** 0.315**

* Correlation is significant at the 0.05 level (2-tailed).
** Correlation is significant at the 0.01 level (2-tailed).

0.316**

0.526**

24 h
LATCH
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The results of multiple linear regression analysis of multiple events or interventions during
labor are presented in Table 21 for the entire study population. The only significant effect was a
negative effect at the first breastfeeding (3 hours postpartum) when the mother received high
volumes of IV fluids (lactated Ringer’s solution) (p = 0.021). Other labor and neonatal variables
were not useful in predicting LATCH scores at 3, 12, or 24 hours postpartum. Table 22 shows
the R2 values as variables are added to the model. The largest R2 value (0.083) was achieved at
24 hours (Table 22), indicating that the variability of LATCH scores accounted for by the labor
and neonatal variables altogether was not more than approximately 8% at any of the three time
points. Thus, study findings did not support the hypothesis that healthy term infants born to
mothers with multiple stressful labor interventions or events demonstrate less effective
breastfeeding, whether or not labor analgesia was used.
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Table 21. Multiple Linear Regression Analysis of Labor Variables as Predictors of Total LATCH Scores at 3, 12, and 24
Hours Postpartum: Total Sample (n = 102)
Total LATCH 1 (3 h)

Total LATCH 2 (12 h)

Total LATCH 3 (24 h)

Β
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

Duration of 2nd
stage of labor

-0.008
(0.007)

0.272

-.110
(-.022-.006)

-0.005
(0.006)

0.387

-.086
(-.016-.006)

-0.007
(0.005)

0.051

-.155
(-.016-.002)

Duration of 3rd
stage of labor

-0.008
(0.25)

0.759

-.031
(-.058-.043)

0.023
(0.020)

0.254

.114
(-.017-.064)

-0.012
(0.016

0.454

-.075
(-.044-.020)

Duration of total
labor

-0.008
(0.007)

0.279

-.008
(-.002-.006)

-0.005
(0.006

0.365

-.095
(-.017-.006)

-0.007
(0.005)

0.127

-.160
(-.016-.002)

Induction

-0.037
(0.305)

0.904

-.012
(-.641-.568)

0.034
(0.244)

0.891

.014
(-.451-.519)

0.135
(0.194)

0.487

.070
(-.249-.519)

Rupture of
membranes

-0.175
(0.279)

0.532

-.067
(-.728-.378)

-0.302
(0.222)

0.176

-.143
(-.743-.138)

-0.214
(0.176)

0.228

-.127
(-.563-.136)

Oxytocin

-0.173
(0.357)

0.629

-.063
(-.881-.535)

0.084
(0.284)

0.768

.038
(-.480-.648)

0.117
(0.225)

0.605

.066
(-.330-.564)

Epidural placed

-0.124
(0.290)

0.671

-.048
(-.700-.453)

-0.004
(0.232)

0.988

-.002
(-.463-.456)

-0.190
(0.183)

0.301

-.116
(-.552-.173)

GBS positive

-0.033
(0.289)

0.910

-.012
(-.608-.542)

-0.254
(0.229)

0.271

-.113
(-.710-.202)

-0.221
(0.181)

0.224

-.123
(-.580-.137)

Perineal laceration

0.022
(0.171)

0.896

.014
(-.318-.363)

-0.044
(0.136)

0.744

-.034
(-.314-.225)

0.084
(0.107)

0.433

.081
(-.128-.295)

Total IV fluids
infused

0.000
(0.000)

0.021

-.304
(-.001-.000)

-5.891
(0.00)

0.706

-.051
(.000-.000)

-8.377
(0.000)

0.945

-.009
(.000-.000)

Variable
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Table 22. R2, F, and Probability for Regression Analysis of Labor Variables as Predictors of Total LATCH Scores at 3, 12,
and 24 Hours Postpartum: Total Sample (n = 102)
Total LATCH 3 h

Total LATCH 12 h

Total LATCH 24 h

R2

F

p

R2

F

p

R2

F

p

Duration of 2nd stage labor

0.012

1.222

0.272

0.007

0.753

0.387

0.024

2.456

0.120

Duration of 3rd stage labor

0.013

0.653

0.759

0.021

1.037

0.254

0.030

1.510

0.454

Duration of total labor

0.013

0.653

0.279

0.021

1.037

0.365

0.030

1.510

0.127

Induced

0.013

0.436

0.904

0.021

0.691

0.9891

0.034

1.164

0.487

Rupture of membranes

0.017

0.423

0.532

0.039

0.987

0.176

0.049

1.246

0.228

Oxytocin

0.020

0.383

0.629

0.040

0.800

0.768

0.052

1.043

0.605

Epidural placed

0.021

0.347

0.671

0.040

0.660

0.988

0.062

1.050

0.301

GBS positive

0.022

0.296

0.910

0.052

0.742

0.271

0.077

1.119

0.224

Perineal laceration

0.022

0.258

0.896

0.053

0.656

0.744

0.083

1.052

0.433

Total IV fluids infused

0.077

0.857

0.021

0.055

0.594

0.706

0.083

0.926

0.945

Variable

Model

0.566

0.799

0.507
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Within the Epidural Group
Women who receive epidural analgesia may be even more likely than women without
epidural analgesia to have multiple stressful interventions and events during labor or
immediately postpartum (e.g., oxytocin administration, induction of labor, ruptured membranes,
total IV fluids administered, longer long duration of labor, meconium staining, and need for baby
suctioning), which might affect the neonates’ breastfeeding behaviors. Therefore, a second
multiple linear regression analysis of the effects of labor and neonatal variables was performed in
the epidural group alone.
To examine possible linear relationships among labor and neonatal variables, Pearson
correlation coefficients among variables were examined. The correlation matrix is presented in
Table 23.
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Table 23. Correlation Matrix for Labor Variables and LATCH Scores in the Epidural Group (n = 51)
Duratio
n S2

Rupture
memb

Total IV

Oxytocin

Inductio
n

Dilatio
n

Total
S2&3

1.5%
lido

0.25%
bupiv

Total
Baby
Apgar Apgar Wt loss 3 h
12 h
24 h
epidural suction Meconium 1 min 5 min (%) LATCH LATCH LATCH

Duration S2
Rupture memb

-0.082

Total IV

-0.097

0.097

Oxytocin

0.182

-0.150

-0.182

Induction

0.038

-0.263

0.104

0.530**

Dilation

-0.228

-0.239

0.110

-0.040

-0.092

0.959**

-0.061

-0.074

0.154

0.051

-0.260

1.5% lidocaine

0.130

-0.042

0.039

0.137

0.094

-0.026

0.086

0.25% bupiv

-0.255

-0.047

0.051

-0.312*

-0.219

0.225

-0.189 -0.175

Total epidural

0.165

0.091

0.150

-0.250

-0.346* -0.290*

Baby suction

0.710

0.009

-0.116

0.056

0.018

-0.129

0.013 -0.025 -0.080

0.320*

Meconium

-0.083

-0.032

-0.116

-0.083

-0.207

-0.209

-0.056 -0.005 0.134

-0.002

0.088

Apgar 1 min

0.184

-0.012

-0.012

-0.070

0.089

-0.136

0.235

0.140

0.235

0.371

0.059

Apgar 5 min

-0.067

0.169

-0.169

-0.133

-0.139

-0.296*

-0.115 -0.270 0.351*

0.038

0.263

0.328*

0.286*

Wt loss (%)

0.064

0.115

0.047

0.233

0.152

0.018

0.086

0.568

0.017

0.258

-0.163

0.099

-0.099 -0.003

3 h LATCH

-0.125

-0.033

-0.289*

-0.050

0.170

-0.096

-0.114 0.224

0.099

-0.091

0.038

0.193

-0.011 0.156

12 h LATCH

-0.117

-0.078

-0.258

0.099

0.095

-0.110

-0.072 0.205

0.051

-0.183

-0.050

0.062

0.142 -0.148 -0.054 0.620**

24 h LATCH

-0.253

0.082

-0.037

0.105

0.208

-0.020

-0.275 0.026 -0.111

-0.277

-0.129

0.091

-0.014 0.030

Total S2&3

0.155

0.193 -0.220

0.111

0.075

0.165 0.331* 0.467**

Bupiv = bupivacaine; rupture memb = ruptured membrane; S2 = 2nd stage of labor; S2&3 = 2nd and 3rd stages of labor; total epidural = total epidural infusate; wt loss
= neonatal weight loss.
* Correlation is significant at the 0.05 level (2-tailed). ** Correlation is significant at the 0.01 level (2-tailed)
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The regression analysis for the epidural group is presented in Table 24. As in the total
sample, only total IV fluids (lactated Ringer’s solution) contributed significantly to model for the
first LATCH session at 3 hours postpartum (p = 0.012). Thus, high volumes of IV fluids may
lower the total LATCH score at 3 hours postpartum. No variable showed an independent
significant effect on LATCH scores during the second or third breastfeeding session. Table 25
shows the R2 values as variables are added to the model. Altogether, in women undergoing
epidural analgesia, these variables contributed 30% of the variability in LATCH scores in the
model at 3 hours and 15% at 12 hours, and 30 % at 24 hours. However, no statistical significance
was achieved for the model.
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Table 24. Multiple Linear Regression Analysis for Labor and Neonatal Variables as Predictors of Total LATCH Scores at 3,
12, and 24 Hours Postpartum: Epidural Group (n = 51)
Total LATCH 3 h

Total LATCH 12 h

Total LATCH 24 h

Variable

Β
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

B
(SE)

p

β
(95%CI)

Oxytocin

-0.134
(0.381)

0.726

-.050
(-.900-.632)

0.208
(0.300)

0.490

-.011
(-.394-.811)

0.176
(0.237)

0.742

.105
(-.301-.653)

Induction

0.611
(0.413)

0.145

-.229
(-.219-1.440)

0.138
(0.331)

0.679

.065
(-.528-.804)

0.330
(0.258)

0.208

.198
(-.189-.849)

Total epidural
infusate

-0.001
(0.005)

0.811

-.036
(-.011-.009)

-0.003
(0.004)

0.513

-.1099
(-.011-.005)

-0.005
(0.003)

0.118

-.230
(-.011-.001)

Rupture of
membranes

0.014
(0.405)

0.972

.005
(-.800-.829)

-0.116
(0.323)

0.722

-.054
(-.766-.535)

0.248
(0.244)

0.314

.147
(-.243-.740)

Total IV fluids

-0.001
(0.000)

0.012

-.373
(-.001-.000)

0.000
(0.000)

0.091

-.260
(-.001-.000)

-5.351
(0.000)

0.748

-.048
(.000-.000)

Extent of dilation

-0.056
(0.157)

0.722

-.056
(-.372-.259)

-0.092
(0.129)

0.482

-.115
(-.352-.169)

-0.088
(0.100)

0.385

-.140
(-.291-.114)

Total stage 2 & 3

-0.009
(0.009)

0.327

-.144
(-.028-.009)

-0.006
(0.008)

0.451

- .116
(-.021-.010)

-0.011
(0.006)

0.054

-.287
(-.023-.000)

Meconium

0.735
(0.534)

0.176

.200
(-.343-1.812)

0.053
(0.453)

0.907

.018
(-.860-.967)

0.193
(0.337)

0.569

.084
(-.487-.873)

Baby suctioned

-0.225
(0.421)

0.597

-.084
(-1.075--.626)

-0.195
(0.357)

0.587

-.093
(-.916-.526)

-0.232
(0.264)

0.384

-.139
(-.766-.301)

1.5% lidocaine

0.421
(0.226)

0.072

.290
(-.040-.881)

0.295
(0.196)

0.142

.258
(-.104-.694)

0.089
(0.157)

0.572

.092
(-.229-.408

0.25%
bupivacaine

0.137
(0.150)

0.370

.181
(-.170-.444)

0.065
(0.134)

0.632

.106
(-.208-.338)

-0.135
(0.102)

0.196

-.264
(-.345-.074)
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Table 25. R2, F, and Probability for Regression analysis of Labor and Neonatal Variables as Predictors of Total LATCH
Scores at 3, 12, and 24 Hours Postpartum: Epidural Group (n = 51)
Total LATCH 1 (3 h)

Total LATCH 2 (12 h)

Total LATCH 3 (24 h)

Variable

R2

F

p

R2

F

p

R2

F

p

Oxytocin

0.003

0.124

0.726

0.010

0.483

0.490

0.011

0.550

0.462

Induction

0.046

1.159

0.145

0.013

0.324

0.679

0.044

1.094

0.208

Total epidural infusate

0.047

0.777

0.811

0.022

0.358

0.513

0.093

1.597

0.118

Rupture of membranes

0.047

0.571

0.972

0.025

0.296

0.722

0.113

1.458

0.314

Total IV fluids

0.172

1.873

0.012

0.086

0.845

0.091

0.115

1.165

0.748

Extent of dilation

0.175

1.552

0.722

0.096

0.780

0.482

0.130

1.094

0.385

Total stage 2 & 3

0.193

1.470

0.327

0.108

0.745

0.451

0.206

1.592

0.054

Meconium

0.228

1.550

0.176

0.108

0.638

0.907

0.212

1.412

0.569

Baby suctioned

0.233

1.386

0.597

0.115

0.591

0.587

0.227

1.334

0.384

1.5% lidocaine

0.305

1.448

0.072

0.157

0.616

0.142

0.260

1.157

0.572

0.25% bupivacaine

0.305

1.195

0.370

0.146

0.465

0.632

0.297

1.152

0.196

Model

0.332

0.910

0.359
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Summary of the Study Results
Breastfeeding behaviors measured with the LATCH Breastfeeding Assessment Tool did
not differ significantly between the groups at any of the three time points studied (3, 12, and 24
hours after birth) and were not related to total amount of drugs administered. The presence of
multiple stressful events and interventions during labor, e.g., duration of labor, large amount of
IV fluids, oxytocin administration, induction of labor, and meconium staining/suctioning of the
baby, did not significantly affect breastfeeding behavior in the overall study population (n =
102), altogether contributing not more than 8% of the variability of LATCH scores in the
regression model. Within the group receiving epidural analgesia (n = 51), which had
significantly longer duration of labor, higher rates of oxytocin administration and induction of
labor, and larger amounts of IV fluid administration, the combination of these factors contributed
about 30% of the variability of LATCH scores in the regression model at 3 and 24 hours.
However, the model was not significant in this group. These results are discussed in Chapter 5.
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Chapter 5: Discussion
This chapter discusses the results of the study in relation to the theoretical framework of
neonatal breastfeeding behaviors, and the findings are compared to similar research studies in the
scientific literature. The strengths and limitations of the study and implications for clinical
practice are described, and recommendations for continued research are given.
The current study assessed breastfeeding behaviors in the first 24 hours postpartum in
neonates whose mothers used epidural analgesia with hydromorphone for labor and delivery
compared with neonates whose mothers used no analgesia. The primary hypothesis of the study
was that healthy term infants of mothers who receive epidural analgesia with hydromorphone
would demonstrate less effective breastfeeding behaviors at 3, 12, and 24 hours of age when
compared with infants whose mothers received no analgesia. The findings did not support this
hypothesis. Assessment of breastfeeding behaviors with the LATCH Breastfeeding Assessment
Tool (D. Jensen et al., 1994) showed no significant differences at any time point in breastfeeding
behaviors between neonates born to mothers who used epidural analgesia containing
hydromorphone and neonates whose mothers used no analgesia for labor. With a total sample
size of 102, the study had the power to detect a medium effect size if a true effect existed.
The second hypothesis—that effectiveness of breastfeeding would be related to the
duration of infusion/amount of drug given—was also not supported. Regression analyses showed
no significant effects of total amount of epidural infusate, total dose of lidocaine, total dose of
bupivacaine, or degree of dilation at the time of placement of the epidural.
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The third hypothesis—that the presence of multiple stressful events or interventions during
labor or immediately after birth (e.g., duration of labor, large amount of IV fluids, oxytocin
administration, induction of labor, and meconium staining/suctioning of the baby) would be
related to less effective breastfeeding, whether or not labor analgesia was used—was also not
supported. The only significant variable was administration of a large amount of IV fluids
(lactated Ringer’s solution). Taken together, these variables accounted for no more than
approximately 8% of the variability in LATCH scores in the overall study population (n = 102),
and the model was not significant. This sample size was large enough to have an 80% chance of
detecting a true difference if it had existed.
Mothers who chose to receive epidural analgesia (n = 51) had significantly longer duration
of labor, higher rates of oxytocin administration, induction of labor, and larger amounts of IV
fluid administration compared to those who did not choose to have analgesia. Within the epidural
group, the combination of stressful factors contributed about 30% of the variability of LATCH
scores in the regression model at 3 and 24 hours, suggesting that having an epidural and then also
needing multiple labor interventions may indeed have a negative effect on breastfeeding.
However, this effect was not significant, and the sample size of 51 was too small to have the
power to detect a true effect of this size if it did exist. Therefore, no conclusion can be drawn.
These data indicate that, by itself, epidural analgesia with hydromorphone has no effect on
breastfeeding behaviors as measured during the first 24 hours after birth by the LATCH
assessment tool, at least in this population of healthy term neonates born in a hospital
environment strongly supportive of breastfeeding.
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Comparison with Results Reported in the Literature
As discussed in Chapter 2, review of published reports of empirical studies specific to
labor epidural analgesia and breastfeeding (French et al., in press) found conflicting results: 11
studies found that epidural analgesia was not implicated in adverse breastfeeding outcomes (10
found no effect and 1 found a positive effect), and 12 studies showed negative associations
between epidural analgesia and breastfeeding success. Comparison of the current study with
these published studies is difficult because of methodological differences, including differences
in study design. Only three were randomized, some were prospective cohort studies, as was the
current study, and some were retrospective surveys. The type and dosage of epidural drug used
also varied. No study used hydromorphone as the epidural opioid. Most used fentanyl or did not
give information on the opiate used. The studies also varied widely in timing and techniques for
measuring breastfeeding success. Only a few studies reported using any kind of standardized
breastfeeding instrument (Baumgarder, Muehl, Fischer, & Pribbenow, 2003a; Beilin et al., 2005;
Chang & Heaman, 2005; Radzyminski, 2003; J. Riordan et al., 2000), and only three of these
used the LATCH tool to assess breastfeeding behaviors. Two found negative effects of the
epidural analgesia on LATCH scores (Baumgarder et al., 2003b; J. Riordan et al., 2000), and one
found no effect (Chang & Heaman, 2005). All three of these studies performed at least one
assessment during the first 24 hours after birth, and all three were prospective cohort studies.
Potential Influences on the Study Results
Furthermore, the following factors need to be considered:


It is possible that the LATCH assessment tool was not sensitive enough to detect subtle
differences in breastfeeding behavior due to epidural analgesia.
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The type of epidural medications used in this study (ultralow-dose bupivacaine and
hydromorphone) may have provided such a low amount of drug exposure to the neonate
that any effects of the medication may have been too small to detect.



The study was not randomized, and factors that may play a role in determining
breastfeeding behaviors were different in each group.



The breastfeeding support provided by the hospital’s BFHI environment may have helped
to overcome potential negative effects of the epidural medications.
Usefulness of Breastfeeding Assessment Tools in Detecting Effects of Epidural
Analgesia
LATCH Breastfeeding Assessment
The LATCH breastfeeding tool was chosen because it reflects aspects of the individual

neonate’s feeding activities as well as maternal variables that are used to predict breastfeeding
problems. High interrater reliability (85.7-100%) was found among lactation consultants using
the tool (Adams & Hewell, 1997). Significant correlation between mother’s ratings of how well
she thought breastfeeding went (0 = not at all well to 3 = very well) and the evaluators’ LATCH
scores (n = 132, r = 0.56, p = 0.001) supported the construct validity of the tool (J. Riordan et al.,
2001). In two studies (S. P. Kumar, Mooney, Wieser, & Havstad, 2006; J. Riordan et al., 2001),
LATCH scores were predictive of breastfeeding duration up to 6 weeks. Both studies found
higher LATCH scores for those who were still breastfeeding at 6 weeks compared with those
who weaned before 6 weeks.
The LATCH scoring system was a relatively easy data collection tool to use for this study,
and easy to score, with clear criteria for each category of breastfeeding. It was observational and
well tolerated by the mothers. Many of the women liked being in the study because they got
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instant feedback on how well the neonate was feeding. Also, many liked the extra attention they
were getting from the data collectors. This brought into question whether the presence of the data
collector had any effect on the breastfeeding session. The system gave the caregiver key
components of maternal and neonatal variables of effective breastfeeding behaviors and defined
areas where intervention may be needed. The tool was defined to pick up abnormalities. When
the observer in the room provided positive feedback, the mothers felt they were successful. Even
neonates that breastfed poorly were able perform key components of an effective breastfeeding
session, which were interpreted as positive feedback by the mother. This was part of the purpose
of developing the instrument (D. Jensen et al., 1994).
The LATCH score is based on observations by the data collectors and is subject to their
interpretation. The score is dependent on the ability of the researcher to use the instrument.
Subjectivity and bias can occur with instruments that rely on observation methods (Polit & Beck,
2012). Observer bias was minimized by keeping the data collectors (or the PI and the lactation
consultant) blinded to the participants’ use or non-use of epidural analgesia. Both the PI and the
lactation consultant had extensive training in using the LATCH tool.
There were some factors the LATCH tool did not assess that would have been helpful
during the breastfeeding sessions. Attitudes and opinions of the mother related to frequency of
feeding and who initiated or ended the feed—mother, baby, or possibly staff. All the mothers had
breastfed previously and had predetermined from their experience the patterned frequency of
feeding. When neonates were feeding well at the breast, many mothers would stop the feed,
determining they had had enough milk or stop and ask for formula because they thought the baby
wasn't getting enough milk. Information was given to mothers about infant feeding cues and
baby-led feeding was optimal for the development of a mother/neonate feeding dyad. Because
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the amount of milk being consumed by the infant can't be seen or measured, extra reassurance
should be provided to these mothers. The attitudes of the mother and her perception of the
breastfeeding experience contribute to the success of breastfeeding. A simple addition to the
LATCH such as to how often the baby is fed or who initiates the feeding would add to the body
of knowledge.
It is important to note that during the first 24 hours of life a considerable number of
neonates do not have a good latch or audible swallow, with several bursts of sucking preceding
the swallow. The LATCH tool was designed to detect these differences in a neonate <24 hours
old and therefore provided a mechanism to analyze the coordination of the suck-swallow cycle,
which is so important when assessing breastfeeding behaviors. Items also included whether the
infant was not able to latch, needed help with latch, or latched, or whether there were no audible
swallows, a few audible swallows with stimulation, or spontaneous and intermittent swallows.
The criteria for scoring were clear. The scores defined the breastfeeding behaviors and were
useful in data interpretation. Although the LATCH lacked some measures that may have been
helpful, and although it depended on the researcher’s ability to observe and use the instrument
correctly, it was sensitive enough to detect differences between neonates. Thus, it proved to be a
useful way to measure which neonates were able to exhibit successful breastfeeding behaviors in
this study.
As described in Chapter 4, the original study plan was to conduct the NACS and the
LATCH together at the 3, 12 and 24 hours after delivery, but the test was discontinued because
of difficulties in finding appropriate times when the neonates would be in equivalent states of
arousal and when it could be performed without disturbing the neonate’s sleep or distressing the
mother. There were also occasional difficulties in scheduling the LATCH test. During the first 24
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hours of life, many neonates may be slow to feed and may have a long period of sleep after they
are born (Holmes, 2013). All of the infants in this study were healthy and breastfed vigorously
within 40 minutes of delivery. They would then sleep for hours, making it very difficult to get
the first LATCH score at the 3-hour time point. Nevertheless, we were able to perform three
LATCH breastfeeding assessments of all neonates in a 24 hour period.
Assessment of Neonatal Neurobehavior
It is well known that term infants are born with the reflexes such as rooting, sucking, and
swallowing which are necessary for feeding. In order for the neonate to feed the behavioral states
are also important in facilitating the reciprocal communication and relation with the mother
during feeding. For assessment purposes there are predictable patterns of behavior in neonatal
cranial nerve function and maturation as well as reflexes (Als, 1991). Cranial nerve function and
maturation are required for the neonate to breastfeed, especially the cranial nerves V, VII, IX,X,
XI, and XII. It therefore would seem logical that if some factor such as analgesia depresses the
functioning of one of these cranial nerves, it would result in an altered corresponding feeding
behavior associated with that nerve. Effective and efficient feeding requires the neonate to be in
an awake state ( the psychomotor ability to cue they are ready to feed) must have enough
oropharyngeal muscle strength (tone) to latch onto the breast and maintain the breast in the
mouth, create enough oral pressure to form a maternal teat and maintain the muscle tone to
elevate the tongue to massage the alveolar ducts and rhythmically coordination of breathing with
sucking and swallowing which involves the functional interaction of lips, jaw, palate, tongue,
larynx, pharynx and esophagus (Bu'Lock et al., 1990). To accomplish this, the neonate has to
have intact function of their cerebral and brainstem structures and 6 of the 12 cranial nerves (V,
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VII, IX, X, XI, and XII). These nerves are involved in the muscle tone of the face, structures of
the mouth, swallowing and breathing.
For the infant to latch onto the breast the infant must be able to respond to the environment
in an organized alert state. The more an infant that can regulate and manage their state the more
alert the neonate is. Awake and alert infants are able to latch onto the breast and maintain their
latch; thus, the better they will feed. Cranial nerve V, the trigeminal nerve, and cranial nerve VII,
the facial nerve, are necessary for the neonate to open its mouth, move its lips to the breast, and
create suction with the tongue and soft palate involved in rooting, latching, and sucking
responses. Cranial XI, the gloss pharyngeal nerve controls the gag reflex. Suctioning a neonate
may cause hyper responsive gagging which in turn can inhibit deep latch at the breast. Cranial
nerve X, the Vagus nerve allows for flexion and extension of the head, neck, and extremities. It
also controls breathing and heart function, therefore disruption of this nerve could interfere with
the suck-swallow-breath coordination. If the neonate cannot flexion their neck they will not be
able to latch on. Cranial nerve XI, the spinal accessory nerve controls muscles involved in head
position, torticollis, and airway patency. An active tone of these muscles allows the neonate to
move their head and maintain spatial relation to the body and other objects (Amiel-Tison, 1976).
Absence of active tone would mean the neonate could not lift their head or move their head
toward the breast. Once the neonate is attached to the breast, Active tone allows the neonate to
maintain the attachment without their head falling forward breaking the suction.
Cranial nerve XII, the hypoglossal nerve controls tongue movements that produce
sequential, smooth contractions of the voluntary and involuntary muscles of the tongue.
Disruption of this nerve manifests as nonsequential, erratic, and weak tongue movements which
interfere with normal sucking and swallowing and milk intake.
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The information provided by the LATCH Breastfeeding Assessment Tool in relation to
neurobehaviors involved in breastfeeding was clinically useful for the purposes of this study. The
breastfeeding behaviors involved in the infants ability to breastfeed correlate with tests of
passive tone, adaptive responses and primary reflexes on the NACS neurobehavior test. For
example the NACS has 5 tests for adaptive response which is the ability of the neonate to
respond to their environment. When observing the breastfeeding session, the infant’s ability to
manage sensory stimuli and observations of consolability when the neonate is agitated would
manifest as a good latch and the ability of the infant to feed well. There are three tests for
reflexes on the NACS which are related to the function of cranial IX, X, XI, and XII. There are 4
tests for passive tone on the NACS related to the function of cranial nerve V and VII.
Severe neonatal injury or depression is easy to detect and readily apparent by standard
neurologic exams that are performed on the neonate shortly after birth and again at 24 hours
postpartum. However mild injury or depression is not as readily observable in the neonate.
Infants that have subtle neurologic signs of drug depression display mild hypotonia, mediocre
primary reflexes, and poor habituation to outside stimuli. Therefore many of the neurobehavior
the NACS evaluates can be evaluated through breastfeeding observations using a valid tool such
as the LATCH. If a normal healthy infant can't latch and maintain breastfeeding immediately
after birth something is wrong. It was not necessary to put the baby through a neurologic exam
when the information could be gleaned from the breastfeeding session.
Ultralow-dose Epidural Analgesia Medications
Most drugs, including those used for analgesia and anesthesia, readily cross the placenta by
passive diffusion. Diffusion is dependent on a concentration gradient across the placenta with
drugs, including opioids and local anesthetics passively moving from areas of high concentration
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to low. Maternal blood concentration of local anesthetics and opioids is determined by the
physiochemical characteristics of the drug, the amount of drug given, the site of administration,
metabolism, and excretion and effects of adjuvants (Santos, Karpel, & Noble, 1999; Santos &
Pedersen, 1994). In order for epidurally administered bupivacaine and hydromorphone to affect
the fetus they must be absorbed into maternal circulation before fetal transfer, and the maternal
blood concentration determines fetal drug exposure (Griffiths & Campbell, 2014).
Hydromorphone is a mu receptor agonist with pharmacokinetic properties intermediate
between highly hydrophilic morphine and highly lipophilic opioids such as fentanyl and
sufentanil (Reisine & Pasternak, 1996). After epidural administration, the amount of drug that
penetrates dura and pia-arachnoid to enter the CSF and spinal compartments is inversely
proportional to its lipid solubility and polarity (Chrubasik et al., 1993; Herz & Teschemacher,
1971; Plummer et al., 1990; Sinatra et al., 2000; Yaksh et al., 1988). For example, high lipid
solubility increases systemic absorption and reduces availability of the drug in the dorsal horn of
the spinal cord. Therefore, more drug is continually needed to extend the limited duration of
action (Bernards, 2004; Sinatra et al., 2000). Hydrophilic opioids have more difficulty traversing
neural and vascular membranes, staying in the spinal compartment, increasing the availability of
drug on the dorsal horn of the spinal cord, ensuring that a lower concentration of drug is needed
for continued receptor site activity (Sinatra et al., 2000). Because placental transfer of
hydrophilic opioids is impeded, they diffuse across slowly and are unlikely to attain effective
concentration in the fetus (Reynolds, 2011; Syme et al., 2004).
This gain in opioid-mediated analgesic effect provides a local anesthetic “dose-sparing”
effect, allowing the use of bupivacaine as an adjunct rather than primary analgesic where
infusions are 2 to 2.5 times as dilute as those traditionally seen in continuous labor epidural
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infusions (Sinatra et al., 2000). Very little data exists on neonatal exposure to epidurally
administered hydromorphone in the mother. However, these theoretical considerations are
supported by the unpublished study conducted by the author of this dissertation and colleagues at
Yale New Haven Hospital (Shah, French, Dai, & Snegovskikh, unpublished data, 2012)
described in the section on epidural medications in Chapter 2. In that study, 10 healthy
parturients with uncomplicated pregnancies received an initial 100 g hydromorphone and a 9
mL 0.25% bupivacaine bolus, followed by continuous infusion of 0.05% bupivacaine and 3
g/mL hydromorphone. Whereas the average maternal venous concentration of bupivacaine was
0.23 ± 0.18 μg/mL, only two of the 10 umbilical venous samples had detectable levels of
bupivacaine, with an umbilical/maternal ratio approaching 0, much lower than in a comparable
study of bupivacaine with fentanyl (Bader et al., 1995). The only umbilical vein samples with
detectable bupivacaine levels were from patients who required more than one additional bolus.
The average hydromorphone concentration was 0.26 ± 0.09 ng/mL in the maternal vein samples
and 0.23 ± 0.09 ng/mL in the umbilical vein samples, with a calculated umbilical/maternal ratio
of 0.88 ± 0.18, comparable to the fentanyl levels found in the Bader et al. (1995) study, despite
the higher concentration of hydromorphone in the infusate. Neither our study nor the Bader et al
(1995) study found evidence of drug accumulation with increasing length of infusion time, and
results suggested rapid placental transfer and equilibration of both fentanyl and hydromorphone
between maternal and neonatal blood.
Thus, the lower overall concentration of bupivacaine in the infusate in the current study
and the greater hydrophilicity of hydromorphone as compared to fentanyl may have contributed
to the lack of detectable effects in the neonate. This conclusion is also consistent with our finding
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that duration of epidural hydromorphone infusion (total amount of hydromorphone) had no effect
on breastfeeding behaviors.
Differences in the Patients’ Labor Experience
As it was not ethically possible to perform a randomized controlled trial of epidural
analgesia vs no epidural during labor, the study population was selected to be as homogeneous as
possible to limit external influences on the results. To keep factors such as experience with labor,
familiarity and confidence with the maternal role, and the mother’s comfort level in caring for
her newborn as similar as possible, both groups consisted of multiparous women who had
previously breastfed. Furthermore, the labor experience was similar for both groups regarding
the care they received from caregivers, all participants had support persons, and high-risk
pregnancies were excluded so that no complications were expected during labor or delivery.
Nevertheless, there were differences between the group with epidural analgesia and the
unmedicated group.
Longer Duration of Labor
Previous studies showed epidural analgesia is associated with a longer duration of stage 2
labor (Anim-Somuah et al., 2011). Similarly, the women in the epidural group in the current
study had a longer duration of labor measured from stage 2 through stage 3 compared with the
unmedicated group (p = <0.0001). Longer duration of stage 2 labor can lead to very tired
mothers and stressed babies, making breastfeeding difficult. However, when analyzed as an
independent variable in the regression analyses in this study, duration of labor was not
significantly related to breastfeeding effectiveness scores.
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Instrumented Delivery
Moreover, labor epidural analgesia and longer stage 2 labors have been associated with
higher rates of instrumented vaginal delivery (forceps and vacuum) in some previous studies
(Anim-Somuah et al., 2011; Nyuyen et al., 2010). One meta-analysis of randomized control trials
found the use of epidural analgesia was associated with a 2-fold increase in instrumental vaginal
deliveries (Halpern et al., 1999). However, others have found mixed results (Leighton &
Halpern, 2002). In the present study, one woman in the epidural group had a vacuum-assisted
delivery, but this did not produce any significant findings related to her infant’s breastfeeding
behavior scores. Our study results suggest that, although the women in the epidural group had
longer stage 2 labors, the low-dose epidural infusate was not potent enough to impair the strength
of pushing and create a need for instrument delivery.
Oxytocin Administration
The women in the epidural group in our study were given oxytocin to induce or augment
labor significantly more often than women who remained unmedicated during labor (47.1% vs.
22.9%; p = 0.002). These data support the results of others showing that women who receive
epidural analgesia for labor pain have higher rates of oxytocin augmentation than unmedicated
parturients (Anim-Somuah et al., 2011; Chang & Heaman, 2005; Wiklund et al., 2009). Some
studies suggest exogenous oxytocin augmentation along with epidural analgesia may reduce the
normal rise in endogenous serum oxytocin levels in response to sucking (Jonas et al., 2009) and
may shorten breastfeeding duration (Beilin et al., 2005). Other studies have found negative
effects of synthetic oxytocin on feeding behaviors. In our study, multiple linear regression
analyses showed that oxytocin did not have an independent effect on breastfeeding behavior.

181
Induction of Labor
The epidural group also had significantly more women in whom labor was induced
compared to the unmedicated group (39.2% vs. 22.9%; p = 0.0027). Women may have been
more likely to request an epidural when they undergo labor induction because the intensity of
labor tends to be greater after induction than with spontaneous labor. This is in agreement with
other studies that also found significantly higher rates of epidural analgesia for relief of pain in
induced labor (Alexander et al., 2001; Duff & Sinclair, 2000; Prysak & Castronova, 1998).
While examining the effects of labor induction on obstetric outcomes in a study of 410 women,
Bodner-Adler and colleagues also found that the use of epidural (p = 0.001) and oxytocin (p =
0.006) was significantly increased in the induction group compared with the control group
(Bodner-Adler et al., 2005). Furthermore, the need to augment labor with oxytocin was increased
in women who were induced (Prysak & Castronova, 1998). Although the combination of these
factors might be expected to negatively influence breastfeeding, we found no independent effects
of labor induction on breastfeeding scores.
Intravenous Fluids
In addition, the epidural group received a greater amount of IV fluids compared to the
unmedicated group (p = <0.001). This may be the result of factors related to the differences in
the labor experience between women who received epidural analgesia and those who were
unmedicated. Women who request an epidural must have an IV catheter in place, and before the
epidural is placed they must receive a fluid bolus of 500-1000 mL of lactated Ringer’s solution.
Most of the women in the unmedicated group were patients of a midwife group and often would
come to the hospital only after they had been in an active labor pattern for some time and had
had significant cervical dilation. If the women were not group B streptococcus positive and did
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not require antibiotics, they could choose not to have an IV catheter placed. Twenty-six (51%) of
the women in the nonmedicated group did not have an IV. Thus, the significant difference
between groups in the amount of IV fluids received was not unexpected. Multiple linear
regression analysis only of data from the epidural analgesia group showed that high volumes of
IV fluids had a significant independent effect on the first breastfeeding session (p = 0.01). Given
the difference in amount of IV fluids received, this result led to an expectation of a difference in
breastfeeding behaviors between the groups, which was not the case.
Multiple linear regression analysis also showed a significant independent effect of higher
volumes of IV fluids on the 3-hour LATCH score in the entire study population (p = 0.02). As
49% of the unmedicated group did receive IV administration of Ringer’s solution, it is also
possible that factors related to the volume of IV fluids may have been at work in both groups.
When mothers receive IV fluids, neonates also may have hyponatremia and lose more weight
compared with neonates whose mothers received fluids only by mouth (Dahlenburg, Burnell, &
Braybrook, 1980; Noel-Weiss, Woodend, Peterson, Gibb, & Groll, 2011). The neonates in both
groups in our study were feeding well, with weight losses of less than 7% in all neonates. We
found no significant difference between the groups in the percentage of neonatal weight loss
during the first 48 hours postpartum. However, early postpartum maternal breast, nipple, and
areola edema has been described in association with IV fluid hydration of the mother during
labor (Kujawa-Myles, Noel-Weiss, Dunn, Peterson, & Cotterman, 2015; V. Miller & Riordan,
2004). Edema may cause latching problems, nipple pain, low milk transfer, or poor breast milk
volumes, which may in turn have a negative effect on neonatal breastfeeding behaviors.
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Nevertheless, it is not clear whether the findings regarding IV fluid administration
represent a true effect. We did not use a correction factor to compensate for the relatively large
number of significance tests in this study. Thus, it may have been a chance result.
Influence of the Baby-Friendly Hospital Environment
We had expected that epidural analgesia and the various stressors it involves, particularly
the combination of longer duration of labor, greater use of instruments during delivery, oxytocin
administration, and more frequent induction of labor, would result in significantly reduced scores
for breastfeeding effectiveness on the LATCH assessment scale in the epidural group. However,
this hypothesis was not confirmed. One explanation for the lack of difference between groups
may be that any negative effects of epidural analgesia might have been overcome by factors
operating to promote breastfeeding success in both groups. High success rates in both groups
may have precluded detection of any detrimental effects.
As noted in Chapter 2, breastfeeding can be considered successful if the total LATCH
score is greater than 7 at two feeds in 24 hours (Baumgarder et al., 2003b; Bramson et al., 2010).
This criterion was reached by a high proportion of both groups in this study. Total LATCH
scores above 7 were achieved in more than 70% of both groups at the 3-hour breastfeeding
session, more than 80% at 12-hour session, and approximately 95% at the 24-hour session (see
Table 12). The mean LATCH score was greater than 8 at all three feeds, and greater than 9 at 24
hours in both groups.
The study hospital was following the Baby-Friendly Hospital Initiative by implementing
the 10 Steps for Successful Breastfeeding program and working toward achieving accreditation
from Baby-Friendly USA as a Baby-Friendly Hospital (World Health Organization, 1998). All
neonates in this study were placed skin-to-skin after delivery and all breastfed within the first 40
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minutes. The infants “roomed in,” breastfed on demand, and the mothers had access to lactation
consultants around the clock. All the postpartum nurses were trained in using the LATCH tool as
an intervention and teaching instrument, and a LATCH score is documented in the electronic
medical record every 8 hours as a matter of routine. LATCH assessments for the study were
independent of these scores. None of the study neonates received a pacifier or formula. In
addition, the vitamin K shot and eye ointment were not administered until 24 hours postpartum.
These practices are the standard of care and a similar environment was provided for all the
patients. This breastfeeding-friendly environment may have limited the effects of other variables
on breastfeeding and may have ameliorated any negative influences of the epidural analgesia in
this study.
Breastfeeding is both a nutritional method and a process of connection between the mother
and infant. John Bowlby first introduced the idea of attachment as a biological response between
mother and infant that organized neurobehavior (Bowlby, 1982). Studies of mother-infant
interaction have highlighted the role of the infant’s perceptual, communicative, and interactive
competency (Brazelton et al., 1983). The bi-directionality of the mother-infant interaction is
characterized by synchrony and reciprocity (Bowlby, 1982; Tronick & Cohn, 1989). The early
postpartum period is an important time for mother and infant to develop this synchrony and
reciprocity and is known as the “sensitive” period (Kennell et al., 1974). The neonate placed
skin-to-skin with the mother during this sensitive period enhances the long-term interaction
between mother and neonate and mothers were more likely to be breastfeeding at 1 and 4 months
after delivery and for a longer duration (Bystrova et al., 2009; E. R. Moore et al., 2012; Salariya
et al., 1978; Wiberg et al., 1989). If this interaction is interrupted for any reason, and the baby is
less alert, less able to orient, and less able to show organized movement, this may interfere with
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the mother-infant relationship (A.D. Murray et al., 1981; Sepkoski et al., 1992) and subsequently
impact breastfeeding.
Skin-to-skin contact in the immediate postpartum allows the neonates innate behaviors to
occur. The neonate next to the mother’s skin helps regulate their temperature, crying, respirations
and nursing behaviors. It assists the neonate in the transition to extrauterine life by decreasing the
stress of birth through the mother's warmth, touch, and odor, guiding the neonate to her nipple
and release of maternal oxytocin. Spontaneous vaginal delivery with immediate maternal-infant
skin-to-skin contact increases the likelihood of successful baby-led breastfeeding (Righard &
Alade, 1990; Widstrom et al., 2011). The timing of the first breastfeed is associated with
duration of breastfeeding. Bramson and colleagues analyzed data from a prospective cohort on
21,842 mother-infant pairs and determined the longer the mother and infant experienced skin-toskin in the first 3 hours after delivery the more likely she was to be exclusively breastfeeding
during her hospital stay (Bramson et al., 2010). The earlier the initiation of the first breastfeed
and/ or the mother-neonate contact the longer the duration of breastfeeding (Berra et al., 2003;
Buxton et al., 1991; Salariya et al., 1978). The unstructured interactions and responses between
mother and neonate allow hormonal levels in both to change in response to one another.
Limitations and Strengths of the Study
The study was limited by its nonrandomized nature, which rules out definitive conclusions
regarding cause and effect (Polit & Beck, 2012). However, attempts at randomizing women to an
epidural or unmedicated group have resulted in high crossover rates (Dickinson, Paech,
McDonald, & Evans, 2002; Nikkola et al., 1997). Self-selection to epidural vs unmedicated
groups would likely be associated with various confounding variables that would influence
results, such as the general opinion of the mother regarding interventions for childbirth. Because
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the decision to have epidural analgesia was voluntary, certain characteristics leading to the
decision may also have influenced results. Two women declined to participate after the study
was described to them. Demographic information on those who decline participation would have
been valuable in determining the direction and nature of bias (Polit & Hungler, 1999).
The study was limited regarding the selection of the convenience sample. Minorities were
underrepresented, making the study less generalizable. However, white and minority women
were equally represented in the two groups. In addition, the research findings apply only to
healthy multiparous women and infants with no complications of pregnancy and delivery. The
findings of this study are therefore generalizable only to healthy term infants born in a BabyFriendly environment where immediate skin-to-skin, rooming-in, and breastfeeding on demand
are the standard of care. Also, the findings of this study also only apply to the first 3, 12, and 24
hours of life.
A further limitation was that only a certain number of potential predictor variables could be
analyzed, and the study did not address the mothers’ attitudes, feelings, or opinions toward
breastfeeding.
There were several factors that strengthen the quality of this research. Many previous
studies did not have any type of comparative group. Although this study was not randomized, it
was able to compare women with epidural analgesia with unmedicated women in a similar
environment. Equal numbers of women were included in each group, and efforts were made to
achieve a relatively homogeneous study population. Also all the medicated women received the
same medication at the same dose. Many studies have wide variations in the type and
concentrations of epidural medications used or include systemic opioids which influence the
findings.
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The LATCH assessment method was noninvasive. Patients did not mind having an
observer, and the assessment did not hinder the breastfeeding sessions or other interaction
between the mother and infant.
Implications for Nursing Practice
The benefits of breastfeeding are important enough that healthcare providers should
encourage and support breastfeeding. However, because their own beliefs and opinions may
influence their patients, healthcare providers should remain cautious when providing information
about possible risks and barriers to breastfeeding. Systemic opioids used in labor have been
clearly associated with attenuating the neonate’s ability to breastfeed in the early postpartum,
leading to concern on the part of both caregivers and mothers about pain medications during
labor. The literature so far has provided inconsistent data on the effects of epidural analgesics on
breastfeeding outcomes. Currently, most women in the US choose to have epidural analgesia, but
they are often frightened about the effect labor analgesic medications might have on the fetus or
neonate, and therefore they may decline to breastfeed if they need pain relief. Women in labor
place a high priority on pain relief—so high that they may be willing to sacrifice breastfeeding
for pain relief in the immediate moment. If the mother feels she did not make a good decision
during labor, it can lead to anxiety during the feeding and anxiety about breastfeeding.
Although no conclusions can be drawn from these data as to the comparative effects of
different epidural medications, the current study shows that epidural analgesia with a low dose of
hydromorphone is not likely to have an effect on breastfeeding behaviors. Women in this study
breastfed equally well whether they had epidural analgesia or no analgesia. All of the babies in
this study fed vigorously the first hour after birth. The neonates were alert, rooting, and searching
for the breast. Based on these data, if a mother has decided to have epidural analgesia during
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labor, nurses can recommend and facilitate breastfeeding without worrying that the epidural
would harm the infant by decreasing breastfeeding success, at least if hydromorphone is used as
the epidural opioid. We therefore conclude that in this population, it is unwarranted to counsel
women to not receive epidural medication for labor pain relief because it may negatively affect
breastfeeding. If the correct amount of medication is administered it, is now possible for women
go through labor pain free and still breastfeed.
Although not significant, the finding that the presence of multiple stressful events or
interventions contributed about 30% of the variability of LATCH scores in the regression model
at 3 and 24 hours suggests that mothers who have a long duration of labor, receive oxytocin
administration or large amounts of IV fluid, or in whom labor is induced, may need more
intensive help from the nurse or lactation consultant to achieve success in breastfeeding.
This study highlighted the importance of objective assessments in enabling nurses to
analyze and help the mother correct feeding problems. There are many reasons that some babies
do not breastfeed well, and it is important to identify factors that may impede breastfeeding in
the immediate postpartum. The identification of such factors can improve breastfeeding
outcomes. The mothers in this study were interested in how we were measuring breastfeeding
behaviors during the breastfeeding observation sessions, and the LATCH tool helped nurses to
teach them how to recognize feeding cues, the infant’s ability to latch correctly, rhythmic
sucking, audible swallows, mother’s comfort, and positioning. The LATCH scoring system is
used at the study hospital for frequent breastfeeding evaluations from delivery room to discharge
home. In addition to allowing objective assessments, this use of the LATCH tool provides
mothers with nursing attendance throughout a breastfeeding session.
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Assessment of LATCH scores can serve as a basis for nurses to give breastfeeding
assistance and anticipatory guidance. Lactation consultants and nurses can prioritize assistance,
focusing on mothers and infants with low LATCH scores that indicate a need for prompt
intervention and support. Breastfeeding is strongly encouraged in the current healthcare
environment but so is early discharge home. Use of the LATCH tool can help postnatal
caregivers to identify mothers at risk for weaning and who need postdischarge follow-up. The
most frequent causes of breastfeeding difficulties in hospital and at home are sore nipples,
problems with the infant latching on or sucking, and “not enough milk.” Many women may stop
breastfeeding before they want to as a result of these problems. Nurses in the hospital play a
significant role in providing the support needed by women in breastfeeding establishment. To
prevent the common breastfeeding problems, early assessment, support, and education are
imperative. All breastfeeding issues should be attended to during the hospital stay with a followup plan in place for unresolved issues.
Clinicians should provide anticipatory guidance about common breastfeeding issues likely
to occur in the coming weeks, such as management of sore nipples, correct latching and
unlatching techniques, and alternating feeding positions to reduce friction exerted by the infant’s
mouth during feeding. Without guidance, many women stop breastfeeding prematurely as a
result of these problems. With continued support in the community, many of these problems are
preventable. The early discontinuation of breastfeeding can cause distress and disappointment to
the mothers and health problems for her and her infant. This is where public health nurses can
continue the work and care of hospital nurses in providing breastfeeding support and education
to the mother-infant dyad. Breastfeeding support can consist of praise, reassurance, instruction,
and time to answer the mothers’ questions.
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Support by both professionals and lay supporters has a positive impact on breastfeeding
outcomes (Renfrew, McCormick, Wade, Quinn, & Dowswell, 2012). However, lay support and
combinations of lay and professional support were more effective for exclusive breastfeeding
continuation than professional support alone (Renfrew et al., 2012). The authors indicated that as
a strategy to improve breastfeeding behaviors, face-to-face support was associated with greater
success than telephone support. When support was offered only if women sought help, it was
unlikely to be effective. This suggests women should be offered regular scheduled ongoing
visits.
Prenatal nurses are in an excellent position to educate mothers about the benefits of
breastfeeding. Decisions about how a women is going to feed her baby are made before the
pregnancy or in the prenatal course (Earle, 2002; Ertem et al., 2001; Scott, Binns, & Aroni, 1997;
Scott et al., 2001). Up-to-date information on the benefits of breastfeeding and positive messages
about breastfeeding by prenatal clinicians during the pregnancy help mothers make informed
choices. Prolonged breastfeeding is associated with high maternal self-efficacy (Dennis, 2002;
Meedya et al., 2010). A women's exposure to breastfeeding and her personal experience with
breastfeeding have a positive effect on her confidence in her breastfeeding ability (Blyth et al.,
2002; Dennis, 2002). Maternal attitudes toward breastfeeding also affect duration of
breastfeeding. Women who perceived breastfeeding to be easier, more convenient, and healthier
than bottle feeding breastfed longer than those who regarded breastfeeding as inconvenient,
uncomfortable, or more difficult (Dennis, 2002). Similarly, intended duration of breastfeeding
was associated with actual duration of breastfeeding (Dennis, 2002; Meedya et al., 2010). This is
important to prenatal nurses, because it has been suggested that simply asking women who
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intend to breastfeed how long they plan to do so is an efficient method of identifying prenatally
those who are at risk for short breastfeeding duration (O'Campo, Faden, Gielen, & Wang, 1992).
Providing effective breastfeeding support requires highly skilled and knowledgeable nurses
or lactation consultants who can be available to provide the necessary guidance needed by the
mother and infant in their early breastfeeding experience. Nurse managers and hospital
administrators must evaluate the resources available to meet the needs of mothers and infants to
extend the breastfeeding success from birth, through discharge, and into the home environment.
Communication between hospital and community nurses is vital to the continuity of
breastfeeding supportive care. The community setting would benefit from an objective
breastfeeding assessment tool, such as the LATCH scale, in order to help public health nurses to
reinforce and continually reassess breastfeeding skills and knowledge, while providing the eye of
the skilled observer and the experience of a trained clinician.
Implications for Future Research
To be useful clinically, the results of this study need to be generalizable to other
populations and other types of epidural medications. Thus, future studies should include
primiparas and women of different ethnic backgrounds and birth experiences. As the results of
this study apply only to epidural analgesia with ultralow-dose bupivacaine and hydromorphone,
comparative studies should be conducted with different concentrations of bupivacaine and
fentanyl doses compared with the hydromorphone to determine whether the type of drug, dose,
or drug interaction affects breastfeeding behavior. When it is not ethically possible or feasible to
randomly assign patients to receive different treatments, carefully planned prospective
comparative cohort studies should be performed to provide at least some means of comparing
interventions.
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Studies should measure breastfeeding success using an objective breastfeeding scoring
system, such as the LATCH system, and record the specific time point after delivery when the
first breastfeeding attempt occurred. A breastfeeding analysis should be completed in the first 3
hours after delivery and then at 24 hours postpartum. Evidence-based recommendations can then
be made to change practice in order to improve labor outcomes and provide additional
breastfeeding support to the women who need it most postpartum.
This study has highlighted the complexity of the potential influences on breastfeeding.
Epidural analgesia is just one of the intrapartum interventions that can affect the course of labor
and breastfeeding. The relationship of epidural analgesia with breastfeeding involves complex
interactions among the various intrapartum interventions. One intervention may lead to another
in a cascade that may either directly or indirectly affect breastfeeding. Future studies on labor
epidural analgesia and breastfeeding need to view labor, birth, and interventions as a whole—in
an integrated process that must be evaluated for potential adverse effects on the course of labor,
neonatal and maternal behavior, and breastfeeding.
Conclusion
Labor epidural analgesia provides women with excellent pain relief. Although the study
was limited by its nonrandomized nature, these data indicate that, by itself, epidural analgesia
with low-dose hydromorphone does not decrease the effectiveness of breastfeeding behaviors as
measured during the first 24 hours after birth by the LATCH assessment tool. However, women
who receive epidural analgesia have an increased risk of experiencing multiple stressful events
or interventions during labor, which may contribute to breastfeeding difficulties. Women in this
situation may need more intensive help from the nurse or lactation consultant to achieve success
in breastfeeding.
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Appendices

Appendix A: Patient Information Sheet

The research group of the Department of Anesthesiology of Yale University, School of Medicine.
Effect of Labor Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and
Breastfeeding Behavior in the First 24 Hours of Life

A. PATIENTSTUDY ID
NUMBER_________________________

C. DELIVERY INFORMATION
1. Time of
Delivery________________________________
2. Time of
Placenta________________________________
3. Apgars 1 minute____________5
minutes__________
4. Baby Weight at
Birth__________________________
5. Weight at 24
hours___________________________
5. Duration of Labor_____________________
First stage______________________________
Second
stage_______________________________
Third
Stage________________________________

B. Maternal INFORMATION
1. ASA: I II III IV
Height: ________Weight:
___________LMP__________
2.
PMH:______________________________________
_________
___________________________________________
__________
____________________________________
3.
PSH:______________________________________
__________
4. Allergy:
___________________________________________
5. MEDICATIONS:
__________________________________
___________________________________________
______________GESTATIONAL
INFORMATION
1. Gestational Age______________________
2. G____P_____
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D. EPIDURAL-RELATED COMPLICATIONS
1. Maternal
Hypotension____________________
Corrective Action____________
Duration_____________

2. Fetal Bradycardia_______________
Corrective Action___________
Duration_______________
3.MaternalTemp______________
Corrective Action___________________
Duration_____________________
4.Pitocin During Labor Yes____No_______
Total ML of Infusion______________
5. AROM SROM
6. Total Fluids

E. EPIDURAL INFORMATION
1. TIME EPIDURAL
PLACED_________________________
2.TOTAL DOSE AND TYPE LOCAL
ANESTHETIC 1.5%
LIDO____________________________TIME_____
_____
.25%
BUPIE_______________TIME_________________
____
3.TOTAL DOSE DILAUDID AT
INSERTION_________
TIME__________________
4.INFUSION RATE_________________________
5.TIME EPIDURAL
REMOVED_____________________
6. NUMBER OF BOLUSES AND TIMES OF
BOLUS____________________________________
________
BOLUS____________________________________
________
BOLUS____________________________________
________
7. DILATION AT TIME OF EPIDURAL
PLACEMENT_______________________________
_______

F. INSTRUMENT DELIVERY
Yes_______ (Circle Vacuum or
Forceps)No________
G.
Episiotomty____________Tear________________
_
Use of Local Anesthetic Yes No (Circle)
If yes type and amount_____________________
Time______________________________________
________
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Appendix B: Copyright Permission for LATCH Breastfeeding Assessment Tool
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Appendix C: Copyright Permission for the Neurologic and Adaptive Capacity Score
[NACS]
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Appendix D: Brazelton Institute Certification
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Appendix E: Protocol Approval, IRB Approval, and IRB Authorization Agreement
Protocol Approval
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Yale University Human Investigation Committee Applications
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Yale University
Human Investigation Committee
Request for Approval of Amendment to Add or Remove
Co-Investigator(s) and Study Personnel
100 FR 11 (2014-1)
Instructions: This form should be used only to submit to the HIC requests to add or remove coinvestigators or other study personnel* from active protocols. The updated HIC application and
any other study documents incorporating requested changes should be submitted as usual to the
HIC at time of reapproval unless the personnel are individually named on the consent form (e.g.,
consenting personnel; medical back-up; etc.) If so, the updated consent form must be submitted
with this request.
* A separate form is available and must be used for a change in principal investigator.
HIC Protocol Number:_1407014373_
Date: 3/28/15
Title of Research Project:_ :Effect of Labor Epidural Analgesia With Hydromorphone on
Neonatal Neurobehavior and Breastfeeding Behavior in the First 24 Hours of Life
Name of Principal Investigator:_Keun Sam Chung MD
PI Signature:____________________________________________________________
PI Campus Address: Yale University School of Medicine, 333 Cedar Street, TMP 3, P.O. Box 208051,
New Haven, CT, 06520-8051
Email: keun.chung@yale.edu

Phone Number: 203-737-1818

Correspondent Name: Cynthia French

E-mail: cyntfre@aol.com

Yale Cancer Center CTO Correspondent (If
applicable) Name:

E-mail:

Please complete a new line for each addition or removal of study personnel (to extend the grid, press
TAB from the last cell in the last row of the grid, and a new row will automatically be created):









Name – Enter the full name and degree of the person to be added to or removed from the study.
Add or Remove – Enter ‘Add’ or ‘Remove’ as appropriate for each person being added or
removed from the protocol.
Role of Personnel – Please identify the study role of the added or removed personnel: CoInvestigator, Study Personnel, Correspondent or Consultant (see definitions in the HIC
Application Instructions, p. 10, at http://www.yale.edu/hrpp/forms-templates/biomedical.html)
HSPT Training – Has this person completed required Human Subjects Protection Training? If
not completed through Yale University, please submit copies of any certificate of completion.
HIPAA Training – Has this person completed the required HIPAA Training? If not completed
through Yale University, please submit copies of any certificate of completion.
Yale Affiliation – Please identify whether this person is a faculty member, an employee, trainee
or student of Yale University. If Yale-affiliated, please identify their position with Yale. If nonYale-affiliated, please identify the organization with which they are affiliated.
NetID – Please indicate the Yale researcher’s NetID. This will provide accurate information for
training completion information.

308

In Investigator Interests:
Do any new research personnel who are responsible for the design, conduct or reporting of this
project, or any of their family members (spouse or dependent child) have an incentive or interest,
financial or otherwise, that may affect the protection of the human subjects involved in this
project, the scientific objectivity of the research or its integrity? Note: The Principal Investigator
(Project Director), upon consideration of the individual’s role and degree of independence in
carrying out the work, will determine who is responsible for the design, conduct, or reporting of
the research.
See Disclosures and Management of Personal Interests in Human Research
http://www.yale.edu/hrpp/policies/index.html#COI
 Yes
X No
Does a newly added member on the research team who is determined by you to be responsible
for the design, conduct or reporting of this research have any patent (sole right to make, use or
sell an invention) or copyright (exclusive rights to an original work) interests related to this
research protocol?
 Yes
X No
If yes to either question above, list names of the investigator or responsible person:

The Yale University Principal Investigator, all Yale University co-investigators, and all Yale
University individuals who are responsible for the design, conduct or reporting of research must
have a current financial disclosure form on file with the University’s Conflict of Interest Office.
Yale New Haven Hospital personnel who are listed as con-investigators on a protocol with a
Yale University Principal Investigator must also have a current financial disclosure form on file
with the University’s Conflict of Interest Office. If this has not been done, the individual(s)
should follow this link to the COI Office Website to complete the form:
http://www.yale.edu/coi/
NOTE: The requirement for maintaining a current disclosure form on file with the University’s
Conflict of Interest Office extends primarily to Yale University and Yale-New Haven Hospital
personnel. Whether or not they are required to maintain a disclosure form with the
University’s Conflict of Interest Office, all investigators and individuals deemed otherwise
responsible by the PI who are listed on the protocol are required to disclose to the PI any
interests that are specific to this protocol.
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Name

Add or Ability to
Remov consent
e
(check box
if Yes)

Katrina Pinkerton- Add
Lloyd

CoHSPT &
Yale
Investigator,
HIPAA
Affiliation/nonStudy
Training
Yale Affiliation
Personnel,
?
(identify
Correspondent
Y/N/
institution)
or Consultant?
N/A
Co-Investigator
Yale University
Yes
Student

Does this amendment add any new study locations?  Yes
If yes, list location:

X No

NetID

Kp389
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Yale University
Human Investigation Committee
Request for Approval of Amendment to Add or Remove
Co-Investigator(s) and Study Personnel
100 FR 11 (2014-1)
Instructions: This form should be used only to submit to the HIC requests to add or remove coinvestigators or other study personnel* from active protocols. The updated HIC application and
any other study documents incorporating requested changes should be submitted as usual to the
HIC at time of reapproval unless the personnel are individually named on the consent form (e.g.,
consenting personnel; medical back-up; etc.) If so, the updated consent form must be submitted
with this request.
* A separate form is available and must be used for a change in principal investigator.
HIC Protocol Number:___1407014373____________________
Date: Jan 27,
2015
Title of Research Project:__ Title of Research Project: Old Title Maternal and Neonatal
Hydromorphone and Bupivacaine Concentrations After Epidural Analgesia During Labor and its
Effect on Neonatal Neurobehavior and Breastfeeding
New Title: Effect of Labor Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and
Breastfeeding Behavior in the First 24 Hours of Life

______________________________________________________________
Name of Principal Investigator:_Denis Snegovskikh MD
PI Signature:____________________________________________________________
PI Campus Address: Yale University School of Medicine 333 Cedar St, TMP 3, P.O. Box 208051, New
Haven, Ct 06520-8051
Email: denis.snegovskikh@yale.edu

Phone Number: 203-737-1818

Correspondent Name: Cynthia French CRNA

E-mail: cyntfre@aol.com

Yale Cancer Center CTO Correspondent (If
applicable) Name:

E-mail:

Please complete a new line for each addition or removal of study personnel (to extend the grid, press
TAB from the last cell in the last row of the grid, and a new row will automatically be created):







Name – Enter the full name and degree of the person to be added to or removed from the study.
Add or Remove – Enter ‘Add’ or ‘Remove’ as appropriate for each person being added or
removed from the protocol.
Role of Personnel – Please identify the study role of the added or removed personnel: CoInvestigator, Study Personnel, Correspondent or Consultant (see definitions in the HIC
Application Instructions, p. 10, at http://www.yale.edu/hrpp/forms-templates/biomedical.html)
HSPT Training – Has this person completed required Human Subjects Protection Training? If
not completed through Yale University, please submit copies of any certificate of completion.
HIPAA Training – Has this person completed the required HIPAA Training? If not completed
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through Yale University, please submit copies of any certificate of completion.
Yale Affiliation – Please identify whether this person is a faculty member, an employee, trainee
or student of Yale University. If Yale-affiliated, please identify their position with Yale. If nonYale-affiliated, please identify the organization with which they are affiliated.
NetID – Please indicate the Yale researcher’s NetID. This will provide accurate information for
training completion information.

In Investigator Interests:
Do any new research personnel who are responsible for the design, conduct or reporting of this
project, or any of their family members (spouse or dependent child) have an incentive or interest,
financial or otherwise, that may affect the protection of the human subjects involved in this
project, the scientific objectivity of the research or its integrity? Note: The Principal Investigator
(Project Director), upon consideration of the individual’s role and degree of independence in
carrying out the work, will determine who is responsible for the design, conduct, or reporting of
the research.
See Disclosures and Management of Personal Interests in Human Research
http://www.yale.edu/hrpp/policies/index.html#COI
 Yes
X No
Does a newly added member on the research team who is determined by you to be responsible
for the design, conduct or reporting of this research have any patent (sole right to make, use or
sell an invention) or copyright (exclusive rights to an original work) interests related to this
research protocol?
 Yes
X No
If yes to either question above, list names of the investigator or responsible person:

The Yale University Principal Investigator, all Yale University co-investigators, and all Yale
University individuals who are responsible for the design, conduct or reporting of research must
have a current financial disclosure form on file with the University’s Conflict of Interest Office.
Yale New Haven Hospital personnel who are listed as con-investigators on a protocol with a
Yale University Principal Investigator must also have a current financial disclosure form on file
with the University’s Conflict of Interest Office. If this has not been done, the individual(s)
should follow this link to the COI Office Website to complete the form:
http://www.yale.edu/coi/
NOTE: The requirement for maintaining a current disclosure form on file with the University’s
Conflict of Interest Office extends primarily to Yale University and Yale-New Haven Hospital
personnel. Whether or not they are required to maintain a disclosure form with the
University’s Conflict of Interest Office, all investigators and individuals deemed otherwise
responsible by the PI who are listed on the protocol are required to disclose to the PI any
interests that are specific to this protocol.
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Add or
Remove
Name

Zachary
Walton MD

Add

Ability to Co-Investigator, HSPT &
Yale
consent
Study
HIPAA
Affiliation/non(check box
Personnel,
Training? Yale Affiliation
if Yes)
Correspondent
Y/N/
(identify
or Consultant?
N/A
institution)
Co-Investigator
Yale
Y
Anesthesiology
Fellow

Does this amendment add any new study locations?  Yes
If yes, list location:

X No

NetID

Zdw4
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Yale University and University of Connecticut IRB Authorization Agreement
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Appendix F: Study Information for Physicians, Midwives, etc.
Effect of Labor Epidural Analgesia with Hydromorphone on Breastfeeding and Neonatal
Neurobehavioral Outcomes in the First 24 Hours of Life

Given the benefits of breastfeeding and widespread recommendations for its promotion, it is
important to identify factors that impact early breastfeeding success. Epidural analgesia is the
most effective method of pain relief currently available for women during labor, and the majority
of infants born in the United States are exposed to maternal analgesia, however, effects of
specific types of epidural analgesia on breastfeeding and neonatal neurobehavioral outcomes are
still unknown. The use of hydromorphone as the narcotic in the epidural infusion appears to
represent a promising alternative to fentanyl and may deliver acceptable analgesia without the
unintended side effects seen with traditional opioid infusions. If so, neonates whose mothers
receive labor epidural analgesia with hydromorphone and those whose mothers do not receive
labor analgesia may show similar breastfeeding and neurobehavioral outcomes, however, results
of previous research are inconclusive and further studies are needed.
The primary purpose of this study is to assess breastfeeding and neonatal neurobehavior in
neonates whose mothers have received a continuous epidural infusion of bupivacaine (local
anesthetic) and hydromorphone (narcotic) for labor pain in comparison with neonates whose
mothers have not received epidural analgesia. A secondary purpose of the study is to determine
whether there is a relationship between the duration of continuous epidural infusion and
breastfeeding or neurobehavioral outcomes.
A prospective observational cohort study will be conducted at Yale New Haven Hospital.
Eligible subjects will be mothers who intend to breastfeed and who will self-select to undergo
labor with epidural analgesia containing hydromorphone as the narcotic or labor without pain
medication. A total of 102 mother-infant dyads will be recruited, with 51 dyads in each group.
Infant breastfeeding behaviors will be measured using the LATCH breastfeeding assessment
tool, and neurobehavioral responses (central nervous system function) will be measured with the
Neurologic and Adaptive and Capacity Scoring System (NACS). Assessments will take place at
approximately 3, 12, and 24 hours of postnatal age.
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Appendix G: Information Flyer for Nurses, Midwives, and Residents

Hi, my name is Cynthia French MS CRNA, I'm a nurse anesthetist at Yale New Haven Hospital
and a PhD candidate at University of Connecticut. My dissertation is titled 'Effect of Labor
Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and Breastfeeding
Behavior in the First 24 Hours of Life 'and has been approved by the Human Investigation
Committee at Yale University and we will begin data collection soon.
Purpose: The primary purpose of this study is to assess breastfeeding and neonatal
neurobehavior in 51 neonates whose mothers have received a continuous epidural infusion of
bupivacaine (local anesthetic) and hydromorphone (narcotic) for labor pain in comparison with
51 neonates whose mothers have not received epidural analgesia.
Participants: Healthy multips with previous breastfeeding and a desire to breastfeed again.
Healthy babies with no complications of pregnancy. Infant breastfeeding behaviors will be
measured using the LATCH breastfeeding assessment tool, and neurobehavioral responses
(central nervous system function) will be measured with the Neurologic and Adaptive and
Capacity Scoring System (NACS). Assessments will take place at approximately 3, 12, and 24
hours of postnatal age.
Recruitment on Labor and Birth: Rachel Rachler CRNA, Angelique Garay CRNA and Zach
Walton MD will recruit and consent the patients.
Nurses, midwives and residents can alert a study team member of a possible candidate for the
study based on the inclusion criteria.
Call: Rachel and Angelique 688-2676; Zach Walton MD Anesthesia Workroom
Your support is appreciated so much, thank-you!
If you have any questions or want to discuss this further please contact Cynthia French MS
CRNA 307-699-2410
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Appendix H: Text for Nurses and Midwives for Speaking With Prospective Subjects
For the Labor and Delivery Nurses
Cynthia French is a nurse anesthetist at Yale and PhD candidate at UConn. Her study is looking
at labor epidural analgesia and its effect on breastfeeding initiation in the first 24 hours. The
study will compare babies born to mothers who had no medication for pain during labor and
mothers who had epidural analgesia for labor pain. Would you like to talk with a co-investigator
about the study? They could explain it to you and you can decide if you want to participate.

318
Appendix I: Oral Information for Prospective Participants
Text to be used when obtaining informed consent:
My name is ________________________ and I'm a ________________________(CRNA,
Resident, Fellow) at Yale. One of the nurse anesthetists at Yale is a PhD candidate at UConn and
she is doing a study to find out if medication used in epidurals for labor has an effect on babies
ability to initiate breastfeeding in the first few hours after birth. We are asking you if you would
participate in this study that will compare babies born to mothers with no pain medication during
labor and babies born to mothers who used epidural medication for pain relief during labor.
Your participation is entirely voluntary and you can withdraw at any time without the care you
are receiving being affected.
If you agree to participate Cynthia French or a nurse will observe a breastfeeding session at
approximately 4, 12 and 24 hours depending on when the baby feeds. The nurses on the
postpartum unit observe breastfeeding as part of the normal care you receive. We will
coordinate with the postpartum nurse to observe breastfeeding at the same time, so there will be
as few interruptions as possible during this very special time for your family.
After the breastfeeding assessments are done, information about your labor and delivery such as
types of medication used, babies Apgar scores, and weight will be reviewed and deidentified,
meaning your name is not linked with the information.
Again your participation is entirely voluntary and you can withdraw at any time without the care
you are receiving being affected.
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Appendix J: Written Informed Consent Form
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Appendix K: Neurologic and Adaptive Capacity Score (NACS)

Reproduced with permission of the copyright owner (John Wiley & Sons).
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Appendix L: LATCH Feeding Record
Effect of Labor Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and
Breastfeeding Behavior in the First 24 Hours of Life
Participant Study Id Number _______________
Date/Time:__________________
Age in hours and minutes_________________

Delivery

LATCH FEEDING RECORD
Method : BR= Breast F= Formula/ml EBM=Expressed breast milk
Other Feeding Method: Specify
Date

Time

Feeding Method

L

A

T

C

H

Tota
l

Comments/Neonate
BS
Amt BR/F in ml

15 minutes observation sessions
0

1

Latch

To sleepy or reluctant
No latch achieved

Repeated attempts
Hold nipple to mouth
Stimulate to suck

Audible
Swallow

None

A few with stimulation

Type of Nipple

Inverted

Comfort of
Breast

Engorged
Cracked bleeding large
blisters or bruising
Severe discomfort

Hold

Full assist

Flat
Filing
Reddened small blisters
or bruising
Mild/moderate
discomfort
Minimal assist
Teach one side mother
does other
Staff holds mother takes
over

2
Grasp breast
Tongue down
Lips flanged
Rythmical sucking
Spontaneous and
intermittent<24 hrs
Spontaneous and
freq˃24 hrs
Everted after stimulation
Soft
Tender

No assist from staff
Mother able to position
and hold baby

Reproduced with permission of the copyright owner (Wolters Kluwer Health).

